John D. Puskas, MD, MSc, FACS, FACCCURRICULUM VITAE
Revised October, 2022

NAME:

John D. Puskas, MD, MSc, FACS, FACC

CURRENT TITLES AND AFFILIATIONS:
Academic Appointments:
4/2014 - Present

Professor of Cardiovascular Surgery
Icahn School of Medicine at Mount Sinai
New York, NY
Chairman, Department of Cardiovascular Surgery
Mount Sinai Morningside (formerly Saint Luke’s), Mount Sinai Beth Israel andMount Sinai West (formerly Roosevelt) Hospitals
New York, NY

Clinical Appointments:
4/2014 - Present
Staff Surgeon, Mount Sinai Hospital and Mount Sinai Morningside Hospital
4/2014 - Present
Director, Coronary Revascularization Reference Center, Mount Sinai Health System
8/2014 - Present
Founder/Director, Cardiovascular Clinical Research Unit, Mount Sinai Morningside
Hospital
Previous Appointments:
1996 - 2005
Staff Surgeon, Emory University Hospitals
2005 - 2014
Chief of Cardiothoracic Surgery, Emory University Hospital Midtown (formerly Emory
Crawford Long Hospital), Professor of Cardiothoracic Surgery, Emory University
2005 - 2014
Associate Chief, Division of Cardiothoracic Surgery, Dept. of Surgery, Emory University
2005 - 2014
Founder and Medical Director, Physician Assistant Residency Program, Emory University
2005 - 2014
Founder and Director, Clinical Research Unit, Cardiothoracic Surgery, Emory University
2005 - 2014
Director, Emory Center for the Surgical Treatment of Atrial Fibrillation2005 - 2010
Director, Cardiothoracic Surgical Intensive Care Unit, Emory Hospital Midtown
2010 - 2014
Associate Director, Cardiothoracic Intensive Care Unit, Emory Hospital Midtown
2008 - 2014
Director, Non-Board Track Fellowship in Adult Cardiac Surgery, Emory Hospitals
2010 - 2014
Quality Officer, Division of Cardiothoracic Surgery, Emory University Hospitals

John D. Puskas, MD, MSc, FACS, FACC

Page 2 of 60

LICENSURES/BOARDS:
Massachusetts:
Georgia Medical Board:
New York State:
New Jersey State:
Specialty Boards:
1994 - Recert. 20162017 - Recert. 2027
EDUCATION:
1978 - 1982
1982 - 1986
1989 - 1991

#1057916 (exp. 1993)#038072 (exp. 2015)#274324 (2014-present)#25MA10738200 (2019-present)

American Board of Surgery
American Board of Thoracic Surgery
A.B., Summa Cum Laude in Biology, Princeton University
MD, Harvard Medical School
Master of Science in Surgical Science (MSc), University of Toronto

POSTGRADUATE TRAINING:
1986 - 1993
General Surgery Internship and Residency, Department of Surgery, Massachusetts
General Hospital, Harvard Medical School, Director Gerald Austen, MD
1989 - 1991
Lung Transplantation Research Fellowship, Division of Thoracic Surgery, Toronto
General Hospital, Director G. Alexander Patterson, MD
1993
Advanced Fellowship in Tracheal Surgery (six months), Massachusetts General
Hospital, Division of General Thoracic Surgery, Director Hermes C. Grillo, MD
1993 - 1996
Emory University Residency and Fellowship in Cardiothoracic Surgery, Director
Robert A. Guyton, MD
COMMITTEE MEMBERSHIPS AND EXTRAMURAL LEADERSHIP ROLES:
National and International:
1999 - 2002
Committee on New Technologies, Society of Thoracic Surgeons2001 - 2003
Program Committee, International Society for Minimally Invasive Cardiac Surgery
2003 - 2005
Program Committee, The Society of Thoracic Surgeons2009 - 2010
Program Committee, Reviewer, The Society of Thoracic Surgeons
2003 - 2008
Founder and Chair, Publications Committee, International Society for Minimally
Invasive Cardiac Surgery; (founded INNOVATIONS, the journal of ISMICS)
2003 - 2010
Board of Directors, International Society for Minimally Invasive Cardiac Surgery
2004 - Present
Society of Thoracic Surgeons Workforce on Adult Cardiac Surgery
2004 - 2005
Education Committee, American Association for Thoracic Surgery
2004 - 2005
Chair, Program Committee, International Society for Minimally Invasive Cardiac
Surgery
2004
Chair, Consensus Conference, International Society for Minimally Invasive
Cardiac Surgery
2004
In-Training Examination Committee, American Board of Thoracic Surgery
2004 - 2007
Education Committee, Thoracic Surgery Foundation for Research and Education
2004
Member, Working Group on Future Directions in Cardiac Surgery, National
Institutes of Health2004 - 2006
Tech-Con Program Committee, American Association for Thoracic
Surgery/Society of Thoracic Surgeons

John D. Puskas, MD, MSc, FACS, FACC

Page 3 of 60

2006 - 2007
2006 - 2007
2007 - 20082007 - 20122007 - 20112008 - 20092009 - 20172009 - 201220102010 – 20142010 - 20122012 - 20142011 - 20122014
2014 - 2015
2015 - Present

June 27, 20162017 – 2018
2021

Institutional:
1999 – 2003
2002 – 20142002
2003 - 2004
2004 - 2014
2004
2005
2005
2005 - 20142007 - 2014

Chair, Tech-Con Program Committee, AATS/STS
Vice President, International Society for Minimally Invasive Cardiac Surgery
President-Elect, International Society for Minimally Invasive Cardiac Surgery
Chair, Budget Committee, NHLBI Cardiothoracic Surgical Trials Network
Member, Governing Council, American Association for Thoracic Surgery
President, International Society for Minimally Invasive Cardiothoracic
Surgery
Chair, International Relations Task Force, The Society of Thoracic SurgeonsBoard Member, Thoracic Surgery Foundation for Research and Education
Fundraising Committee, Thoracic Surgery Foundation for Research and Education
Chair, Satellite Selection Committee, NHLBI Cardiothoracic Surgical Network
Chair, Dual Antiplatelet Trial Protocol Development Committee, Cardiothoracic
Surgical Network, NHLB/VA Cooperative Study Program
STS Task Force on Grant Development and Funding
Chair, STS Cardiothoracic Surgery/Industry Alliance Committee
Chair, Consensus Conference on Off-Pump CABG, International Society for
Minimally Invasive Cardiac Surgery
Program Committee, American Association for Thoracic Surgery
Founder/co-Director, International Coronary Congress (ICC). The annual ICC
meeting has developed a global impact, consistently attracted delegates from morethan 40 different countries, with world authorities addressing every aspect of stateof-the-art surgical coronary revascularization. This meeting has been held in New
York 2015, 2017, 2019 and 2021; and in New Delhi 2016 (>2000 attendees),
Beijing 2018 (>5000 attendees) and will be held in Tokyo in December, 2022.
(www.internationalcoronarycongress.org)
NIH Study Section member, NHLBI Clinical Trial Pilot Studies (R34) meeting
2016/10 ZHL1 CSR-G (02)Program Chairman, American Association for Thoracic Surgery, annual
meeting. April 28-May 1, 2018.
Founder/President, International Society for Coronary Artery Surgery(ISCAS) The mission of ISCAS is to advance the state of the art in surgicalcoronary revascularization and to improve the care of patients with coronary arterydisease worldwide. ISCAS is the parent organization of the ICC.
(www.iscascoronary.org)
U.S. Surgical Endo-surgery Executive Committee, Emory Dept. of Surgery
Cardiothoracic OR Committee, Emory University Midtown Hospital
Emory Healthcare Reorganization Committee, chaired by John Fox, CEO
Emory University Conflict of Interest Committee
Emory University Hospital Midtown (formerly Crawford Long Hospital) Medical
Advisory Committee, Chaired by John Fox, CEO, Emory Healthcare
Inaugural Woodruff Leadership Academy, Chaired by Michael Johns CEO of
Woodruff Health Sciences Center
Emory Heart Center Steering Committee, Member, chaired by Douglas Morris
Emory Heart Center Steering Committee, Subcommittee on Practice Models,
Member, Chaired by David Vega and Angel Leon
Carlyle Fraser Heart Center, Board Member
Emory Heart & Vascular Center, Member, Board of Directors

John D. Puskas, MD, MSc, FACS, FACC

Page 4 of 60

CONSULTANTSHIPS:
1996 - 1998
1999 - 2010
2000 - 2006
2002 - 2003
2003
2003 - 2007
2006 - 20102017 – Present

U.S. Surgical, Surgeon Advisory Board
Medtronic (OPCAB proctor/consultant)
Quest Medical
St Jude Medical
Novare Surgical
Medtronic (Development of Controlled Intermittent Asystole)
Guidant: Boston Scientific Maquet Cardiac Surgery Strategy Board
Medtronic (OPCAB training)

MANUSCRIPT REVIEWER/EDITORIAL CONTRIBUTIONS:
2000 - Present
Annuals Thoracic Surgery
2000 - Present
Journal of Thoracic and Cardiovascular Surgery
2000 - Present
Heart Surgery Forum2000 - Present
The Lancet
2005 - Present
The Journal of Cardiac Surgery
2005 - Present
Circulation2005 - Present
Innovations
2014 - Present
Journal of the American College of Cardiology
2017 - Present
Journal of the European Association for Cardiothoracic Surgery
HONORS AND AWARDS:
1982
1982
1989 - 1991
2003
2004
2004
2007
2011
2012

Senior Thesis Book Prize, Department of Biology, Princeton University
Sigma Xi Honor Society, Princeton Chapter
E. D. Churchill Fellowship, Department of Surgery Massachusetts General
Hospital
Educational Award, Society of Thoracic Surgeons, to attend the Harvard School of
Public Health/J.F. Kennedy School of Government, Executive Course in "Skills
For The New World Of Health Care"
Woodruff Leadership Academy, Emory University
Award for Best Oral Presentation, International Society for Minimally Invasive
Cardiothoracic Surgery, Annual Meeting
J. Maxwell Chamberlain Memorial Award (best paper in adult cardiac surgery)Society of Thoracic Surgeons Annual Meeting
Honorary Membership, Society for Cardiothoracic Surgery in Great Britain and
Ireland
2nd Place Award, Senior Biomedical Design Competition, Georgia Tech
University (Biomedical Engineering clinical mentor)

SOCIETY MEMBERSHIPS:
1992 - Present
MGH Surgical Alumni Society
1998 - Present
International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS)
1999 - Present
Society of Thoracic Surgeons1999 - Present
American College of Surgeons
2000 - Present
American Association for Thoracic Surgery
2004 - Present
American College of Chest Physicians
2004 - Present
Society of University Surgeons

John D. Puskas, MD, MSc, FACS, FACC

Page 5 of 60

2010 - Present2010 - Present
2011 - Present

American College of Cardiology
Cardiac Surgical Biology Club of the American Association of Thoracic Surgery
MemberSociety for Cardiothoracic Surgery in Great Britain and Ireland (Honorary
Member)PATENTS:
Issued:1. U.S. Patent No. 6,042,538 "Device for Endoscopic Vessel Harvesting"
2. U.S. Patent No. 6,479,523 "Pharmacologic Drug Combination in Vagal-Induced Asystole", licensed toMedtronic.
3. U.S. Patent No. 6,429,217 Pharmacological Drug Combination in Vagal-Induced Asystole", licensed toMedtronic.
4. U.S. Patent No. 6,778,854 "Methods of Indirectly Stimulating the Vagus nerve with an Electrical Field",
licensed to Medtronic.
5. U.S. Patent No. 6,656,960 "Methods of Performing Vagal-Induced Asystole", licensed to Medtronic.
6. U.S. Patent No. 7,072,720 "Devices and Methods for Vagus Nerve Stimulation", licensed to Medtronic.
7. U.S. Patent No.7,142,910 "Methods of Indirectly Stimulating the Vagus Nerve with an Electrical Field",
licensed to Medtronic.
8. U.S. Patent No. 7,310,552 "Apparatus for Indirectly Stimulating the Vagus Nerve with an Electrical Field."
9. U. S. Patent No. 7,340,299 "Methods of Indirectly Stimulating the Vagus Nerve to Achieve Controlled
Asystole."
10. U.S. Patent No. 7,840,278 "Devices and Methods for Vagus Nerve Stimulation."
11. European Patent No. EP1005337 "Pharmacologic Drug Combination in Vagal Induced Asystole"
12. Australian Patent No. 63371/00 "Devices and Methods for Vagus Nerve Stimulation"
13. U.S. Patent No 12/134,842 "Dual Closing Guide for a Surgical Instrument", licensed to Scanlan
International, Inc., manufactured and sold world-wide.
14. U.S. Copyright number TXu001773493/2011-08-28, “The Price Tag Manifesto”.
15. U.S. Patent No 14/030,606 “Novel Sternal Retractor”, licensed to Scanlan International, Inc.
CLINICAL SERVICE AND LEADERSHIP OF QUALITY IMPROVEMENT: Average of approximately
300 major cardiac surgical cases annually as primary surgeon since 1996, with consistently division-leading low
observed/expected mortality ratios and LOS. Specializing in all-arterial no-aortic-touch OPCAB, robotic CABG
and complex referral cases of all types. Active teaching service for CTS advanced fellows, chief residents,
residents and medical students. As the first Quality Officer appointed in the Emory Division of Cardiothoracic
Surgery, convened multidisciplinary teams to systematically create a culture of safety and continuous quality
improvement, leading these teams through near-weekly meetings from 2011-2014. During this time, the Emory
Division of CTS improved its national STS “Star” quality rating from 1-star (lowest 10%) in 2010 to 3-star(highest 10%) in 2014. Similarly, at Mount Sinai Morningside (formerly Saint Luke’s) almost tripled theclinical volume since January 2017 and maintained excellent quality outcomes through team building andrelentless focus on Service and Safety, leading to the coveted STS 3-year, 3-star rating in 2021. Moreover,in 2020, Mount Sinai Morningside was independently ranked for the first time in the top 50 hospitals
nationwide for cardiology and cardiac surgery by US News and World Report (48th); in 2021 that ranking
had improved further to 41st nationally.
PATIENT SATISFACTION SCORES AND COLLEAGUE RATINGS :Personal patient satisfaction scores (online, September, 2022): CG-CAHPS score 5/5 stars (114 responses)“likelihood to recommend provider”; health.usnews.com 5/5 stars (55 reviews); zocdoc 5/5 stars (31 reviews);
healthgrades 5/5 stars (reviews).
America’s Top Doctors Award, Castle Connolly 10 consecutive years, 2011-2021. (www.castleconnolly.com).

John D. Puskas, MD, MSc, FACS, FACC

Page 6 of 60

Wikipedia page: https://en.wikipedia.org/wiki/John_Puskas
PHILANTHROPIC DEVELOPMENT: Personally cultivated and facilitated philanthropic donations frommultiple grateful patients to the Emory University Division of Cardiothoracic Surgery Clinical Research Unit,
totaling approximately $1,050,000.00 through 2013. These funds were vital to establish the financial stability of theEmory CRU and power its growth. At Mount Sinai, cultivated multiple grateful patients and raised funds to build a
new multimedia conference room within our Heart Team offices and to support two Advanced Coronary Surgery
Fellowship salaries 2019-2020 and 2021-2022.
RESEARCH FOCUS: Since founding the Emory University Cardiothoracic Clinical Research Unit (Emory CRU)
in 2005, Dr. Puskas is or has been the national/international PI for five (5) multi-center FDA Investigational
Drug/Device Exemption trials in cardiac surgery/cardiology. Under his Direction, the Emory CRU grew from one
to 17 FTEs, building an infrastructure for the Emory Division of Cardiothoracic Surgery to conduct rigorous clinical
trials to inform evidence-based practice. The database portion of this infrastructure also informs the Quality
Improvement initiatives within the Division. Dr. Puskas wrote the UO-1 grant application that made Emory
University a founding Core Clinical Site within the NHLBI Cardiothoracic Surgical Trials Network in 2007. Healso served as Mentor for Michael Halkos, MD, in his K23 NIH Mentored Career Development Award application,
which was funded in 2012. Since being recruited to the Mount Sinai Health System, Dr. Puskas has founded andco-directs the Cardiovascular Clinical Research Unit at Mount Sinai Beth Israel and Mount Sinai Saint Luke’s, tocreate a multidisciplinary collaborative clinical research infrastructure to allow busy clinical Cardiologists andCardiovascular Surgeons to enroll patients in multiple trials and be academically productive. He wrote, revised andresubmitted a RO-1 grant application to lead a network of 47 clinical sites nationwide to conduct the first RCT of
Hybrid Coronary Revascularization. This grant was funded in July, 2016 (#RO1 HL125488-01A1) and has closed
enrollment, pending follow-up and publication (NCT03089398).
FDA IDE National Principal Investigator (NPI) Roles:
1. COMMENCE, FDA IDE trial NCT01757665 sponsored by Edwards Lifesciences, Irvine CA (2012-2020)(next generation preservation technology for bovine pericardial tissue used in heart valves; 10-yr FU ongoing)
2. PROACT, FDA IDE trial NCT00291525 sponsored by On-X Life Technologies, Austin TX, (2006-2018)(lower anticoagulation regimen for the On-X mechanical heart valve; approved with new FDA IFU)
3. International PI: REQUEST International Registry NCT02385344 sponsored by Medistim, ASA, Sweden(2015-2017) (intraoperative assessment of bypass graft quality by transit-time Doppler; post-market study)
4. eMesh Trial, FDA IDE trial NCT01676376 sponsored by Kips Bay Medical, Minneapolis MN (2012-2015)(external nitinol mesh support for saphenous vein grafts; trial terminated; device not approved)
5. EPIC, FDA IDE trial NCT00355563 sponsored by Cardica Inc., Palo Alto CA (2006-2008) (clampless aortic
anastomotic connector device; approved and marketed)
6. US Surgeon Leader: EXCEL, FDA IDE trial NCT01205776 sponsored by Abbott Vascular, Santa Clara CA(2010-2019) (large international RCT of CABG versus PCI for patients with left main stenosis; ongoing)
7. International PI: VEST, FDA IDE trial sponsored by Vein Graft Solutions, Tel Aviv, Israel, (Q4 2016-2020)(external cobalt-chromium mesh support for saphenous vein grafts in CABG). Presented at AHA 2022.
GRANT SUPPORT ($=Direct Costs):
Federal Research Awards ($=Direct Costs):
1. National Principal Investigator (PD/PI) NHLBI #RO1HL125488-01A1/1UO1HL125488-01A1,
Investigator Initiated Multi-Site Clinical Trial Collaborative, “Hybrid Coronary Revascularization”, Clinical
Coordinating Center, CCC, $1,513,168; Data Coordinating Center (Icahn School of Medicine at Mount

John D. Puskas, MD, MSc, FACS, FACC

Page 7 of 60

Sinai), DCC, $7,346,746 (July 2016 – 2022)
2. Mentor for K23 Mentored Career Development Award to Dr. Michael Halkos, Emory Division of CT

Surgery, #K23HL105892-03, $500,000 (2011-2016)
3. Principal Investigator: NHLBI Cardiothoracic Surgical Trials Network Clinical Center Grant, Award #1

U01 HL088928-01, $1,786,250 (2007-2012)
4. National Principal Investigator: NHLBI CTSN, ARRA Award # 1-RC1HL100951, Hybrid Coronary
Revascularization Observational Study, $1,000,000 (2009-2011)
5. Site Principal Investigator: NHLBl CTSN, Award # 7-001-HL088942 Periop AF and AF Ablation$898,560 (2009-2012)
6. Site Principal Investigator: NHLBl CTSN, Award # Moderate MR, $263,578 (2008-2012)
7. Site Principal Investigator: NHLBI CTSN, Award # Severe MR, $231,123 (2008-2012)
8. Site Principal Investigator: NHLBI CTSN, Award # 7-001-HL088942, Infection Registry $70,567 (20082012)
9. Site Co-Principal Investigator: NHLBI/Mount Sinai/NERI, Award # FREEDOM, $218,194.00, (20062011)
Other:
5/2006 – 5/2012
8/17/2009 - 8/17/2011
Previous Support:
2000 - 2003
2000 - 2003

2000 - 2004
2003 - 2006

2003 - 2007
2003 - 20072005 - 2008
2006 - 2007
7/2007 - 7/2008
12/01/07 - 11/30/2009
7/25/07 - 7/25/09

International Principal Investigator, Medical Carbon ResearchInstitute, PROACT Trial, Award # On-X Valve, $195,830.00.
Principal Investigator, Genzyme, Inc., Award # RENDX00109$201,425.00.
Co-lnvestigator Medtronic Inc. MOSAIC Porcine Valve Prosthesis.
Co-Investigator Prospective Randomized Evaluation of PerfusionAssisted Direct Coronary Artery Bypass and Enhanced Perfusion-Assisted
Direct Coronary Artery Bypass Using Adenosine as Facilitating
Technology for Off Pump Coronary Artery Bypass Surgery(PADCAB/Enhanced PADCAB). Quest Medical Inc.
Principal Investigator Medtronic Surgical Management of Arterial
Revascularization Therapies (SMART) Trial $1,400,000.00
Co-Investigator Corgentech A Phase III, Multi-Center Randomized,
DoubleBlind, Placebo-Controlled Trial of the Ex Vivo Treatment with
CGT003 of Coronary Vein Grafts in Patients Undergoing Coronary Artery
Bypass Graft Procedures (Prevent IV). Award # Prevent IV
Principal Investigator St. Jude Medical, An Observational, Prospective
Evaluation of the SJM Epic Valve Award # EPIC
Co-Investigator Medical Carbon Research Institute Reduced On-X
Morbid Events (ROME) Trial, (MCRI, LLC) Award # ROME
Principal Investigator Cardiogenesis Corporation Award # TRM-05-001
Principal Investigator Cardiothoracic Systems, Inc. Award # Heartstring
Principal Investigator Cardica, lnc. Award # Cardica PassPort
Principal Investigator Maquet (formerly Boston Scientific) Award #Heartstring Transcranial Doppler Study
Principal Investigator Medtronic, Maquet (formerly Boston Scientific),
Carlyle Fraser Heart Center Award # SMART Long-Term Follow-up$600,000.00

John D. Puskas, MD, MSc, FACS, FACC

Page 8 of 60

CLINICAL SERVICE CONTRIBUTIONS:
2017 – Present
2015 – 20162014 – 2015

1996 - 2014
2005-2014
2005-2014
2005-20142011-2014

1996 - 2006
1996 - 2002

Fulltime clinical practice of adult cardiothoracic surgery at Mount Sinai
Morningside (formerly Saint Luke’s) Hospital with four (4) full OR days
each week. Average: approx. 300 major cases annually.
Fulltime clinical practice of adult cardiothoracic surgery at Mount Sinai
Beth Israel Hospital with five (5) full OR days each week. Approx. 300
major cases annually.
Fulltime clinical practice of adult cardiothoracic surgery at Mount Sinai
Hospital with two or more (2) full OR days each week and at Mount Sinai
Beth Israel Hospital with three (3) full OR days each week. Average: over
200 major cases annually.
Fulltime clinical practice of adult cardiothoracic surgery at Emory
University Hospital Midtown with three (3) full OR days each week.
Average: approx 300 major cases annually.
Associate Chief, Division of Cardiothoracic Surgery, Emory University
Department of Surgery
Chief of Cardiothoracic Surgery, Emory University Hospital Midtown
Organized and led weekly Grand Rounds and Morbidity and Mortality
Rounds, Division of Cardiothoracic Surgery, Emory University
Department of Surgery
Quality Officer, Division of Cardiothoracic Surgery, Emory University
Department of Surgery; organized multidisciplinary teams and led nearweekly meetings on two campuses to move Emory’s STS star-rating from
1-star (lowest10% nationally) (2010) to 3-star (highest 10% nationally)(2014)
Regular participation in Emory cardiothoracic transplantation callschedule and performance of heart and lung transplantation as primary
surgeon.
Cross-coverage of Emory General Thoracic Surgical service, as required.

FORMAL TEACHING:
Medical Student Teaching:
1996-2014
Clinical instruction during Emory medical student rotations
1998 - 2000
Clinical instructor in fourth year Surgical Anatomy elective
2003
Mentor, Emory School of Medicine Mentorship Program
2010 - 2012
Mentor, Senior BME Students at Georgia Tech2010 - 2012
Instructor, Rollins School of Public Health Summer School Students, Biostatistics
Graduate Program:2019 – Present2017 – Present
2014 - 2016

Founder/Director, Non-ACGME Track Fellowship in Advanced Coronary
Surgery, Mount Sinai Saint Luke’s (world’s first such program)
Chairman, Department of Cardiovascular Surgery, Mount Sinai Morningside(formerly Saint Luke’s), responsible for didactic and operative training of ACGME
and non-board tract residents and fellows in Cardiothoracic Surgery
Chairman, Department of Cardiovascular Surgery, Mount Sinai Beth Israel,
responsible for didactic and operative training of ACGME and non-board tract
fellows in Cardiothoracic Surgery rotating at Mount Sinai Beth Israel

John D. Puskas, MD, MSc, FACS, FACC

Page 9 of 60

2008 - 2014
1996 - 2014
1996 - 20142003

Founder/Director, Non-Board Track Fellowship in Adult Cardiac Surgery,
Emory Hospitals
ACGME Cardiothoracic Surgery Fellowship Training Programs: Clinical
Instruction, operative training and didactic lectures during rotations at Emory
University Hospital Midtown and Emory University Hospital
General Surgery Residency Program: Clinical instruction and operative training
during rotations at Crawford Long (Emory Midtown) Hospital and on
Transplantation Service at Emory University Hospital
Nursing Education Programs: Invited Speaker: OPCAB with Arterial Grafts:
The Future of Coronary Surgery Emory Cardiovascular Nursing Conference"Setting The Pace 2003". Emory Conference Center

Post-Graduate Extramural Training Programs:
1999-2014
Operative instruction and demonstration of off-pump CABG techniques at Emory
University Hospital Midtown for approximately 200 individual visiting surgeons
and surgical team members, sponsored by Medtronic.
2002

Operative instruction, demonstration of off-pump CABG techniques and one-onone mentoring of attending surgeons at extramural centers in Florida, Texas andPennsylvania, sponsored by The Society of Thoracic Surgeons.

2000 – 2003

Moderator and Faculty Member. Industry-sponsored educational symposia on off
pump CABG. Each symposium provided comprehensive teaching in OPCAB to
40-50 surgeons:Ø Medtronic Off-Pump 2000 -The State of Coronary Bypass
Ø Medtronic Off-Pump 2001
Ø Medtronic Off-Pump 2002
Ø Medtronic Beating Heart Summit: An Advanced Approach.

2001

Invited Faculty, Edwards Life Sciences, Cardiothoracic Chief Resident
Symposium, "State-of-the Art Off-Pump Surgery", Irvine, CA.

2003

Invited Faculty, St. Jude Medical, Cardiothoracic Chief Resident Symposium,"OPCAB with Arterial Conduits Is The Future", Minneapolis, MN

2003

Teaching Presentations at Emory University Hospital Midtown Cardiothoracic
Surgery/Cardiology joint rounds approximately every third month.

2003

Lecture. "OPCAB: State of the Art", given to Carlyle Fraser laboratory fellows
and visiting students from St. Olaf’s College.

2003

Directed and Moderated an industry-sponsored symposium on off-pump CABG
at Emory University Hospital Midtown for 40 surgeons, anesthesiologists, PAs
and RNs, including live tele-surgery, interactive education, panel discussions,lectures from Emory surgical, anesthesia, nursing and PA staff. Off-Pump
CABG: A Team Approach.

John D. Puskas, MD, MSc, FACS, FACC

Page 10 of 60

INVITED LECTURES AT NATIONAL OR INTERNATIONAL CONFERENCES:
1.

University of South Florida, Tampa, Florida. "Minimally Invasive Total Myocardial
Revascularization". Invited Speaker 1998, 1999, 2000.

2.

Minimally Invasive and Laparoscopic Surgery Into The 21st Century. Brisbane, Australia. Invited
Faculty 1998.

3.

Latest Techniques in Minimally Invasive Cardiac Surgery. Brussels, Belgium. Invited Faculty 1998.

4.

A Cardiac Surgery Roundtable, "Coronary Artery Bypass Off-Pump Surgical Techniques andClinical Issues". Scottsdale, Arizona. Invited Speaker 1999.

5.

Latest Techniques In Minimally Invasive Cardiac Surgery. Glasgow, Scotland. Invited Faculty 1999.

6.

Cardiothoracic Techniques and Technologies: "Current Trends in Thoracic Surgery VI". Bal Harbor,
Florida. Invited Faculty 2000.

7.

American College of Cardiology. Anaheim, California. Invited Faculty 2000.

8.

American Association for Thoracic Surgery. "Controversies in Off-Pump Coronary Artery Bypass".
Toronto, Canada. Invited Faculty 2000.

9.

American College of Surgeons, Plenary Session. Chicago, Illinois. Invited Faculty 2000.

10.

Cardiopulmonary Bypass In The 90's. Atlanta, Georgia. Invited Faculty 1996-2001.

11.

Fifth Annual New Era Cardiac Care: Innovation & Technology. Dana Point, California. Invited
Faculty 2002.

12.

American Society of Echocardiography, "Intra Operative Echo for OPCAB". Orlando, Florida.
Invited Speaker 2002.

13.

South Atlantic Cardiovascular Society. Williamsburg, Virginia. Faculty and Invited Speaker 2002.

14.

Utrecht Workshop in Minimally Invasive Cardiac Surgery. Monaco. Invited Faculty, Moderator andSpeaker 2002.

15.

American Heart Association. Chicago, Illinois. Invited Faculty 2002.

16.

7th Annual Advanced Coronary and Peripheral Interventional Symposium: A Case Review Workshop.
Vail, Colorado. Invited Faculty 2002.

17.

Society of Cardiac Surgeons. Montreal, Canada. Invited Faculty 2003.

18.

Medtronic Symposium: Advanced Techniques and Technologies in Cardiac Surgery. Atlanta,
Georgia. Invited Faculty 2003.

19.

American Heart Association. Orlando, Florida. Invited Faculty 2003.

John D. Puskas, MD, MSc, FACS, FACC

Page 11 of 60

20.

Northern Exposure OPCAB Symposium. Toronto, Canada. Invited Speaker 2003.

21.

The Society of Thoracic Surgeons, Plenary Session. San Antonio, Texas. Invited Discussant 2004.

22.

The Society of Thoracic Surgeons. "OPCAB: How I Do It". San Antonio. Texas. Invited Speaker
2004.

23.

The Society of Thoracic Surgeons. "Tips and Techniques for Multivessel OPCAB". San Antonio,
Texas. Invited Speaker 2004.

24.

American Association for Thoracic Surgery, Post Graduate Course, Toronto, Ontario Canada. Invited
Speaker 2004.

25.

International Society for Minimally Invasive Cardiothoracic Surgery. Bangkok, Thailand. Invited
Speaker 2004.

26.

5th Annual Meeting of the Japanese Association for Thoracic Surgery. Sapporo Japan. Invited Speaker
2004.

27.

University of Ottawa Heart Institute Grand Rounds. Ottawa, Canada. Invited Speaker 2005.

28.

6th International Symposium of Redo Cardiac Surgery in Adults. San Francisco, California. Invited
Speaker 2005.

29.

85th Annual Meeting of the American Association for Thoracic Surgery. San Francisco, California.
Invited Speaker 2005.

30.

International Society for Minimally Invasive Cardiothoracic Surgery, Annual Scientific Meeting.
New York, New York. Invited Speaker 2005.

31.

Off-Pump CABG National Symposium. Tokyo, Japan. Invited Speaker 2005.

32.

Japanese Association for Coronary Artery Surgery. Tokyo, Japan. Invited Speaker 2005.

33.

14th Annual Meeting of the International Society for Cardiothoracic Surgery. Beijing, China. Invited
Speaker 2005.

34.

55th Annual Scientific Session of the American College of Cardiology. Atlanta, GA. Invited Speaker
2006.

35.

International Society of Minimally Invasive Cardiothoracic Surgery, Annual Scientific Meeting. San
Francisco, California. Invited Speaker and Invited Moderator 2006.

36.

European Association for Cardiothoracic Surgery Annual Techno-College meeting. Stockholm,
Sweden. Invited Speaker and Invited Moderator 2006.

37.

Southern Thoracic Surgical Association 53rd Annual Meeting. Tucson, Arizona. Invited Speaker andInvited Moderator 2006.

38.

American College of Cardiology Foundation, ACC Symposium. Chicago, Illinois. Invited Speaker

John D. Puskas, MD, MSc, FACS, FACC

Page 12 of 60

2006.
39.

The American Association for Thoracic Surgery 68th Annual Meeting. San Diego, California. Invited
Speaker and Invited Moderator 2006.

40.

International Society Minimally Invasive Cardiothoracic Surgery (ISMICS) Winter Workshop.
Okinawa, Japan. Invited Guest Speaker and Moderator 2006.

41.

The Society of Thoracic Surgeons 43rd Annual Meeting. San Diego, California. Invited Speaker andInvited Moderator 2007.

42.

Emory Practical Intervention Course (EPIC) Live Demonstration Course Surgical Presentation. The
Goal of Optimal Coronary Revascularization". Atlanta, Georgia. Invited Speaker 2007.

43.

The American Association for Thoracic Surgery 87thAnnual Meeting. Washington, DC. Invited
Speaker and Invited Moderator 2007.

44.

International Society of Minimally Invasive Cardiothoracic Surgery, Annual Scientific Meeting.
Rome, Italy. Invited Speaker and Invited Moderator 2007.

45.

The 9th Annual Meeting of Off-Pump CABG Symposium. Tokyo, Japan. Invited Speaker 2007.

46.

Southern Thoracic Surgical Association 54th Annual Meeting. Ft. Myers, Florida. Invited Speaker andInvited Moderator 2007.

47.

American Heart Association Scientific Session. Orlando, Florida. Invited Speaker 2008.

48.

The Society of Thoracic Surgeons 44th Annual Meeting. Ft. Lauderdale, Florida. Invited Speaker andInvited Moderator 2008.

49.

The International Symposium for Cardiac Surgery. "Coronary Artery Bypass, Off-pump CABG:
Evidence and Technique". Fairfax, Virginia. Invited Speaker 2008.

50.

International Society for Minimally Invasive Cardiothoracic Surgery. Annual Scientific Meeting.
Boston, Massachusetts. Invited Speaker and Invited Moderator 2008.

51.

Society Thoracic Surgeons University 4th Annual Meeting. San Francisco, California. Invited
Speaker and Course Director 2009.

52.

American Association for Thoracic Surgery, NIH Grant Writing Workshop. "Developing a ClinicalResearch Program (What It Takes)". Bethesda, Maryland. Invited Speaker 2009.

53.

45th Annual Meeting, Robert M. Jeresaty, M.D. Cardiovascular Symposium. West Hartford,
Connecticut. Invited Speaker 2009.

54.

AATS/STS Postgraduate Symposium. Boston, Massachusetts. Invited Speaker 2009.

55.

International Society for Minimally Invasive Cardiothoracic Surgery, Presidential Address. San
Francisco, California. 2009.

John D. Puskas, MD, MSc, FACS, FACC

Page 13 of 60

56.

The 6th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery. Yokohama,Japan. Invited Speaker 2009.

57.

The American Heart Association and Scientific Sessions. “Management of Postoperative MI”.
Orlando, FL. Invited Speaker and Invited Moderator 2009.

58.

Specialty Hospital of Jordan, Amman, Jordan. Visiting Professor, Cardiovascular Grand Rounds
2009.

59.

ISMICS Winter Workshop. Coronary Artery Bypass Surgery: Changing Times. "Management ofMultivessel Coronary Artery Disease". New Delhi, India. Invited Speaker and Invited Moderator
2009.

60.

46th Annual Meeting. The Society of Thoracic Surgeons. "Long-term Outcomes From The Smart
Study". Fort Lauderdale, FL. Invited Speaker 2010.

61.

The 90th Annual American Association Thoracic Surgery Meeting. Toronto, Ontario, Canada. Invited
Speaker, "Working with Industry" and "Off Pump CABG -Does it Remain Relevant?" InvitedModerator 2010.

62.

American Association for Thoracic Surgery, "Neurocognitive and Neuroanatomic Changes After
Off-Pump vs On Pump CABG: Long Term Follow Up of a Randomized Trial". Toronto, Ontario,
Canada. Invited Speaker 2010.

63.

International Society for Minimally Invasive Cardiothoracic Surgery Annual Meeting, Poster
Competition "Avoidance of Aortic Clamping Is Associated with Fewer Intraoperative Cerebral
Emboli Even in Patients Without Significant Atherosclerosis of the Ascending Aorta: Results of a
Prospective Randomized Trial". Berlin, Germany. Invited Speaker 2010.

64.

Transcatheter Cardiovascular Therapeutics 2010. “CABG Should be Performed Without
Cardiopulmonary Bypass”, “An Update on the NIH Hybrid Planning Grant” and "Hybrid Coronary
Revascularization: Two Interesting Cases from Emory University". Washington, DC. Invited Speaker
2010.

65.

Controversies and Advancement in the Treatment of Cardiovascular Disease: the Tenth in the Series.
"Debate: Beating Heart Treatment of CAD: Surgery Remains the Gold Standard". Beverly Hills,
California. Invited Speaker 2010.

66.

ACCF/AHA Task Force on Practice Guidelines “Guideline on Coronary Artery Bypass Graft Surgery(CABG)”. Washington, DC. Committee Member. 2010.

67.

Northeast Cardiothoracic Surgical Society. "Off Pump CABG: Where Are We in 2010". East
Madison, New Hampshire. Invited Speaker 2010.

68.

Annual Scientific Meeting, Australasian Society of Cardiac and Thoracic Surgeons. “Syntax 3
Results", "The Evidence for Bilateral Internal Thoracic Artery Grafting", “PROACT Study Design
and Recruitment Experience", "Techniques for Safe and Effective Re-Operation in Coronary Bypass
Surgery", "Ischemic Mitral Regurgitation: When to Repair, Replace and Just Graft”, and "Off Pump
Coronary Bypass Surgery". Sydney, Australia. Invited Speaker 2010.

John D. Puskas, MD, MSc, FACS, FACC

Page 14 of 60

69.

On-X Life PROACT Investigators Meeting, “National PI's Update on the PROACT Trial”. Orlando,
Florida. Invited Speaker 2010.

70.

The Society of Thoracic Surgeons 47th Annual Meeting. Meeting Moderator and Invited Speaker.
Thoracic Resident Symposium, "Hybrid Coronary Revascularization-. Satellite Symposium”,"Reduced Anticoagulation Studies and Alternatives”, “STS Workforce Presentation”, “Syntax Trial:
Effective Left main and Multivessel CAD Treatment: A Surgical and Cardiology Perspective", and“Why Randomized Trials in CAD are Important to Surgeons". Invited Speaker, San Diego,
California, 2011.

71.

Society for Cardiothoracic Surgery of Great Britain and Ireland (SCTS), "OPCAB, State of the Art Off-Pump Coronary Artery Bypass Surgery: It's Role in 2011", "Endoscopic Conduit Harvesting".
SCTS Annual Meeting "The Current and Future Status of OPCAB In Revascularization". London,
England. Invited Keynote Speaker and Honorary Member of the SCTS, 2011.

72.

American College of Cardiology ACC.11. “Unprotected Left Main PCI: Change in Guidelines,
Change in Practice Case Presentation", "Left Main Bifurcation-The Surgical Point of view", "Surgicaland Hybrid Point of View", Featured Clinical Research "Reduced anticoagulation for a MechanicalHeart Valve", and “Antiplatelet Therapy in ACS Patients undergoing CABG". New Orleans,Louisiana. Invited Speaker 2011.

73.

Emory Practical Interventional Conference (EPIC) 2011. "Coronary Revascularization in Advanced
Disease, The Role of the Heart Surgeon". Atlanta, Georgia. Invited Speaker 2011.

74.

8th Current Trends in Aortic and Cardiothoracic Surgery, "Is There Still a Raging Debate Over Offpump vs. On-Pump CABG Surgery?" Houston, Texas. Invited Speaker 2011.

75.

American Association Thoracic Surgeons Annual Meeting, AATS Leadership Academy -Current
Division Chiefs Program, “Working with Industry". Invited Guest speaker “Current Status of
Reduced Anti-Coagulation Trial". Moderator, Coronary Artery Disease in 2011 --What the Surgeon
needs to know about Three Year Syntax Outcomes, Other Randomized Controlled Trials in CAD andthe new CABG Guidelines. Speaker "Why Randomized Trials in CAD are important to Surgeons and
How to Discuss them with your Cardiologists". Session Speaker “Sex and Gender: The Impact on
Disease and Patient Outcomes in Cardiothoracic Surgery”, "The Many Faces of Coronary Artery
Disease". Philadelphia, Pennsylvania. Invited Speaker 2011.

76.

Harvard Medical School Alumni Day, "Re-Engineering Coronary Bypass Surgery", Invited Speaker
2011.

77.

National Cardiovascular Controversies (NCC) Resilient Bioprosthesis versus Mechanical Valves".
Greensboro, Georgia. Invited Speaker 2011.

78.

Transcatheter Cardiovascular Therapeutics (TCT) 2011, "The NIH Trial on Hybrid
revascularization: Rationale, Design and Status Update" and "When is Off Pump the Right
Choice"? Invited Speaker 2011.

79.

CABG Guideline Review, American Heart Association (AHA) 2011. “Update on Revascularization
Guidelines”, Orlando, Florida. Invited Speaker and Invited Moderator 2011.

80.

OPCAB lecture, JoHann Leopold Ehrenhaft Lecture, "Innovations in Cardiothoracic Surgery",

John D. Puskas, MD, MSc, FACS, FACC

Page 15 of 60

Carver College of Medicine, University of Iowa. Invited Speaker 2011.
81.

Society of Thoracic Surgeons (STS). Ft. Lauderdale, Florida. Invited Speaker for Duke University
Cardiothoracic Resident Symposium, "Hybrid Coronary Revascularization", 2012.

82.

Society of Thoracic Surgeons (STS) "Bilateral Internal Thoracic Artery Grafting is Associated with
Significantly Improved Long-term Survival, Even Among Diabetic Patients”, Ft. Lauderdale, Florida.
Invited Speaker 2012.

83.

Society of Thoracic Surgeons (STS) "Sternotomy Versus Non-sternotomy LITA-LAD Grafting forSingle Vessel LAD Disease". Ft. Lauderdale, Florida. Invited Speaker 2012.

84.

Society of Thoracic Surgeons (STS). Ft. Lauderdale, Florida. Invited Debate Moderator, “PCI Versus
CABG". 2012.

85.

Florida Valve Meeting, "One moment please... Innovations that may make us re-think everything
about TAVI-Mechanical AVR without anticoagulation". Orlando, Florida. Invited Speaker 2012.

86.

Atlanta Clinical Cardiology Update, "Update on Surgical Coronary Revascularization". Atlanta.
Georgia. Invited Speaker 2012.

87.

American Association for Thoracic Surgery, "Off Pump Coronary Artery Bypass Grafting: Advanced
Techniques and Helpful Hints". San Francisco, California. Invited Speaker 2012.

88.

American Association for Thoracic Surgery, "OPCAB is Better Than Conventional CABG". San
Francisco, California. Invited Moderator and Debater. 2012.

89.

Medical School at Universidad Internacional del Ecuador, Meeting: Transcending Frontiers in
Cardiology and Cardiovascular Disease, "Off Pump Coronary Bypass” and “Surgical Treatment of
Atrial Fibrillation". Quito, Ecuador, Invited Speaker 2012.

90.

International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), Los
Angeles, California. ISMICS Cardiac Masters Day Off Pump Surgery Course, Chairman and Invited
Speaker, 2012.

91.

International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), "OPCAB: Why To
Do It" and “OPCAB: How To Do it”. Los Angeles, California. Invited Speaker 2012.

92.

China Heart Congress and the American Association for Thoracic Surgery International Heart
Symposium, Fuwai Hospital, "Techniques and Outcomes for Robotic Assisted LIMA-LAD and
Stenting of Non LAD Vessel(s)". Beijing, China. Invited Speaker and Moderator 2012.

93.

China Heart Congress and the American Association for Thoracic Surgery, International Heart
Symposium, Fuwai Hospital, "Stand-alone Surgical Treatment for AF1B” and “The Effectiveness of
the LAA Clip as Sole Therapy for Patients with AFIB Who Cannot Take Coumadin". Invited Speaker
2012.

94.

Transcatheter Cardiovascular Therapeutics (TCT), "CABG Will Always Be The Preferred
Approach". Invited Speaker 2012.

John D. Puskas, MD, MSc, FACS, FACC

Page 16 of 60

95.

Transcatheter Cardiovascular Therapeutics (TCT), "Hybrid Revascularization: The Emory
Approach". Invited Speaker 2012.

96.

Transcatheter Cardiovascular Therapeutics (TCT), "Hybrid treatment of coronary artery disease".
Invited Discussant 2012.

97.

Transcatheter Cardiovascular Therapeutics (TCT), "CAD case presentations: CABG, PCI, hybrid or
medical therapy". Invited Discussant 2012.

98.

Turkish Cardiovascular Surgery Society and The American Association for Thoracic Surgery, "Stateof The Heart Update". Anatolia, Turkey. Invited Speaker 2012.

99.

Turkish Cardiovascular Surgery Society and The American Association for Thoracic Surgery, "Tipsof Off-Pump CABG". Anatolia, Turkey. Invited Speaker 2012.

100. 29th Annual Meeting of the Japanese Coronary Association, "From SYNTAX to EXCEL in U.S.".
Tokyo, Japan. Invited Speaker 2012.
101. The 49th Annual Meeting of the Society of Thoracic Surgeons, Duke Thoracic Resident
Symposium, “Hybrid Coronary Revascularization”. Los Angeles, CA. Invited Speaker 2013.
102. The 49th Annual Meeting of The Society of Thoracic Surgeons, Workforce on National Database,“The Ongoing Off-Pump CABG Conundrum: OPCAB is superior to ONCAB”. Los Angeles, CA.
Invited Debate 2013.
103. The 49th Annual Meeting of the Society of Thoracic Surgeons, “Off-Pump and On-Pump Coronary
Revascularization in Patients with Low Ejection Fraction: A Report from the STS National
Database”. Poster presentation 2013.
104. The 49th Annual Meeting of the Society of Thoracic Surgeons, “Hybrid Procedures are the Wave of
the Future”. Los Angeles, CA. Poster presentation 2013.
105. The 49th Annual Meeting of the Society of Thoracic Surgeons, “Mitral Valve Repair Not
Replacement Provides Improved Long-Term Outcomes in Patients with a Low Ejection Fraction”.
Los Angeles, CA. Poster presentation 2013.
106. The 49th Annual Meeting of the Society of Thoracic Surgeons, “Impact of preoperative chroniclung disease on long-term survival for patients undergoing aortic valve replacement”. Poster
Los Angeles, CA. podium presentation 2013.
107. The 49th Annual Meeting of the Society of Thoracic Surgeons, “Readmissions after Cardiac Surgery:
Experience of the NIH/CIHR Cardiothoracic Surgical Trials Network”. Los Angeles, CA. Invited
Speaker, 2013.
108. The 49th Annual Meeting of the Society of Thoracic Surgeons, “Tissue Valves Should Not Be
Used in Patients Younger Than 65”. Los Angeles, CA. Invited Speaker 2013.
109. The 49th Annual Meeting of the Society of Thoracic Surgeons, STS University Course, “Hybrid
Revascularization, Los Angeles, CA. Invited Course Director 2013.

John D. Puskas, MD, MSc, FACS, FACC

Page 17 of 60

110. The 49th Annual Meeting of the Society of Thoracic Surgeons, “Emergent repair of acuteType A dissection and the impact of selective antegrade cerebral perfusion and mild hypothermic
circulatory arrest”. Los Angeles, CA. Poster Presentation 2013.
111. American College of Cardiology 62nd Annual Meeting, “Hybrid Coronary Revascularization for
the Treatment of Coronary Artery Disease: A Multi-Center Observational Study”. San Francisco,
CA. Invited Speaker 2013.
112. American College of Cardiology 62nd Annual Meeting, 2013. “Interventional Cardiologists andCardiac Surgeons: Concordance regarding anatomic eligibility for hybrid coronary
revascularization in > 6,500 patients”. San Francisco, CA. Poster presentation. 2013113. 21st Annual Thomas Ferguson Invited Lecture, “What’s New in Surgical Coronary
Revascularization?” Visiting Professor, Washington University School of Medicine Division of
Cardiothoracic Surgery, St Louis, MO., Invited Speaker 2013.
114. The 93rd Annual Meeting of the American Association for Thoracic Surgery, “Improving
outcomes after coronary artery bypass surgery”. Minneapolis, MN. Invited Speaker 2013.
115. The 93rd Annual Meeting of the American Association for Thoracic Surgery, “Reducing strokein coronary bypass with clampless off-pump surgery”. Minneapolis, MN. Invited Speaker 2013.
116. The 93rd Annual Meeting of the American Association for Thoracic Surgery, “The best care for
cardiothoracic surgical ICU patients is a closed unit run by intensivists”. Minneapolis, MN. Invited
Debate 2013.
117. The 93rd Annual Meeting of the American Association for Thoracic Surgery, “Whatever
happened to OPCAB?” Minneapolis, MN. Invited Speaker 2013.
118. The International Society for Minimally Invasive Cardiac Surgery Annual Meeting, Invited
Course Director, Cardiac Masters Day Program, Prague, Czech Republic. 2013.
119. Transcatheter Cardiovascular Therapeutics (TCT), “On-Pump vs Off-Pump CABG: Have Three
ACC Late Breaking Trials Provided Clarity?”, “Hybrid Therapy: The Best of Both Worlds (andConsiderations for a CTSN-Sponsored Randomized Trial”, Invited Speaker, and Invited Discussant.
San Francisco, CA. October 27-29, 2013.
120. Visiting Professor, Grand Rounds, Department of Cardiothoracic Surgery, Cleveland Clinic
Foundation, Cleveland Ohio. “State of the Art in Surgical Coronary Revascularization”. January,
2014.
121. The 50th Annual Meeting of the Society of Thoracic Surgeons, Invited Chairman, “State of the Art
CABG: the Role of Arterial Grafts, Off-pump and Minimally Invasive Surgery”, Symposium
audiotaped and transcribed for publication in Seminars in Thoracic and Cardiovascular Surgery.
Orlando, FL. January 25-28, 2014.
122. The 50th Annual Meeting of the Society of Thoracic Surgeons, Duke Thoracic Resident
Symposium: Emerging Technology, “Hybrid Coronary Revascularization”, Invited Speaker.

John D. Puskas, MD, MSc, FACS, FACC

Page 18 of 60

Orlando, FL. January 25-28, 2014.
123. International Society for Minimally Invasive Cardiothoracic Surgery Annual Meeting, “Clampless
All Arterial OPCAB is Standard of Care for Multivessel Coronary Artery Disease”. Invited Speaker,
Boston, MA, 2014.
124. Mount Sinai Hospital Cardiology Grand Rounds Expert Panel, “Stable Coronary Artery Disease”.
Invited Speaker 2014125. Transcatheter Cardiovascular Therapeutics (TCT), “Revascularization Decisions in Nondiabetic andDiabetic Patients with Multivessel Disease, The Case for CABG in Most Patients with Multivessel
Disease with and without Diabetes”. Washington, DC, Invited Speaker 2014126. Transcatheter Cardiovascular Therapeutics (TCT), “Didactic Symposia:
Hypertrophic
Cardiomyopathy and Septal Ablation, Session II: Alcohol Septal Ablation”. Washington, DC,
Invited Speaker 2014
127. American Association For Thoracic Surgery, “Beating Heart CABG: How to Do It Safely”, Toronto,
Canada, Invited Speaker 2014.
128. American Association For Thoracic Surgery, “CABG for Complex Coronary Disease in the Diabetic
and in the Elderly A Perspective of “Coming Back” and with “New Technology”. Toronto, Canada.
Invited Speaker 2014.
129. Japanese Association for Coronary Artery Surgery. Tokyo, Japan, Invited Speaker and Moderator
2014.
130. European Association for Cardio-Thoracic Surgery, “New nuggets from late-breaking clinical trials”.
Milan, Italy. Invited Speaker 2014.
131. European Masterclass, “Bilateral Internal Mammary Arteries Bilateral ITA grafts: The facts in 2014”,
Off-Pump Approaches”, An American Perspective of Contemporary CABG, Arterial Grafts and OffPump Surgery”, Oxford, UK. Symposium Co-Chairman and Invited Speaker 2014.
132. Dallas-Leipzig Valve 2014 Meeting “Mechanical Valves with Low Dose Anticoagulation”. Dallas,
TX. Invited Speaker 2014.
133. New York Cardiovascular Symposium “CABG for Complex Coronary Disease in the Diabetic andin the Elderly A Perspective of “Coming Back” and with “New Technology”. New York, NY, Invited
Speaker 2014.
134. Israel Heart Society “Hybrid Coronary Revascularization: A New Treatment Paradigm for Selected
Patients with CAD”. Tel Aviv, Israel. Invited Speaker 2015135. Israel Heart Society “The FDA PROACT Trial: Safe Management of Patients with Lower INR after
Mechanical AVR”. Tel Aviv, Israel. Invited Speaker 2015
136. American Association For Thoracic Surgery (AATS) “Advanced Techniques for State of the Art
Coronary Bypass Surgery (Session)”. Seattle, WA. Invited Course Chair 2015

John D. Puskas, MD, MSc, FACS, FACC

Page 19 of 60

137. American Association For Thoracic Surgery (AATS) “How I Decide Conduits and How I Do It: Case
Review by Expert Panel”. Seattle, WA. Invited Panel Expert 2015
138. American Association For Thoracic Surgery (AATS) “When to use Alternative Strategies: Hybrid,
Connectors, Robot”. Seattle, WA. Invited Speaker 2015139. Inaugural AATS International Coronary Congress. Course Founder and Director 2015, New York.
140. The 1st International Coronary Congress: State of the Art Surgical Coronary Revascularization.
“Updated U.S. CABG Guidelines”. Invited Speaker 2015.
141. The 1st International Coronary Congress: State of the Art Surgical Coronary Revascularization.
“BITA Grafting in Patients with Diabetes: When to Do It & When Not to Do It”. Invited Speaker2015.
142. The 1st International Coronary Congress: State of the Art Surgical Coronary Revascularization.
“The Evidence for All–Arterial OPCAB in 2015”. Invited Speaker 2015.
143. The 1st International Coronary Congress: State of the Art Surgical Coronary Revascularization.
“Tips & Tricks for OPCAB”. Invited Speaker 2015.
144. The 1st International Coronary Congress: State of the Art Surgical Coronary Revascularization.
“Redo CABG Off–Pump”. Invited Speaker 2015.
145. The 1st International Coronary Congress: State of the Art Surgical Coronary Revascularization.
“Redo CABG Off–Pump”. Invited Speaker 2015.
146. Transcatheter Cardiovascular Therapeutics (TCT) “The case for Hybrid Coronary Revascularization(Let’s Split The Difference)”. San Francisco, CA. Organizing Chair and Invited Speaker 2015.
147. American Heart Association Scientific Session (AHA) “Therapeutic Decisions in Non-ST Elevation
Myocardial Infarction”. Orlando, FL. Invited Speaker 2015.
148. Society for Thoracic Surgeons “Redo CABG with Patent Coronary Artery Bypass Grafts”. Phoenix,
AZ. Invited Speaker 2016.
149. Heart Valve Society, “Can We Recommend Reduced Anticoagulation for Mechanical Valves?”, New
York, NY. Invited Speaker, 2016
150. Society for Cardiothoracic Surgery in Great Britain and Ireland, Birmingham, UK. “Alternative
Strategies for CABG”. Invited Speaker 2016.
151. Society for Cardiothoracic Surgery in Great Britain and Ireland, Birmingham, UK. “Redo CABG”.
Invited Speaker 2016.
152. Society for Cardiothoracic Surgery in Great Britain and Ireland, Birmingham, UK. “Total Arterial
Revascularization. How I Decide.” Invited Speaker 2016.

John D. Puskas, MD, MSc, FACS, FACC

Page 20 of 60

153. American Association for Thoracic Surgery “Total Arterial Revascularization, Left and Right”
Invited Speaker, plenary session and “Total Arterial Revascularization” Invited Moderator for Adult
Cardiac Surgery Postgraduate Course, Baltimore MD, May 2016.
154. American Association for Thoracic Surgery “The COMMENCE FDA Trial: Prospective NonRandomized Multicenter Clinical Evaluation of the Edwards Pericardial Aortic Bioprosthesis”,
Invited Speaker, Late Breaking Trials session, Baltimore MD, May 2016.
155. V Curso Bienal Cardiotorax 2016. “Management of mitral regurgitation during coronary surgery”.
Buenos Aires, Argentina, Invited Speaker June 2016.
156. V Curso Bienal Cardiotorax 2016. “Clinical guidelines for choosing myocardial revascularization
conduits”. Buenos Aires, Argentina, Invited Speaker 2016.
157. V Curso Bienal Cardiotorax 2016. “Evolution of off-pump coronary and hybrid treatments”.
Buenos Aires, Argentina, Invited Speaker 2016.
158. V Curso Bienal Cardiotorax 2016. “All Arterial OPCAB in 2016 “Is there scientific evidence?”.
Buenos Aires, Argentina, Invited Speaker 2016.
159. ISMICS 2016 Annual Scientific Meeting. “How I Do Multivessel OPCAB”. Invited Speaker 2016.
160. European Association for Cardiothoracic Surgery 2016. EACTS TV Studio Panel “Should FFRguided CABG become the new standard”. Invited Participant 2016.
161. European Association for Cardiothoracic Surgery 2016. “Reduced anti-coagulation after
mechanical aortic valve replacement: the PROACT Clinical Trial”. Invited Speaker 2016.
162. European Association for Cardiothoracic Surgery 2016. “The COMMENCE Trial: Two-year
outcomes of the Edwards RESILIA aortic bioprosthesis”. Invited Speaker 2016.
163. Transcatheter Cardiovascular Therapeutics Annual Meeting-2016. “Event Title: Hot Topic Lunch:Hybrid Coronary Revascularization: Ready for Prime Time?” (Cosponsored by AATS), InvitedModerator 2016.
164. Transcatheter Cardiovascular Therapeutics Annual Meeting-2016. “Hybrid Coronary
Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational
Study)”. Invited Speaker 2016.
165. Transcatheter Cardiovascular Therapeutics Annual Meeting-2016. “Despite EXCEL And NOBLE,
I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left
Main CAD!”. Invited Lecturer 2016.
166. Second AATS International Coronary Congress, Course Founder/Director, multiple lectures,
November 11-13, 2016, New Delhi, India.
167. The 2nd International Coronary Congress Annual Meeting, New Delhi. “Total Arterial
Revascularization Is the Holy Grail for CABG”. Invited Speaker 2016.
168. The 2nd International Coronary Congress Annual Meeting, New Delhi. “The Right strategy for the
Right Target in the Right Patient”. Invited Moderator 2016.
169. The 2nd International Coronary Congress Annual Meeting, New Delhi. “Can BITA Adequately

John D. Puskas, MD, MSc, FACS, FACC

Page 21 of 60

Supply the Entire Heart?”. Invited Speaker 2016.
170. The 2nd International Coronary Congress Annual Meeting, New Delhi. “Skeletonized BITA Harvest
with the Harmonic Scalpel”. Invited Speaker 2016.
171. The 2nd International Coronary Congress Annual Meeting, New Delhi. “Three Of My Own Cases inWhich TTFM Made a Difference”. Invited Speaker 2016.
172. The 2nd International Coronary Congress Annual Meeting, New Delhi. “Off-Pump Proximal
Anastomotic Techniques to Avoid Atheroembolism”. Invited Speaker 2016.
173. The 2nd International Coronary Congress Annual Meeting, New Delhi. “How I Do OPCAB”. Invited
Speaker 2016.
174. The 2nd International Coronary Congress Annual Meeting, New Delhi. “Moderate Ischemic MR:
CABG or CABG-plus-MV Repair?”. Invited Speaker 2016.
175. The 2nd International Coronary Congress Annual Meeting, New Delhi. “Thoracoscopic Ablation of
Atrial Fibrillation and LAA Exclusion”. Invited Speaker 2016.
176. ACC New York Cardiovascular Symposium-2016. “Hybrid Coronary Revascularization An
Evolving Paradigm in Coronary Care”. Invited Speaker. December 2016.
177. Association of Cardiothoracic Physician Assistants Annual Meeting. “Total Arterial
Revascularization”. Invited Speaker, 2017.
178. American Association Thoracic Surgeons Annual Centennial Meeting (AATS). “Best of Both
Worlds - Hybrid Revascularization (MIDCAB+PCI)”. Invited Speaker 2017.
179. American Association Thoracic Surgeons Annual Centennial Meeting (AATS). “Risk Factors,
Recognition and Management of Peri-operative MI”. Invited Speaker 2017.
180. American Association Thoracic Surgeons Annual Centennial Meeting (AATS). “Summary of NIH
Randomized Trial of Hybrid Coronary Revascularization versus Percutaneous Coronary
Intervention”. Invited Speaker 2017.
181. American Association Thoracic Surgeons Annual Centennial Meeting (AATS). “Comparative
Effectiveness of CABG versus PCI in a Real World STICH Population”. Invited Speaker 2017.
182. American Association Thoracic Surgeons Annual Centennial Meeting (AATS). “A Prospective
Trial of Anticoagulation and Antiplatelet Strategies After Mechanical Aortic Valve Replacement”.
Invited Speaker 2017.
183. AATS Symposium of Advanced Techniques in Coronary Artery Disease 2017. “Case Report andLive Case: One stage Hybrid Procedure for Multivessel Disease discussion”. Invited Discussant
2017.

John D. Puskas, MD, MSc, FACS, FACC

Page 22 of 60

184. AATS Symposium of Advanced Techniques in Coronary Artery Disease 2017. “Alternative for
MIDCAB: multi staged Hybrid procedure”. Invited Speaker 2017.
185. AATS Symposium of Advanced Techniques in Coronary Artery Disease 2017. “Key tips in theManagement of Ischemic MR: Echocardiography, myocardial protection and surgical techniques”.
Invited Speaker 2017.
186. 44th Congress of the Brazilian Society of Cardiovascular Surgery, Rio de Janeiro. “From saphenous
vein to total arterial and minimally invasive: What is the standard of care for CABG today?”.
Invited Lecturer 2017.
187. 44th Congress of the Brazilian Society of Cardiovascular Surgery, Rio de Janeiro. “Changing
paradigms in choice of valve prosthesis - devices & approaches”. Invited Lecturer 2017.
188. 44th Congress of the Brazilian Society of Cardiovascular Surgery, Rio de Janeiro. “Current surgicalapproach for CABG in the presence of ventricular dysfunction”. Invited Speaker 2017.
189. 44th Congress of the Brazilian Society of Cardiovascular Surgery, Rio de Janeiro. “Clinical Trials that
impact on surgical practice”. Invited Commentator 2017.
190. 44th Congress of the Brazilian Society of Cardiovascular Surgery, Rio de Janeiro. “Surgical approach
to ischemic
mitral regurgitation”. Invited Speaker 2017.
191. 44th Congress of the Brazilian Society of Cardiovascular Surgery, Rio de Janeiro. “Are there better
preservation processes for biological valves?”. Invited Speaker 2017.
192. Oxford OPCAB Masterclass-2017. “Full revascularization versus “incomplete” revascularization”.
Invited Speaker 2017.
193. Oxford OPCAB Masterclass-2017. “Latest technology for assessment of graft quality”. Invited
Speaker 2017.
194. Oxford OPCAB Masterclass-2017. “Endo-IMA harvesting technique”. Invited Speaker 2017
195. Oxford OPCAB Masterclass-2017. “OPCAB General Considerations & Unusual Situations”. Invited
Speaker 2017.
196. Oxford OPCAB Masterclass-2017. “Robotic MIDCAB”. Invited Speaker 2017.
197. 22nd Annual Meeting of the Japanese Association for Coronary Artery Surgery. “Treatment Strategy
for Ischemic MR”. Invited Speaker 2017.
198. 22nd Annual Meeting of the Japanese Association for Coronary Artery Surgery. “TheCOMMENCE Trial: two-year outcomes of the Edwards RESILIA aortic bioprosthesis”. Invited
Speaker 2017.
199. 22nd Annual Meeting of the Japanese Association for Coronary Artery Surgery. “Current status ofJohn D. Puskas, MD, MSc, FACS, FACC

Page 23 of 60

OPCAB in USA”. Invited Speaker 2017.
200. 3rd International Coronary Congress, New York. “Advantages of Skeletonized BITA Harvest and
BITA Grafting in Patients with Diabetes”. Invited Speaker 2017.
201. 3rd International Coronary Congress, New York. “Endoscopic Radial Artery Harvest-Techniques andOutcomes”. Invited Speaker 2017.
202. 3rd International Coronary Congress, New York. “All-Arterial Revascularization Gone Bad”. Invited
Speaker 2017.
203. 3rd International Coronary Congress, New York. “Endoscopic Radial Artery Harvest-Techniques andOutcomes”. Invited Speaker 2017.
204. 3rd International Coronary Congress, New York. “Epiaortic Scanning and Clampless Proximal
Anastomoses”. Invited Speaker 2017.
205. 3rd International Coronary Congress, New York. “Tips and Tricks for OPCAB”. Invited Speaker2017.
206. 3rd International Coronary Congress, New York. “3 of My Own Cases Where Graft Flow
Measurement Made A Difference”. Invited Speaker 2017.
207. 3rd International Coronary Congress, New York. “Current Role of Hybrid Coronary
Revascularization: North America Perspective”. Invited Speaker 2017.
208. 3rd International Coronary Congress, New York. “Moderate Ischemic MR: CABG or CABG+MV
Repair?” Invited Speaker 2017.
209. 3rd International Coronary Congress, New York. “Management of Coronary Ectasia and Coronary
Aneurysms in 2017: Bypass, Ligate, or Ignore?”. Invited Speaker 2017.
210. Transcatheter Cardiovascular Therapeutics-2017. “Hybrid Coronary Revascularization: Results toDate (From Meta-analysis to the NIH Multicenter Observational Study)”. Invited Speaker.
211. Transcatheter Cardiovascular Therapeutics-2017. “Opening Salvo: Despite EXCEL and NOBLE, I
Don’t Believe PCI should Be the Standard Revascularization Strategy for Most Patients with Left
Main CAD!”. Invited Speaker.
212. 3rd Annual Sones/Favaloro Scientific Session-2017, Cleveland Clinic. “On-Pump Better Than OffPump CABG?”. Invited Speaker.
213. American Association for Thoracic Surgery 2017: Surgical Treatment of Arrhythmias and Rhythm
Disorders. “CABG/AF Ablation”. Invited Speaker.
214. Society of Thoracic Surgeons 54th Annual Meeting- 2018. “Overcoming Barriers to Adopting
Concomitant Surgical AF Ablation in Daily Practice”. Invited Speaker.
215. Society of Thoracic Surgeons 54th Annual Meeting- 2018. “Management of Diffuse CAD, Full

John D. Puskas, MD, MSc, FACS, FACC

Page 24 of 60

Metal Jacket and Coronary Endarterectomy- Options for Diffuse CAD: Single Anastomosis,
Multiple Anastomoses, Onlay Grafting, Endarterectomy”. Invited Speaker.
216. Society of Thoracic Surgeons 54th Annual Meeting- 2018. “When and How to Do All-Arterial
Grafting- How to Safely Harvest BITAs, Minimizing Risk of DSWI and Optimizing Patency”
Invited Speaker.
217. Society of Thoracic Surgeons 54th Annual Meeting- 2018. “Techniques for Safe and Reliable
OPCAB- How to Mobilize/Displace the Heart to Graft the Anterior, Inferior and Lateral Walls andOptimize Coronary Artery Stabilization”. Invited Speaker.
218. American Association for Thoracic Surgery- 2018, San Diego. Adult Cardiac Program Chairman
219. American Association for Thoracic Surgery- 2018, San Diego. “How to Harvest RA Grafts: Best
Practices”. Invited Speaker.
220. American Association for Thoracic Surgery- 2018, San Diego. “Tips and Tricks for Precise,
Reproducible OPCAB”. Invited Speaker.
221. American Association for Thoracic Surgery- 2018, San Diego. “AVR/CABG/ AF Ablation CABG
Off/On Pump”. Invited Speaker.
222. American Association for Thoracic Surgery- 2018, San Diego. “Debate: Severe Ischemic MR Should
Replaced, Not Repaired in 2018”. Invited Moderator.
223. American Association for Thoracic Surgery- 2018, San Diego. “Expert Opinion #3: Surgical AVR
with the On-X Mechanical Prosthesis Should Be the first (and Last) Procedure For a 50 Year Old
Patient with Severe AS”. Invited Speaker.
224. American Association for Thoracic Surgery- 2018, San Diego.
Revascularization”. Invited Speaker.

“Complex Coronary

225. Oxford OPCAB Masterclass- 2018. “Full revascularization versus incomplete revascularization”.
Invited Speaker.
226. Oxford OPCAB Masterclass- 2018.
Invited Speaker.

“Lessons learned from intraoperative graft assessment”.

227. Oxford OPCAB Masterclass- 2018. “Endo-IMA harvesting technique”. Invited Speaker.
228. Oxford OPCAB Masterclass- 2018. “My top 10 tricks for successful OPCABG”. Invited Speaker.
229. Oxford OPCAB Masterclass- 2018.
situations”. Invited Speaker.

“Arterial grafting: General considerations and unusual

230. Oxford OPCAB Masterclass- 2018. “Pitfalls to avoid with composite arterial conduits”. Invited
Speaker.
231. Oxford OPCAB Masterclass- 2018. “The North American Approach”. Invited Speaker.

John D. Puskas, MD, MSc, FACS, FACC

Page 25 of 60

232. Oxford OPCAB Masterclass- 2018. “Robotic MIDCAB”. Invited Speaker.
233. 4th International Coronary Congress, Beijing. “Progression of Native Disease After CABG: What
Does It Mean For The Patient, Cardiologist and Surgeon?”. Invited Speaker 2018.
234. 4th International Coronary Congress, Beijing. “Special Invited Lecture: The Evidence Base for
OPCABG in 2018”. Invited Speaker 2018.
235. 4th International Coronary Congress, Beijing. “East Meets West”. Invited Speaker 2018.
236. 4th International Coronary Congress, Beijing. “Heart Team Strategy for the Management of CAD:The Reality and the Future”. Invited Speaker 2018.
237. 4th International Coronary Congress, Beijing. “Three Cases In Which Graft Assessment Made A
Difference”. Invited Speaker 2018.
238. 4th International Coronary Congress, Beijing. “The Evidence Base for OPCAB in 2018”. Invited
Speaker 2018.
239. 4th International Coronary Congress, Beijing. “Common Pitfalls of OPCAB”. Invited Speaker 2018.
240. 4th International Coronary Congress, Beijing. “The New Era for CABG”. Invited Speaker 2018.
241. 4th International Coronary Congress, Beijing. “Advantages of Skeletonized BITA”. Invited Speaker2018.
242. 4th International Coronary Congress, Beijing. “Moderate Ischemic MR”. Invited Speaker 2018.
243. 4th International Coronary Congress, Beijing. “No-Aortic-Touch OPCAB”. Invited Speaker 2018.
244. Michigan Society of Thoracic and Cardiovascular Surgeons- 2018. “The Ongoing Evolution of
Surgical Coronary Revascularization”. Invited Keynote Speaker.
245. Transcatheter Cardiovascular Therapeutics-2018. “Hybrid Revascularization as an Alternative to
PCI or CABG”. Invited Speaker.
246. Top Ten Topics In Clinical Cardiology, Mount Sinai Heart- 2018. “Resurgence of CABG: From
Minimally Invasive to Hybrid and Wholly Arterial?”. Invited Speaker.
247. European Association for Cardiothoracic Surgery Meeting, Milan. “For the healthy 50 year old
man with severe AS: SAVR with the On-X Mechanical Prosthesis should be the first (and last)procedure.” Invited Speaker 2018.
248. European Association for Cardiothoracic Surgery Meeting, Milan. “The Hybrid Trial”. Invited
Speaker 2018.
249. European Association for Cardiothoracic Surgery Meeting, Milan. “Can we finally settle the offJohn D. Puskas, MD, MSc, FACS, FACC

Page 26 of 60

pump vs on pump debate?”. Invited Speaker 2018.
250. Korean Society for Thoracic and Cardiovascular Surgery (KSTCVS)- Seoul. “Session: “Evidence
Base for CABG in 2018”. Invited Chairperson 2018.
251. Korean Society for Thoracic and Cardiovascular Surgery (KSTCVS)- Seoul. “Moderate Ischemic
MR: CABG or CABG-plus-MV Repair?”. Invited Speaker 2018.
252. Korean Society for Thoracic and Cardiovascular Surgery (KSTCVS)- Seoul.
Surgical Coronary Revascularization”. Invited Speaker 2018.

“The Future of

253. Philadelphia Cardiovascular Summit- 2018. “Hybrid Coronary Revascularization: collaboration
where it counts”. Invited Speaker.
254. XXIV Annual Meeting of the Russian Association of Cardiovascular Surgery (RACVS), MoscowNovember, 2018. “The REQUEST Registry: Lessons Learned from Intraoperative Assessment of
Graft Patency". Invited Speaker.
255. XXIV Annual Meeting of the Russian Association of Cardiovascular Surgery (RACVS), MoscowNovember, 2018. “Hybrid Coronary Revascularization: A New Treatment Paradigm for Selected
Patients with Coronary Artery Disease ". Invited Speaker.
256. Society of Thoracic Surgeons 55th Annual Meeting- 2019. “Coronary Revascularization Should Be
Performed Only by Dedicated Coronary Artery Bypass Grafting Surgeons”. Invited Speaker.
257. Society of Thoracic Surgeons 55th Annual Meeting- 2019. “The PROACT Trial”. Invited Speaker.
258. Society of Thoracic Surgeons 55th Annual Meeting- 2019. “Indications and Techniques for Left
Internal Mammary Artery to Diagonal to Left Anterior Descending Bridge Anastomoses”. Invited
Speaker.
259. Asian Society for Cardiovascular and Thoracic Surgery, Chennai - February, 2019. “Total arterial
revascularization: How I Decide". Invited Speaker.
260. Asian Society for Cardiovascular and Thoracic Surgery, Chennai – February, 2019. “Advanced
Techniques In CABG and Valve Reconstruction”. Invited Speaker.
261. Asian Society for Cardiovascular and Thoracic Surgery, Chennai – February, 2019. “Complex offpump CABG: Tips and tricks”. Invited Speaker.
262. Asian Society for Cardiovascular and Thoracic Surgery, Chennai – February, 2019. “Priority in
CABG – Completeness of Revascularization or Multiple Arterial Grafts”. Invited Speaker.
263. Asian Society for Cardiovascular and Thoracic Surgery, Chennai—February 2019.
Endoscopic Coronary Bypass Grafting”. Invited Speaker.

“Totally

264. Asian Society for Cardiovascular and Thoracic Surgery- 2019. “Hybrid Revascularization – A
pragmatic approach or an unholy alliance Pro (Pragmatic)". Invited Speaker.

John D. Puskas, MD, MSc, FACS, FACC

Page 27 of 60

265. American Association for Thoracic Surgery- 2019. “Master Video: All Arterial Grafting”. Invited
Speaker.
266. American Association for Thoracic Surgery- 2019. “Robotic Assisted Coronary Bypass Surgery”.
Invited Speaker.
267. American Association for Thoracic Surgery- 2019. “Antiplatelet Therapy After
Revascularization”. Invited Speaker.
268. Oxford OPCAB Masterclass, Ghent, Belgium- 2019. “Full revascularization versus “incomplete”
revascularization”. Invited Speaker.
269. Oxford OPCAB Masterclass, Ghent, Belgium- 2019. “My top 10 tricks for successful OPCABG”.
Invited Speaker.
270. Oxford OPCAB Masterclass, Ghent, Belgium- 2019. “Lessons learned from intraoperative graft
assessment”. Invited Speaker.
271. Oxford OPCAB Masterclass, Ghent, Belgium- 2019. “Endo-IMA harvesting technique”. Invited
Speaker.
272. Oxford OPCAB Masterclass, Ghent, Belgium- 2019. “General considerations and unusual
situations”. Invited Speaker.
273. Oxford OPCAB Masterclass, Ghent, Belgium- 2019. “The North American approach”. Invited
Speaker.
274. 21st Annual Complex Coronary Case Symposium 2019, Mount Sinai Heart: “Revascularization incomplex MV CAD to improve long-term outcomes: CABG for Most”. Invited Speaker/Debater.
275. Japanese Association for Coronary Artery Surgery 24th Annual meeting, Kanazawa, July 2019.
“BITA grafting should be the default operation for CABG”. Invited Speaker.
276. Japanese Association for Coronary Artery Surgery 24th Annual meeting, Kanazawa, July 2019.
“LITA-LAD Anastomosis: How I do it”. Invited Speaker.
277. Japanese Association for Coronary Artery Surgery 24th Annual meeting, Kanazawa, July 2019.
“Revascularization in complex MV CAD to improve long-term outcomes: CABG for Most”.
Invited Keynote Speaker.
278. OPCAB Masterclass Asia-Pacific, September, 2019, Tokyo. “LITA-LAD Anastomosis: How I Do
It”. Invited Speaker.
279. OPCAB Masterclass Asia-Pacific, September, 2019, Tokyo. “OPCAB Techniques”. Invited Keynote
Speaker.
280. OPCAB Masterclass Asia-Pacific, September, 2019, Tokyo. “Quality Control in OPCAB”. Invited
Speaker.

John D. Puskas, MD, MSc, FACS, FACC

Page 28 of 60

281. OPCAB Masterclass Asia-Pacific, September, 2019, Tokyo. “ITA Harvesting”. Invited Speaker.
282. OPCAB Masterclass Asia-Pacific, September, 2019, Tokyo. “Nightmare Cases”. Invited Speaker.
283. OPCAB Masterclass Asia-Pacific, September, 2019, Tokyo. “What Surgeons Need to Know About
FFR”. Invited Speaker.
284. OPCAB Masterclass Asia-Pacific, September, 2019, Tokyo. “Robotic ITA Harvest”. Invited Speaker.
285. OPCAB Masterclass Asia-Pacific, September, 2019, Tokyo. “Hybrid Coronary Revascularization”.
Invited Speaker.
286. European Association for Cardiothoracic Surgery 33rd Annual meeting, Lisbon, October 2019. “Howto build a specialized coronary program”. Invited Moderator.
287. European Association for Cardiothoracic Surgery 33rd Annual meeting, Lisbon, October 2019. “Whathave we learned in 3 decades of off-pump? OPCABG 3.0”. Invited Speaker.
288. European Association for Cardiothoracic Surgery 33rd Annual meeting, Lisbon, October 2019.
“Hybrid CABG: what to do and what not to do”. Invited Speaker.
289. European Association for Cardiothoracic Surgery 33rd Annual meeting, Lisbon, October 2019.
“Session Title: Coronary Artery Revascularization, what is the role of surgery today”. Invited
Panelist.
290. 5th International Coronary Congress Annual meeting, New York, December 2019. Course Director.
291. 5th International Coronary Congress Annual meeting, New York, December 2019. “The American
Technique”. Invited Speaker.
292. 5th International Coronary Congress Annual meeting, New York, December 2019. “Panel
Discussion of Techniques for Coronary Endarterectomy and Stentectomy”. Invited Panelist.
293. 5th International Coronary Congress Annual meeting, New York, December 2019. “Special Invited
Lecture: Techniques for safe, reproducible OPCAB.” Invited Speaker.
294. 5th International Coronary Congress Annual meeting, New York, December 2019. “Advanced
techniques in OPCAB”. Invited Speaker.
295. 5th International Coronary Congress Annual meeting, New York, December 2019. “Hybrid
Revascularization: What will it take to make HCR mainstream?”. Invited Speaker.
296. 5th International Coronary Congress Annual meeting, New York, December 2019. “Coronary
Surgery should be a subspecialty”. Invited Speaker.
297. The Society of Thoracic Surgeons 56th Annual meeting, New Orleans, January 2020. “On-X Heart
Valve – Topic: PROACT Update”. Invited Speaker.

John D. Puskas, MD, MSc, FACS, FACC

Page 29 of 60

298. The Society of Thoracic Surgeons 56th Annual meeting, New Orleans, January 2020.
“Intraoperative Coronary Graft Assessment”. Invited Speaker.
299. The Society of Thoracic Surgeons 56th Annual meeting, New Orleans, January 2020. “STS 2020
Video Roundtable Filming – Topic: Stenting, Bypass, and/or Lifestyle Changes to Treat Patientswith Severe But Stable Heart Disease”. Invited Speaker.
300. The Society of Thoracic Surgeons 56th Annual meeting, New Orleans, January 2020. “CABG for
Stable CAD: Results of the Ischemia Trial”. Invited Speaker.
301. The Society of Thoracic Surgeons 56th Annual meeting, New Orleans, January 2020. “DEBATE:
Multi-Arterial Off-Pump versus Traditional Coronary Artery Bypass Grafting - Why I Prefer MultiArterial, Off-Pump, No-Touch CABG”. Invited Speaker.
302. Mount Sinai Department of Cardiology Grand Rounds, August, 2020. “State-of-the-Art CABG in2020”. Invited Keynote Speaker (virtual).
303. Global Virtual OPCAB Masterclass, September, 2020. “What Drives Me Towards OPCAB”.
Invited Speaker (virtual).
304. Global Virtual OPCAB Masterclass, September, 2020. “Surgical Preparation for OPCAB”. Invited
Speaker (virtual).
305. Global Virtual OPCAB Masterclass, September, 2020. “Grafting the Inferior Wall Off-Pump”.
Invited Speaker (virtual).
306. Global Virtual OPCAB Masterclass, September, 2020. “Graft Selection, Distribution and An-Aortic
OPCAB”. Invited Speaker (virtual).
307. Global Virtual OPCAB Masterclass, September, 2020. “Quality Assessment in OPCAB:
Intraoperative TTFM and HIFU”. Invited Speaker (virtual).
308. Global Virtual OPCAB Masterclass, September, 2020. “Preventing Stroke in OPCAB: Minimizing
Aortic Manipulation.” Invited Speaker (virtual).
309. 34th Annual Meeting of the European Association for Cardiothoracic Surgery, October, 2020
(virtual). “Hybrid Revascularization: When and How”. Invited Speaker (virtual).
310. 34th Annual Meeting of the European Association for Cardiothoracic Surgery, October, 2020
(virtual). “Achieving the Best Exposure in OPCAB”. Invited Speaker (virtual).
311. 34th Annual Meeting of the European Association for Cardiothoracic Surgery, October, 2020
(virtual). “What Does ISCHEMIA Tell Us About CABG?”. Invited Speaker (virtual).
312. 34th Annual Meeting of the European Association for Cardiothoracic Surgery, October, 2020
(virtual). “OPCAB in 2020: When, Why and Who?”. Invited Speaker (virtual).
313. 67th Annual Conference of the Indian Association of Cardiovascular-Thoracic Surgeons (Virtual),

John D. Puskas, MD, MSc, FACS, FACC

Page 30 of 60

February 2021. “Bridging the Gap between Best Evidence and Common Practice in CABG: Simple
Techniques to Consider in All Patients”. Invited Speaker (virtual).
314. Mount Sinai Department of Cardiology Grand Rounds September 2021. “The Ongoing Evolution of
Surgical Coronary Revascularization”. Invited Speaker (virtual).
315. CMICSC (Hybrid) Meeting, October 2021, Wuhan, China. “OPCAB Should Be Offered to All
Patients with Stable Ischemic Heart Disease”. Invited Speaker (virtual).
316. 35th Annual Meeting of the European Association for Cardiothoracic Surgery, Barcelona (Hybrid),
October 2021. “When CABG Works Well and When it Does Not.” Invited Speaker (virtual).
317. Association of Thoracic and Cardiovascular Surgeons of Asia/STS Thailand Annual Meeting
November, 2021. “CABG in Ascending Aortic Disease: Surgical Principles of Anaortic OPCAB”.
Invited Speaker (virtual).
318. New York Society of Thoracic Surgeons Annual Meeting November 2021. “Innovation in
Cardiothoracic Surgery Through Clinical Trials: Trials and Tribulations”. Invited Keynote Speaker(virtual).
319. American Heart Association Scientific Sessions November 2021. “Efficacy and safety of an
external support device for saphenous vein coronary bypass grafts: the VEST trial”. Invited
Speaker.
320. CardioExcellence 2021 Annual Meeting. “State-of-the-Art Surgical Coronary Revascularization in2021”. Invited Speaker (virtual).
321. Brazilian Society of Cardiovascular Surgeons 2021 Annual Meeting. “Myocardial
Revascularization in Left Main Stem Stenosis: CABG Remains the Best Therapy for Most
Patients”. Invited Keynote Speaker (virtual).
322. All-Russia Minimally Invasive Cardiac and Arrhythmia Surgery (AMICS) Meeting (Hybrid),
November, 2021, Moscow. “OPCAB: Surgical Principles”. Invited Speaker (virtual).
323. 7th Annual Meeting of the International Coronary Congress, New York, December, 2021 (inperson). “How to Use BITA for CABG”. Invited Speaker.
324. 7th Annual Meeting of the International Coronary Congress, New York, December, 2021 (inperson). “Hybrid CABG”. Invited Speaker.
325. 7th Annual Meeting of the International Coronary Congress, New York, December, 2021 (inperson). “Endoscopic RA Harvesting: Barriers to Adoption”. Invited Speaker.
326. 7th Annual Meeting of the International Coronary Congress, New York, December, 2021 (inperson). “Operative Strategy Session, Case Presentation”. Invited Speaker.
327. 7th Annual Meeting of the International Coronary Congress, New York, December, 2021 (inperson). “Endarterectomy and Stentectomy”. Invited Speaker.

John D. Puskas, MD, MSc, FACS, FACC

Page 31 of 60

328. 7th Annual Meeting of the International Coronary Congress, New York, December, 2021 (inperson). “OPCAB on the Lateral Wall”. Invited Speaker.
329. 7th Annual Meeting of the International Coronary Congress, New York, December, 2021 (inperson). “Building a Successful CABG Program in the Most Competitive US Market”. Invited
Speaker.
330. Society of Thoracic Surgeons 58th Annual Meeting (Hybrid) Miami Beach, January 2022. “TheTransition for Open Chest CABG to Multi-Arterial Robotic OPCAB”. Invited Speaker (virtual).
331. Indian Society of Coronary Surgeons 2022 Inaugural (Hybrid) Meeting. “Management of Diffuse
CAD: Stentectomy/Endarterectomy for LAD Full Metal Jacket with In-Stent Restenosis”. Invited
Speaker (virtual).
332. Mount Sinai Heart, Advanced Innovations in Heart Failure 2022 (Virtual) Meeting. “SurgicalCoronary Revascularization in Patients with Low Ejection Fraction”. Invited Speaker (virtual).
333. Transcatheter Therapeutics Asia Pacific 2022 Annual (Virtual) Meeting. “CABG Remains the BestTherapy for Most Patients with LM Stenosis”. Invited Speaker (virtual).
334. University of Toronto Division of Cardiac Surgery Grand Rounds May 2022. “State-of-the-Art
CABG in 2022: The Ongoing Evolution of Surgical Coronary Revascularization.” Invited Keynote
Speaker (virtual).
335. Society of Thoracic Surgeons Inaugural Coronary Conference, Ottawa, June 2022. “OPCAB:
Surgical Principles”. Invited Speaker.
336. Society of Thoracic Surgeons Inaugural Coronary Conference, Ottawa, June 2022.
“Stentectomy/Endarterectomy for LAD Full Metal Jacket with In-Stent Restonosis”. Invited
Speaker.
337. Mount Sinai Heart, Latest Advances in Coronary Revascularization, August 2022. “Stentectomy:
New Hope for Refractory Angina”. Invited Speaker.
338. Mount Sinai Heart, Latest Advances in Coronary Revascularization, August 2022. “Total Arterial
Grafting: No-Aortic-Touch Technique”. Invited Speaker.
339. China Heart Congress, Beijing 2022 (Hybrid). “Total Arterial Grafting: No-Aortic-Touch
Technique”. Invited Speaker (virtual).
340. 68th Annual Conference of the Indian Association of Cardiovascular and Thoracic Surgeons, April
2022. “Management of Diffuse CAD: Stentectomy/Endarterectomy for LAD Full Metal Jacket with
in-Stent Restenosis.” Invited Speaker (virtual).
341. 44th Annual Meeting of the National Arab American Medical Association (Hybrid), September
2022. “State-of-the-Art CABG: Total Arterial Grafting by No-Aortic-Touch Technique”. Invited
Speaker (virtual).
342. 36th Annual Meeting of the European Association for Cardiothoracic Surgery, Milan, October 2022.

John D. Puskas, MD, MSc, FACS, FACC

Page 32 of 60“Quality Assessment by Intraoperative TTFM and HIFUS”. Invited Speaker.
343. 36th Annual Meeting of the European Association for Cardiothoracic Surgery, Milan, October 2022.
“Optimizing Conduits for CABG”. Invited Plenary Session Moderator.
*****************************************************************************************
PEER REVIEWED BIBLIOGRAPHY (SCOPUS H-index 62;
September 29, 2022):

Google Scholar H-index 79 accessed1.

Distefano R, Kupiec-Weglinski JR, Puskas JD. 1987. Therapeutic efficacy of anti-interleukin-2
receptor monoclonal antibodies in experimental organ transplantation. Surgery Forum; XXXVIII:
344346.

2.

Puskas JD, Maccherini M, Keshavjee S, Slutsky AS, Patterson GA, Edelson JD. 1990. Low
potassium dextran is superior to Eruo-Collins as a preservative solution in a type II pneumocyte cell
culture model. American Rev Respiratory Dis; 141 (4):A406.

3.

Cardoso PFG, Spino M, Mayer E, Shi SO, Pop RD, Puskas JD, Perrier 0, Tong J, Baines AD,
Patterson GA. 1991. Use of an isolated in-situ canine lung perfusion model to evaluate dopamine
clearance by the lung. Journal Pharm Exper Therapeutics;259(3):1271-1276.

4.

Shapiro ME, Kirkman RL, Reed MH, Puskas JD, Mazoujian G, Letvin NL, Carpenter CB, Milford
EL, Waldmann TA, Stron TB. 1987. Monoclonal anti-IL-2 receptor antibody in primate renaltransplantation. Transplant Proc; 19(1):594-598.

5.

Oka T, Puskas JD, Mayer E, Cardoso PF, Shi SO, Wisser W, Slutsky AS, Patterson GA. LowPotassium UW solution for lung preservation. 1991. Comparison with regular UW, LPO, and EuroCollins solutions. Transplantation; 52(6):984-988.

6.

Shaw LR, Miller JO, Slutsky AS, Maurer JR, Puskas JD, Patterson GA, Singer PA. 1991. Ethics oflung transplantation with live donors. Lancet; 338(8768):678-681.

7.

Ueno T, Yokomise H, Oka T, Puskas JD, Mayer E, Slutsky AS, Patterson GA.1991. The effect of
PGE-1 and temperature on lung functions following preservation. Transplantation; 52(4):626-630.

8.

Mayer E, Cardoso PF, Puskas JD, Patterson GA, Oelert H. 1992. Revascularization of heterotopic
isotransplants of the rat trachea using an omentum flap. Pneumologie;46(5): 190-195.

9.

Mayer E, Cardoso PF, Puskas JD, Patterson GA, Oelert H. 1992. {Revascularization of heterotopic
isotransplants of the rat trachea using an omentum flap} [German]. Pneumatologie, 46(5):190-195.

10.

Mayer E, Cardoso PF, Puskas JD, DeCampos K, Oka T, Oardick I, Patterson GA. 1992. The effectof basic fibroblast growth factor and omentopexy on revascularization and epithelial regeneration ofheterotopic rat tracheal isografts. Journal of Thoracic and Cardiovascular Surgery; 104(1):180-188.

11.

Mayer E, Puskas JD, Cardoso PF, Shi S, Slutsky AS, Patterson GA. 1992. Reliable eighteen-hourlung preservation at 4 degrees and 10 degrees C by pulmonary artery flush after high-dose
prostaglandin E1 administration. Journal of Thoracic and Cardiovascular Surgery;1 03(6):1136-

John D. Puskas, MD, MSc, FACS, FACC

Page 33 of 60

1142.
12.

Puskas JD, Hirai T, Christie N, Mayer E, Slutsky AS, Patterson GA. 1992. Reliable thirty-hour lungpreservation by donor lung hyperinflation. Journal of Thoracic and Cardiovascular Surgery;104(4):1075-1083.

13.

Puskas JD, Winton TL, Miller JO, Scavuzzo M; Patterson GA 1992. Unilateral donor lungdysfunction does not preclude successful contra lateral single lung transplantation. Journal ofThoracic and Cardiovascular Surgery; 103(5):1015-1017.

14.

Puskas JD, Cardoso PF, Mayer E, Shi S. Slutsky AS, Patterson GA. 1992. Equivalent eighteen-hourlung preservation with low potassium dextran or Euro-Collins solution after prostaglandin E1
infusion. Journal of Thoracic and Cardiovascular Surgery; 104(1):83-89.

15.

Matsuzaki Y, Waddell TK, Puskas JD, Hirai T, Nakajima S, Slutsky AS, Patterson GA. 1993.
Amelioration of post-ischemic lung reperfusion injury of prostaglandin E1. Am Rev Respir Dis 148(4pt 1):882-889.

16.

Hirai T, Waddell TK, Puskas JD, Wada H, Hitomi S, Gorczynski RM, Slutsky AS, Patterson GA.
1993. Prolonged lung allograft survival with a short course of FK 506. Journal of Thoracic andCardiovascular Surgery;105(1):1-8.

17.

Puskas JD, Allen MS, Moncure AC, Wain JC Jr., Hilgenberg AD, Wright C, Grillo HC, Mathisen
OJ. 1993. Pulmonary arteriovenous malformations: therapeutic options. The Annals of Thoracic
Surgery; 56(2):253-257.

18.

Puskas JD, Gertler JP. 1994. Internal jugular to axillary vein bypass for subclavian vein thrombosis
in the setting of brachial arteriovenous fistula. Journal of Vascular Surgery, 19(5):939-942.

19.

Puskas JD, Oka T, Mayer E, Wisser W, Downey GP, Slutsky AS, Patterson GA. 1994. Hemodilution
reduces early reperfusion injury in an ex vivo rabbit lung preservation model. The Annals of Thoracic
Surgery; 57(3):731-735.

20.

Waddell TK, Hirai T, Piovesan J, Oka T, Puskas JD, Patterson GA, Slutsky AS. 1994. The effect ofheat shock on immediate post-preservation lung function. Clin Invest Med 17(5):405-413.

21.

Puskas JD, Mathisen OJ, Grillo HC, Wain JC, Wright CD, Moncure AC, 1995. Treatment strategies
for bronchopleural fistula. Journal Thoracic and Cardiovascular Surgery; 109(5):989-996.

22.

Craver JM, Puskas JD, Weintraub W, Shen y, Guyton RA, Gott JP, Jones EL. 1995. Outcome in 600
octogenarians undergoing cardiac surgery: comparison with younger age groups. Journal American'
College of Cardiology; (2): 183A.

23.

Puskas JD, Wright CE, Ronson RS, Brown W, Gott JP, Guyton RA. 1998. Off-pump multivessel
coronary bypass via sternotomy is safe and effective. The Annals of Thoracic Surgery, 66:1068-1072.

24.

Bufkin Bl, Puskas JD, Vinten-Johansen J. Shearer ST, Guyton RA. 1998. Controlled intermittent
asystole: Pharmacologic potentiation of vagal-induced asystole. The Annals of Thoracic Surgery
66:1185-1190.

John D. Puskas, MD, MSc, FACS, FACC

Page 34 of 60

25.

Craver JM, Puskas JD, Weintraub WW, Shen Y, Guyton RA, Gott JP, Jones EL, Whitehead JB.
1999.601 Octogenarians undergoing cardiac surgery: Outcome and comparison with younger age
groups. Th Annals of Thoracic Surgery; 67:1104-1110.

26.

Puskas JD, Wright CE, Miller PK, Anderson TE, Gott JP, Brown WM III, Guyton RA. 1999. A
randomized trial of endoscopic versus open saphenous vein harvest in coronary bypass surgery. The
Annals of Thoracic Surgery; 68(4):1509-1512.

27.

Puskas JD, Wright CE, Ronson RS, Brown WM, Gott JP, Guyton RA.1999. Clinical outcomes andangiographic patency in 125 consecutive off-pump coronary bypass patients. The Heart Surgery
Forum 2(3):216-221.

28.

Guyton RA, Thourani VH, Puskas JD, Shanewise JS, Steele MA, Palmer-Steele Cl, Vinten-Johansen
J. 2000. Perfusion-assisted direct coronary artery bypass: selective graft perfusion in offpump cases.
The Annals of Thoracic Surgery; 69(1):171-175.

29.

Puskas JD, Thourani VH, Vinten-Johansen J, Guyton RA. 2000. Active perfusion of coronary grafts
facilitates complex off-pump coronary artery bypass surgery. Heart Surgery Forum 3(3).

30.

Puskas JD, Winston DA, Wright CE. Gott JP, Brown WM. Craver .IM, Jones El. Guyton RA.
Weinthraub WS. 2000. Stroke after coronary artery operation: incidence, correlates, outcome andcost. The Annals of Thoracic Surgery; 69(4): 1053-1056.

31.

Thourani VH. Weinthraub WS. Craver JM, Jones El, Gott JP, Brown WM, Puskas JD, Guyton RA.
2000. Influence of concomitant CABG and urgent/emergent status on mitral valve replacement
surgery. The Annals of Thoracic Surgery; 70(3):783-784.

32.

Puskas JD, Vinten-Johansen J, Muraki S, Guyton RA. 2001. Myocardial protection for off-pumpcoronary artery bypass surgery. Seminars in Thoracic Cardiovascular Surgery; 13(1):82-88.

33.

Puskas JD, Thourani VH, Marshall JJ, Dempsey SJ, Steiner MA, Sammons BH, Brown WM III.
Gott JP, Weintraub WS, Guyton RA. 2001. Clinical outcomes, angiographic patency, and resource
utilization in 200 consecutive off-pump coronary bypass patients. The Annals of Thoracic Surgery;
71(5):1477-1483.

34.

Puskas JD, Thourani VH, Vinten-Johansen J. Guyton RA. 2001. Active perfusion of coronary grafts
facilitates complex off-pump coronary artery bypass surgery. Heart Surgery Forum; 4(1):65-68.

35.

Morris CD, Budde .IM, Velez DA. Muraki S. Zhao ZA, Puskas JD, Guyton RA, Vinten-Johansen J.
2001. Electroplegia: an alternative to blood cardioplegia for arresting the heart during conventional(on-pump) cardiac operation. The Annals of Thoracic Surgery; 72(3):679-687.

36.

Muraki S, Morris CD, Budde JM, Otto RN, Zhao ZA, Puskas JD, Guyton RA, Vinten-Johansen J.
2002. Preserved myocardial blood flow and oxygen supply-demand balance with active coronary
perfusion during simulated off-pump coronary artery bypass grafting. Journal of Thoracic andCardiovascular Surgery; 123(1): 53-62.
Denzin DR, Puskas JD. 2002. Redo off-pump coronary artery bypass via left thoracotomy: A casereport Surgical Physician Assistant; 8(9): 18-22.

37.

John D. Puskas, MD, MSc, FACS, FACC

Page 35 of 60

38.

Hart JC, Puskas JD, Sabik JF. 2002. Off-pump coronary revascularization: current state of the art.
Seminars in Thoracic & Cardiovascular Surgery; 14(1): 70-81.

39.

Cooper WA, Corvera JS, Thourani VH, Puskas JD, Craver JM, Lattouf OM, Guyton RA. 2003.
Perfusion-assisted direct coronary artery bypass provides early reperfusion of ischemic myocardium
and facilitates complete revascularization. The Annals of Thoracic Surgery; 75(4): 1132-1139.

40.

Puskas JD, Williams WH, Duke PG, Staples JR, Glas KE. Marshall JJ, Leimbach M, Huber P, Garas
S, Sammons BH, McCall SA, Petersen RJ, Bailey DE, Chu H, Mahoney EM, Weintraub WS. Guyton
RA. 2003. Off-pump coronary artery bypass grafting (OPCAB) provides complete revascularization
while reducing myocardial injury, transfusion requirements and length of stay (LOS): A prospective
randomized comparison of 200 unselected patients having OPCAB versus conventional CABG.
Journal of Thoracic and Cardiovascular Surgery; 125(4):797-808.

41.

Ronson RS, Puskas JD, Thourani VH, Velez DA, Bufkin BL, Glass K, Guyton RA. Vinten-Johansen
J. 2003. Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiatedvagus nerve stimulation in normal and hibernating myocardium. The Annals of Thoracic Surgery;
75:1929-1936.

42.

Puskas JD, Sharoni E, Petersen R, McCall S, Williams W, Duke P, Guyton RA. 2003. Angiographic
graft patency and clinical outcomes among diabetic patients after off-pump versus conventional
coronary artery bypass grafting: Results of a perspective randomized trial. Heart Surgery Forum:
6(S1):527.

43.

Delarosa J, Kerendi F, Petersen R, Guyton RA, Puskas JD. 2003. Risk factors and outcomes
associated with failed wean from cardiopulmonary bypass. Heart Surgery Forum 6(S1):546.

44.

Puskas JD, Sharoni E, Williams W, Petersen R, Duke P, Guyton RA. 2003. Is routine use of
temporary epicardial pacing wires necessary after either OPCAB or conventional CABG/CPB? Heart
Surgery Forum; 6(S7):547.

45.

Corvera JS, Morris CD, Budde JM, Velez DA, Puskas JD, Lattouf OM, Cooper WA, Guyton RA.
Vinten·Johansen J. 2003. Pretreatment with phenoxybenzamine attenuates the radial artery's
vasoconstrictor response to alpha-adrenergic stimuli. Journal of Thoracic and Cardiovascular
Surgery; 126(5):1549·1554.

46.

Sharoni E, Shanewise J, Song H, Duke P, Glas K, Staples J, Petersen R, Guyton RA, Puskas JD.
2003. Preoperative demographic risk stratification for significant atherosclerosis of ascending aorta.
Heart Surgery Forum; 6(S7):522.

47.

Song HK, Petersen RJ, Sharoni E, Guyton RA, Puskas JD. 2003. Safe evolution towards routine off·
pump coronary artery bypass: negotiating the learning curve. European Journal of Cardiac Thoracic
Surgery; 24(6):947-952.

48.

Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, Staples JR, Glas KE,
Marshall JJ, Leimbach ME, McCall SA, Petersen RJ, Bailey DE, Weintraub WS, Guyton RA. 2004.
Off-Pump vs. conventional coronary artery bypass grafting: Early and 1-year graft patency, cost andquality-of-life outcomes: A randomized trial. Journal American Medical Association; 291:18411949.

John D. Puskas, MD, MSc, FACS, FACC

Page 36 of 60

49.

Song HK, Sharoni E. Williams B Jr, Guyton RA, Puskas JD. 2004. Long-term left internal mammary
artery graft patency for coronary artery disease associated with pseudoxanthoma elasticum. The
Annals of Thoracic Surgery: 78(2):691-693.

50.

Staples JR, Tanaka KA, Shanewise JS, Glas KE, Merlino JD, Cooper WA, Puskas JD, Lattouf OM.
2004. The use of the SonoSite ultrasound device for intraoperative evaluation of the aorta. Journal of
Cardiothoracic & Vascular Anesthesia; 18(6):715-718.

51.

Puskas JD. 2004. Invited commentary. The Annals of Thoracic Surgery; 78(5):1602-1603.

52.

Serna DL. Thourani VH, Puskas JD. 2005. Antifibrinolytic agents in cardiac surgery: current
controversies. Seminars in Thoracic and Cardiovascular Surgery; 17(1):52-58.

53.

Kerendi F, Puskas JD, Craver JM. Cooper WA, Jones EL, Lattouf OM, Vega JD, Guyton RA. 2005.
Emergency coronary artery bypass grafting can be performed safely without cardiopulmonary bypass
in selected patients. The Annals of Thoracic Surgery; 79(3):801-806.

54.

Baumgartner WA, Burrows S, del Nido PJ, Gardner T J, Goldberg S, Gorman RC, Letsou GV,
Mascette A, Michler RE, Puskas JD, Rose EA, Rosengart TK, Selke FW, Shumway SJ, Wilke N.
2005. Recommendations of the National Heart, Lung and Blood Institute Working Group on Future
Direction in Cardiac Surgery. Circulation; 111 (22):3007-3013.

55.

Halkos ME, Craver JM, Thourani VH, Kerendi F, Puskas JD, Cooper WA, Guyton RA. 2005.
Intraoperative radiofrequency ablation for the treatment of atrial fibrillation during concomitantcardiac surgery. The Annals of Thoracic Surgery; 80(1):210-216.

56.

Staton GW, Williams WH, Mahoney EM, Hu J, Chu H, Duke PG, Puskas JD. 2005. Pulmonary
outcomes of off-pump vs. on-pump coronary artery bypass surgery in a randomized trial. Chest;
127(3):892-901.

57.

Sharoni E, Song HK, Peterson RJ, Guyton RA, Puskas JD. 2006. Off Pump coronary bypass surgery
for significant left ventricular dysfunction: safety, feasibility, and trends in methodology over timean early experience. Heart; 92:499-502.

58.

Halkos ME, Cooper WA, Petersen R, Puskas JD, Lattouf OM, Carver JM, Guyton RA: 2006. Earlyadministration of clopidogrel is safe after off-pump coronary artery bypass surgery. The Annals ofThoracic Surgery; 81(3):815-819.

59.

Noora J, Puskas JD, 2006. Off-pump CABG through sternotomy: For whom? Current Opinion in
Cardiology, 21:573-577.

60.

Tanaka KA, Thourani VH, Williams WH, Duke PG, Levy JH, Guyton RAJ, Puskas JD. 2007.
Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.
Journal of Anesthesia; 21:297-303.

61.

Pusca SV, Puskas JD. 2007. Revascularization in heart failure: coronary bypass or percutaneous
coronary intervention? Heart Failure; 3(2):211-228.

62.

Puskas JD, Kilgo PO, Kutner M. Pusca SV. Lattouf OM, Guyton RA. 2007. Off-pump techniques

John D. Puskas, MD, MSc, FACS, FACC

Page 37 of 60

disproportionately benefit women and narrow the gender disparity in outcomes after coronary artery
bypass surgery. Circulation; 116 (11 Suppl):1192-1199.
63.

Puskas JD, Lin E, Bailey D, Guyton RA 2007. Thoracoscopic radiofrequency pulmonary vein
isolation and atrial appendage occlusion. The Annals of Thoracic Surgery; 83(5): 1870-1872.

64.

Vassiliades TA Jr, Reddy VS, Puskas JD, Guyton RA. 2007. Long-term results of the endoscopic
atraumatic coronary artery bypass. The Annals of Thoracic Surgery; 83(3):979-984.

65.

Kerendi F, Thourani VH, Puskas JD, Kilgo PO, Osgood M, Guyton RA, Lattouf OM. 2007. Impactof heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery. The Annalsof Thoracic Surgery; 84(5):1548-1553.

66.

Tanaka KA, Thourani VH, Williams WH, Duke PG, Levy J, Guyton RA, Puskas JD. 2007. Heparin
anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. Journal of
Anesthesia; 21 (3):297-303.

67.

Puskas JD, Steele M. 2007. Would you like some cardiopulmonary bypass with your coronary
revascularization? Circulation; 116(16):1756-1758.

68.

Lattouf OM, Puskas JD, Thourani VH, Noora J, Kilgo PO, Guyton RA. 2007. Does the number ofgrafts influence surgeon choice and patient benefit of off-pump over conventional on-pump coronary
artery revascularization in multi-vessel coronary artery disease? The Annals of Thoracic Surgery;
84(5):1485-1494.

69.

Puskas JD, Edwards FH, Pappas PA, O'Brien S, Peterson ED, Kilgo PO, Ferguson TB Jr. 2007.
Off-pump techniques benefit men and women and narrow the gender disparity in mortality after
coronary bypass grafting. The Annals of Thoracic Surgery; 84(5):1447-1454.

70.

Halkos ME, Thourani VH, Lattouf OM, Kilgo PO, Guyton RA, Puskas JD. 2008. Preoperative
hemoglobin A 1 c predicts sternal wound infection after coronary artery bypass surgery with bilateralversus single internal thoracic artery grafts. Innovations: Technology and Techniques in
Cardiothoracic and Vascular Surgery; 3(3)131-138.

71.

Halkos ME, Puskas JD, Lattouf OM, Kilgo P, Guyton RA, Thourani VH. 2008. Impact of
preoperative neurologic events on outcomes after coronary artery bypass grafting. The Annals ofThoracic Surgery; 86(2):504-510.

72.

Lattouf OM, Thourani VH, Kilgo PO, Halkos ME, Baio KT, Myung R, Cooper WA, Guyton RA,
Puskas JD. 2008 Influence of on-pump versus off-pump techniques and completeness ofrevascularization on long-term survival after coronary artery bypass. The Annals of Thoracic Surgery;86(2):504-510.

73.

Halkos ME, Puskas JD, Lattouf OM, Kilgo PO, Kerendi F, Song HK, Guyton RA, Thourani VH.
2008. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary
artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery; 136(3):631-640.

74.

Puskas JD, Kilgo PO, Lattouf OM, Thourani VH, Cooper WA, Vassiliades TA, Chen EP, Vega JD,
Guyton RA. 2008. Off-pump coronary bypass provides reduced mortality and morbidity andequivalent 10-year survival. The Annals of Thoracic Surgery; 86(4):1139-1146.

John D. Puskas, MD, MSc, FACS, FACC

Page 38 of 60

75.

Kerendi F, Morris CD, Puskas JD. 2008. Off-pump coronary bypass surgery for high-risk patients:
only in expert centers? Current Opinion in Cardiology, 23(6):573-578.

76.

Halkos ME, Lattouf OM, Puskas JD, Kilgo P, Cooper WA, Morris CD, Guyton RA, Thourani VH.
2008. Elevated preoperative hemoglobin A 1 c level is associated with reduced long-term survival
after coronary artery bypass surgery. The Annals of Thoracic Surgery; 86(5):1431-1437.

77.

Thourani VH, Myung R, Kilgo PO, Thompson K, Puskas JD, Lattouf OM, Cooper WA, Vega JD,
Chen EP, Guyton RA. 2008. Long-term outcomes after isolated aortic valve replacement in
octogenarians: a modern perspective. The Annals of Thoracic Surgery; 86(5):1458-1465.

78.

Puskas JD. 2009. The current status of anastomotic devices for coronary artery bypass surgery.
Innovations: Technology & Techniques in Cardiothoracic & Vascular Surgery; 4(1):9-12.

79.

Kalogeropoulos AP, Georgiopoulou W, Giamouzis G, Smith AL, Agha SA, Waheed S, Laskar S,
Puskas JD, Dunbar S, Vega JD, Levy WC, Butler J . 2009. Utility of the Seattle Heart Failure Modelin Patients with Advanced Heart Failure. Journal of the American College of Cardiology; 27(53)334342.

80.

Halkos ME, Puskas JD. 2009 Are All Bileaflet Mechanical Valves equal? Valvular Heart Disease.
Current Opinion in Cardiology, 24(2): 136-141.

81.

Sarin EL. Puskas JD, Kilgo PD, Thourani VH, Guyton RA, Lattouf OM. 2009. Off-pump coronary
artery bypass grafting is associated with reduced operative mortality and in-hospital adverse eventsin patients with left main coronary artery disease. Innovations: Technology and Techniques in
Cardiothoracic and Vascular Surgery (4)2:80-85.

82.

Puskas JD, Halkos ME, Balkhy H, Caskey M, Connolly M, Crouch J, Diegeler A, Gummert J,
Harringer W, Subramanian V, Sutter F, Matschke K, EPIC Trial Investigators. 2009. Evaluation of
the PAS-Port proximal anastomosis system in coronary artery bypass surgery (the EPIC trial) Journalof Thoracic and Cardiovascular Surgery; 138(1):125-132.

83.

Halkos ME. Puskas JD. 2009. Off-pump versus on-pump coronary artery bypass grafting. Surgical
Clinics of North America; 89(4) 912-922.ix.

84.

Halkos ME, Chen EP, Sarin EL, Kilgo P, Thourani VH, Lattouf OM, Vega JD, Morris CD,
Vassiliades T, Cooper WA, Guyton RA, Puskas JD. 2009. Aortic valve replacement for aortic
stenosis in patients with left ventricular dysfunction. The Annals of Thoracic Surgery; 88(3):746-751.

85.

Cooper WA, Thourani VH, Guyton RA, Kilgo P, Lattouf OM, Chen EP, Morris CD, Vega D,
Vassiliades TA, Puskas JD. 2009. Racial disparity persists after on-pump and off-pump coronary
artery bypass grafting. Circulation; 120(11 Suppl):S59·64.

86.

EI-Chami M, Kilgo P, Thourani V, Lattouf OM, Delurgio DB, Guyton RA, Leon AR, Puskas JD.
2009. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft.
Journal American College of Cardiology,(55)12:1370-1376.

87.

Puskas JD, Thourani VH, Kilgo P, Cooper W, Vassiliades TA, Vega JD, Morris CD, Chen E,

John D. Puskas, MD, MSc, FACS, FACC

Page 39 of 60

Schmotzer B, Guyton RA, Lattouf OM. 2009. Off-pump coronary artery bypass disproportionately
benefits high-risk patients. Ann Thoracic Surg 88(4):1142-1147.
88.

Halkos ME, Kerendi F, Myung R. Kilgo P, Puskas JD, Chen EP. 2009. Selective antegrade cerebral
perfusion via right axillary artery cannulation reduces morbidity and mortality after proximal aortic
surgery. Journal Thoracic and Cardiovascular Surgery; 138(5):1081-1089.

89.

Halkos ME, Puskas JD. 2009. Teaching off-pump coronary artery bypass surgery. Seminars inThoracic Cardiovascular, 21 (3):224-228.

90.

Puskas JD. 2009. Invited Editorial: ISMICS Means Innovations. Innovations; 4(5):241-247.

91.

Eldaif SM, Thourani VH, Puskas JD. 2010. Cerebral emboli generation during off-pump coronary
artery bypass grafting with a clampless device vs partial clamping of the ascending aorta. Innovations;5(1):7-11.

92.

Zhao ZA, Puskas JD, Xu OX, Wang NP, Mosunjac M, Guyton R, Vinten-Johansen J, Mathey R.
2010. Improvement In cardiac function with small intestine extracellular matrix is associated withrecruitment of C-Kit cells, myofibroblasts, and macrophages after myocardial Infarction. Journal
American College of Cardiology; 55(12):1250·1261.

93.

Puskas JD, Mack MJ, Smith CR 2010. Letter to the Editor: “On-pump versus off-pump CABG".
New England Journal of Medicine; 362(9):851.

94.

Cheng DC, Martin J, Ferdinand FD, Puskas JD, Diegeler A, Allen KB, 2010. Endoscopic vein graft
harvesting: Balancing the risk and benefits. Innovations; 5(2):70-73.

95.

Ad N, Cheng DCH, Martin J, Berglin EE, Change BC, Doukas G, Gammie JS, Nitta T, Wolf RK,
Puskas JD. 2009. Consensus Statement, surgical ablation for atrial fibrillation in cardiac surgery: A
consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery(ISMICS) Innovations; 5(2):74-83.

96.

Cheng DCH, Ad N, Martin J, Berglin EE, Chang BC, Doukas G, Gammie JS, Nitta T, Wott RW,
Puskas JD. 2010. Surgical ablation for atrial fibrillation in cardiac surgery: A meta-analysis andsystematic review. Innovations; 5(2}:84-96.

97.

Eldaif SM, Lattouf OM, Kilgo P, Guyton RA, Puskas JD, Thourani VH. 2010. Long-term outcomes
after CABG with concomitant Co2 transmyocardial revascularization in comparison with CABG
alone. Innovations; 5(2): 1 03-1 08.

98.

EI-Chami MF, Kilgo P, Thourani VH, Lattouf OM, Delurgio DB, Guyton RA, Leon AR, Puskas JD.
2010. New onset atrial fibrillation predicts long-term mortality after coronary bypass graft. Journal
American College of Cardiology, 55(13):1370-1376.

99.

Halkos ME, Kilgo P, Lattouf OM, Puskas JD, Guyton RA, Thourani VH. 2010. The effect of diabetes
mellitus on in-hospital and long-term outcomes after heart valve operations. The Annals of Thoracic
Surgery, 90(1}:124-130.

100. Leshnower BG, Myung RJ, Kilgo PO, Vassiliades TA, Vega JD, Thourani VH, Puskas JD, Guyton
RA, Chen EP. 2010. Moderate hypothermia and unilateral selective antegrade cerebral perfusion: aJohn D. Puskas, MD, MSc, FACS, FACC

Page 40 of 60

contemporary cerebral protection strategy for aortic arch surgery. The Annals of Thoracic Surgery;90(2):547-554.
101. Halkos ME, Puskas JD. 2010. Off-pump coronary surgery: Where do we stand in 2010? Current
Opinion in Cardiology; 25(6):583-588.
102. Prasad SM. Li S, Rankin JS, O'Brien SM, Gammie JS, Puskas JD, Shahian OM, Chedrawy EG,
Massad MG. 2010. Current outcomes of simultaneous carotid endarterectomy and coronary artery
bypass graft in North America. World Journal of Surgery; 34(10):2292-2298.
103. Kane L, Puskas JD. 2010. Quadricuspid Aortic Valve: Intraoperative transesophageal
echocardiograph image. Innovations; 5(6):453-455.
104. Keeling WB, Halkos ME, Puskas JD. 2010. Management of patients with a calcified aorta or low
ejection fraction undergoing multivessel coronary revascularization. Seminars in Thoracic andCardiovascular Surgery; 22(3):250-252.
105. Kerendi F, Halkos ME, Puskas JD, Lattouf OM, Kilgo P, Guyton RA, Thourani VH. 2011. Impact
of off-pump coronary artery bypass surgery on postoperative pulmonary complications in patientswith chronic lung disease. The Annals of Thoracic Surgery; 91(1):8-15.
106. Sarin EL, Kayatt MO, Kilgo P, Dara A, Puskas JD, Lattouf OM, Chen EP, Halkos ME, Guyton RG,
Thourani VH. 2011. Short-and long-term outcomes in octogenarian patients undergoing off-pumpcoronary artery bypass grafting compared with on-pump coronary artery bypass grafting.
Innovations; 6(2):110-115.
107. Thourani VH, Keeling WB, Kilgo PO, Puskas JD, Lattouf OM, Chen EP, Guyton RA. 2011. The
impact of body mass index on morbidity and short- and long-term mortality in cardiac valvularsurgery. The Journal of Thoracic and Cardiovascular Surgery; 142(5):1052-1061.
108. Thourani VH, Sarin EL, Keeling B, Kilgo PO, Guyton RA, Oara AB, Puskas JD, Chen EP, Cooper
WA, Vega JO, Morris CD, Lattouf OM. 2011. Long-term survival for patients with preoperative renal
failure undergoing bioprosthetic or mechanical valve replacement. The Annals of Thoracic Surgery;
91(4):1127-1134.
109. Thourani VH, Keeling WB, Sarin EL, Guyton RA, Kilgo PO, Oara AB, Puskas JD, Chen EP, Cooper
WA, Vega JO, Morris CD, Halkos ME, Lattouf OM. 2011. Impact of preoperative renal dysfunction
on long-term survival for patients undergoing aortic valve replacement. The Annals of Thoracic
Surgery; 91(6):1798-1807.
110. Puskas JD, Stringer A, Hwang SN, Hatfield B, Smith AS, Kilgo PO, William WH. 2011.
Neurocognitive and neuroanatomic changes after off-pump versus on-pump coronary artery bypass
grafting: Long-term follow-up of a randomized trial. Journal of Thoracic and Cardiovascular
Surgery; VS 141(5):1116-1127.
111. Keeling WB, Kilgo PO, Chowdhury R, Chen E, Myung R, Cooper W, Puskas JD, Lattouf OM,
Guyton RA, Thourani V. 2011. Impact of aortic versus femoral arterial cannulation for minimallyinvasive valve procedures on postoperative stroke and renal failure. Innovations; 6 (3): p 162.
112. Puskas JD, Williams WH, O'Donnell R, Patterson RE, Sigman SR, Smith AS, Baio KT, Kilgo PO,

John D. Puskas, MD, MSc, FACS, FACC

Page 41 of 60

Guyton RA. 2011. Off-pump and on-pump coronary artery bypass grafting are associated with similar
graft patency, myocardial ischemia and freedom from reintervention: Long-term follow-up of arandomized trial. The Annals of Thoracic Surgery; 91(6):1836-1843.
113. Boulton BJ, Kilgo P, Guyton RA, Puskas JD, Lattouf OM, Chen EP, Cooper WA, Vega JD, Halkos
ME, Thourani VH. 2011. Impact of preoperative renal dysfunction in patients undergoing off-pumpversus on-pump coronary artery bypass. The Annals of Thoracic Surgery; 92(2):595-602.
114. Keeling WB, Chen EP, Kilgo P, Guyton RA, Lattouf OM, Puskas JD, Vega JO, Halkos ME,
Thourani VH. 2011. Outcomes of surgical treatment for acute ascending aortic dissection in
octogenarians. Journal American College of Surgeons; 213(3):S32.
115. Leshnower BG, Guyton RA, Puskas JD. 2011 Why randomized clinical trials are important tocardiac surgeons. Current Opinion in Cardiology; 26(6):536-540.
116. Halkos ME. Rab ST, Vassiliades TA, Morris DC, Douglas JS, Kilgo PO, Liberman HA. Guyton RA,
Thourani VH, Puskas JD. 2011. Hybrid coronary revascularization versus off-pump coronary artery
bypass for the treatment of left main coronary stenosis. The Annals of Thoracic Surgery; 92(6):2155-2160.
117. Halkos ME, Puskas JD. 2011. Cognitive impairment following cardiopulmonary bypass: strategies
for its prevention. Heart 97(21):1726-1727.
118. Halkos ME, Vassiliades TA, Douglas JS, Morris DC, Rab ST, Liberman HA, Samady H, Kilgo PO,
Guyton RA, Puskas JD. 2011. Hybrid coronary revascularization versus off pump coronary bypass
grafting for the treatment of multivessel coronary artery disease. The Annals of Thoracic Surgery;
92(5):1695-1702.
119. EI Zayat Hisham, Puskas JD, Hwang S, Thourani VH, Lattouf OM, Kilgo P, Halkos ME. 2011.
Avoiding the clamp during off-pump coronary artery bypass reduces cerebral embolic events: Resultsof a prospective randomized trial. Interact Cardiovascular Thoracic Surgery; 14(1):12·16.
120. Thourani VH, Keeling WB, Kilgo PO, Puskas JD, Lattouf OM, Chen EP, Guyton RA. 2011. The
impact of body mass index on morbidity and short- and long-term mortality in cardiac valvularsurgery. The Journal of Thoracic and Cardiovascular Surgery; 142(5):1052-1061.
121. Jacobs JP, Edwards FH, Shahian OM, Haan CK, Puskas JD, Morales DL, Gammie JS, Sanchez JA,
Brennan JM. O'Brien SM, Dokholyan RS, Hammill BG, Curtis LH, Peterson ED, Badhwar V, George
KM, Mayer JE JR, Chitwood WR JR, Murray GF, Grover FL. 2011. Successful linking of the Societyof Thoracic Surgeons Adult Cardiac Surgery Database to Centers for Medicare and Medicare
Services. The Annals of Thoracic Surgery; 92(1):32-37; discussion 38-39.
122. Hillis LD, Smith PK, Anderson JL, Bittle JA, Bridges CR, Byrne JG, Cigarroa JE, DiSesa VJ,
Hiratzka LF, Hutter AM, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel
MR, Puskas JD, Sabik JF, Seines 0, Shahian OM, Trost JC, Winniford MD. 2011. ACCF/AHA
Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary, Journal American
College of Cardiology, 58(24):2585-2614.
123. Elfstrom KM, Hatefi D. Kilgo PD. Puskas JD, Thourani VH, Guyton RA, Halkos ME. 2011. What
happens after discharge? An analysis of long-term survival in cardiac surgical patients requiring

John D. Puskas, MD, MSc, FACS, FACC

Page 42 of 60

prolonged intensive care. Journal of Cardiac Surgery; 27(1):13-19.
124. Hillis LO, Smith PK, Anderson JL, Bittle JA. Bridges CR, Byrne JG, Cigarroa .IE, DiSesa VJ,
Hiratzka LF, Hutter AM, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel
MR, Puskas JD, Sabik JF, Seines 0, Shahian OM, Trost JC, Winniford MD. 2011. ACCF/AHA
guideline for coronary artery bypass graft surgery: Executive summary. The Journal of Thoracic andCardiovascular Surgery; 143(1):4-34.
125. Chowdhury R, White 0, Puskas JD, Thourani VH, Chen EP, Lattouf OM, Cooper WA, Myung R.
Guyton RA, Halkos ME. 2012. Risk factors for conversion to cardiopulmonary bypass during off
pump coronary artery bypass surgery. The Annals of Thoracic Surgery; 93(6): 1936-1942.
126. Leshnower BG, Guyton RA, Myung RJ, Puskas JD, Kilgo PO, McPherson L, Chen EP. 2012.
Expanding the indications for the David V aortic root replacement: Early results. The Journal ofThoracic and Cardiovascular Surgery; 143(4):879-884.
127. Polomsky M, Puskas JD. 2012. Off-pump coronary artery bypass grafting. Circulation Journal;
76(4):784-790.
128. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, DiSesa VJ, Hiratzka
LF, Hutter AM Jr., Jessen ME, Keeley EC, Lahey SJ, Lange RAt London MJ, Mack MJ, Patel MR,
Puskas JD, Sablk JF, Seines 0, Shahian OM, Trost JC, Winniford MD. 2012. Special Articles: 2011
ACCF/AHA Guideline for coronary artery bypass graft surgery: executive summary: a report of theAmerican College of Cardiology Foundation/American Heart Association Task Force on practiceguidelines. Anesthesia Analogies; 114(1):11-45.
129. EI Chami MF, Kilgo PO, Elfstrom KM, Halkos ME, Thourani VH, Lattouf OM, Delurglo DB,
Guyton RA, Leon AR, Puskas JD. 2012. Prediction of new onset atrial fibrillation after cardiac
revascularization surgery. American Journal Cardiology, E Journal May 25. 2012.
130. Leshnower BG, Myung RJ, Thourani VH, Halkos ME. Kilgo PO, Puskas JD, Chen EP. 2012.
Hemiarch replacement at 28 degrees C: an analysis of mild and moderate hypothermia in 500 patients.
The Annals of Thoracic Surgery; 93(6)1910-1916.
131. Chowdhury R. White 0, Kilgo PO, Puskas JD, Thourani VH, Chen EP, Lattouf OM, Cooper WA,
Myung RJ, Guyton RA, Halkos ME. 2012. Risk factors for conversion to cardiopulmonary bypass
during off-pump coronary artery bypass surgery. The Annals of Thoracic Surgery; 93(6):1936-1942.
132. Smith PK, Michler RE, Woo YJ, Alexander JH, Puskas JD, Parides MK, Hahn RT, Williams JB,
Dent JM, Ferguson TB Jr., Moquete E, Rose EA, Page P, Jeffries NO, O'Gara PT, Ascheim DO.
2012. Design, rationale and initiation of the surgical interventions for moderate ischemic mitral
regurgitation trial: A report from the Cardiothoracic Surgical Trials Network. Journal of Thoracic
and Cardiovascular Surgery; 143(1):111-117.
133. Thourani VH, Sarin EL, Kilgo PO, Lattouf OM, Puskas JD, Chen EP, Guyton RA. 2012. Short-and
long-term outcomes in patients undergoing valve surgery with end stage renal failure receiving
chronic hemodialysis. Journal of Thoracic and Cardiovascular Surgery; 144(1):117-123.
134. Puskas JD, Kilgo PO, Thourani VH. Lattouf OM, Chen E, Vega JD, Cooper W, Guyton RA, Halkos
ME. 2012. The Society of Thoracic Surgeons 30-day predicted risk of mortality score also predicts

John D. Puskas, MD, MSc, FACS, FACC

Page 43 of 60

long-term survival. The Annals of Thoracic Surgery; 93(1):26-35.
135. Rab ST, Douglas JS, Puskas JD, Halkos ME, Guyton RA, Vassiliades TA. 2012. Hybrid Coronary
Revascularization for the Treatment of Left Main Coronary Stenosis. Catheterization andCardiovascular Interventions 80(2): 238-44.
136. Puskas JD, Sadiq A, Vassiliades TA, Kilgo PO, Lattouf OM. 2012. Bilateral Internal Thoracic Artery
Grafting Is Associated With Significantly Improved Long-Term Survival, Even Among Diabetic
Patients. The Annals of Thoracic Surgery, 94(3): 710-716.
137. Halkos ME, Vassiliades TA, Myung R, Kilgo PD, Thourani VH, Cooper WA, Guyton RA, Lattouf
OM, Puskas JD. 2012. Sternotomy Versus Nonsternotomy LIMA-LAD Grafting for Single-Vessel
Disease. The Annals of Thoracic Surgery, 94(5): 1469-1477.
138. Tong BC, Huber JC, Ascheim DD, Puskas JD, Ferguson TB, Blackstone EH and Smith PK. 2012.
Weighting composite endpoints in clinical trials: essential evidence for the heart team. The Annals ofThoracic Surgery 94(6):1908-1913.
139. Thourani VH, Chowdhury R, Gunter RL, Kilgo PD, Chen EP, Puskas JD, Halkos ME, Lattouf
OM, Cooper WA, Guyton RA. 2013. The Impact of Specific Preoperative Organ Dysfunction in
Patients Undergoing Aortic Valve Replacement. The Annals of Thoracic Surgery, 95(3):838-845.
140. Polomsky M, He X, O’Brien SM, Puskas JD. 2013. Outcomes of Off-Pump versus On-Pump
Coronary Artery Bypass Grafting: Impact of Preoperative Risk. Journal of Thoracic andCardiovascular Surgery, 145(5):1193-1198.
141. Jacobs JP, O’Brien SM, Shahian DM, Edward FH, Badhwar V, Dokholyan RS, Sanchez JA,
Morales DL, Prager RL, Wright CD, Puskas JD, Gammie JS, Haan CK, George KM, Sheng S,
Peterson ED, Shewan CM, Han JM, Bongiorno PA, Yohe C, Williams WG, Mayer JE, Grover FL.
2013. Successful Linking of the Society of Thoracic Surgeons Database to Social Security Data to
Examine the Accuracy of Society of Thoracic Surgeons Mortality Data. Journal of Thoracic andCardiovascular Surgery, 145(4):976-983.
142. Daniel WT, Kilgo PD, Puskas JD, Thourani VH, Lattouf OM, Guyton RA, Halkos ME. 2013.
Trends in Aortic Clamping use During Coronary Artery Bypass Surgery: Effect of Aortic
Clamping Strategies on Neurologic Outcomes. Journal of Thoracic and Cardiovascular Surgery,
147 (2):652-657.
143. Keeling WB, Kilgo PD, Puskas JD, Halkos ME, Lattouf OM, Guyton RA, Thourani VH. 2012.
Off-Pump Coronary Artery Bypass Grafting Attenuates Morbidity and Mortality for Patients with
Low and High Body Mass Index. Journal Thoracic and Cardiovascular Surgery, 146(6): 14421448.
144. Horvath KA, Acker MA, Chang H, Bagiella E, Smith PK, Iribame A, Kron IL, Lackner P,
Argenziano M, Ascheim DD, Gelijns AC, Michler RE, Van Patten D, Puskas JD, O’Sullivan K,
Kliniewski D, Jeffries, NO, O’Gara PT, Moskowitz AJ, Blackstone EH. 2013. Blood transfusion
and infection after cardiac surgery. The Annals of Thoracic Surgery, 95(6):2194-2201.
145. Kayatta MO, Dineen SP, Sica G, Puskas JD, Pickens A. 2013. Primary Pericardial Mesothelioma
in a 19-Year-Old Presenting as Pericarditis. The Annals of Thoracic Surgery, 96(2): 680-681.

John D. Puskas, MD, MSc, FACS, FACC

Page 44 of 60

146. Moss E, Puskas JD. 2013. Editorial Comment “Endoscopic Vein Harvest: Standard of Care?”European Journal of Cardio-Thoracic Surgery (2013)1-2.
147. Keeling WB, Williams ML, Slaughter MS, Zhao Y, Puskas JD. 2013. Off-pump and on-pumpcoronary revascularization in patients with low ejection fraction: a report from The Society ofThoracic Surgeons National Database. The Annals of Thoracic Surgery, 96(1):83-89.
148. Gunter RL, Kilgo P, Guyton RA, Chen EP, Puskas JD, Cooper WA, Halkos ME, Lattouf OM,
Babaliaros V, Myung R, Leshnower B, Thourani VH. 2013. Impact of preoperative chronic lungdisease on survival after surgical aortic valve replacement. The Annals of Thoracic Surgery,96(4):1322-1328.
149. Comas GM, Leshnower BG, Halkos ME, Thourani VH, Puskas JD, Guyton RA, Kilgo PD, Chen
EP. 2013. Acute type A dissection: Impact of antegrade cerebral perfusion under moderate
hypothermia. The Annals of Thoracic Surgery, 96(6):2135-2141.
150. Halkos ME, Walker PF, Vassiliades TA, Douglas JS, Devireddy C, Guyton RA, Finn AV, Rab ST,
Puskas JD and Liberman HA. 2013 Clinical and angiographic results after hybrid coronary
revascularization. The Annals of Thoracic Surgery, 97(2):484-490.
151. Sergeant P and Puskas JD. 2013. Imperitia culpae adnumeratur. The Annals of Thoracic Surgery
96(3):751-754.
152. Head SJ, Borgemann J, Osnabrugge RL, Kieser TM, Falk V, Taggart DP, Puskas JD, Gummert JF,
Kappetein AP. 2013. Coronary artery bypass grafting: Part 2--optimizing outcomes and future
prospects. European Heart Journal, 34 (37), 2873-2886.
153. Acker, M. A., M. K. Parides, L. P. Perrault, A. J. Moskowitz, A. C. Gelijns, P. Voisine, P. K.
Smith, J. W. Hung, E. H. Blackstone, J. D. Puskas, M. Argenziano, J. S. Gammie, M. Mack, D. D.
Ascheim, E. Bagiella, E. G. Moquete, T. B. Ferguson, K. A. Horvath, N. L. Geller, M. A. Miller, Y.
J. Woo, D. A. D'Alessandro, G. Ailawadi, F. Dagenais, T. J. Gardner, P. T. O'Gara, R. E. Michler,
and I. L. Kron. 2014. Mitral-valve repair versus replacement for severe ischemic mitral
regurgitation. N Engl J Med, 370: 23-32.
154. Bakaeen, F. G., A. L. Shroyer, J. S. Gammie, J. F. Sabik, L. D. Cornwell, J. S. Coselli, T. K.
Rosengart, S. M. O'Brien, A. Wallace, D. M. Shahian, F. L. Grover, and J. D. Puskas. 2014. Trends
in use of off-pump coronary artery bypass grafting: Results from the Society of Thoracic Surgeons
Adult Cardiac Surgery Database. J Thorac Cardiovasc Surg, 148: 856-3, 64.e1; discussion 63-4.
155. Caceres, M., Y. Ma, J. S. Rankin, P. Saha-Chaudhuri, B. R. Englum, J. S. Gammie, R. M. Suri, V.
H. Thourani, F. Esmailian, L. S. Czer, J. D. Puskas, and L. G. Svensson. 2014. Mortality
characteristics of aortic root surgery in North America. Eur J Cardiothorac Surg, 46: 887-93.
156. Carabello, B. A., and J. D. Puskas. 2014. Transcatheter aortic valve replacement: the leak goes on.
JACC Cardiovasc Interv, 7: 1033-5.
157. Daniel, W. T., 3rd, P. Kilgo, J. D. Puskas, V. H. Thourani, O. M. Lattouf, R. A. Guyton, and M. E.
Halkos. 2014. Trends in aortic clamp use during coronary artery bypass surgery: effect of aortic
clamping strategies on neurologic outcomes. J Thorac Cardiovasc Surg, 147: 652-7.

John D. Puskas, MD, MSc, FACS, FACC

Page 45 of 60

158. Daniel, W. T., H. A. Liberman, P. Kilgo, J. D. Puskas, T. A. Vassiliades, C. Devireddy, W. Jaber,
R. A. Guyton, and M. E. Halkos. 2014. The impact of clopidogrel therapy on postoperative bleeding
after robotic-assisted coronary artery bypass surgery. Eur J Cardiothorac Surg, 46: e8-13.
159. Gelijns, A. C., A. J. Moskowitz, M. A. Acker, M. Argenziano, N. L. Geller, J. D. Puskas, L. P.
Perrault, P. K. Smith, I. L. Kron, R. E. Michler, M. A. Miller, T. J. Gardner, D. D. Ascheim, G.
Ailawadi, P. Lackner, L. A. Goldsmith, S. Robichaud, R. A. Miller, E. A. Rose, T. B. Ferguson, Jr.,K. A. Horvath, E. G. Moquete, M. K. Parides, E. Bagiella, P. T. O'Gara, and E. H. Blackstone.
2014. Management practices and major infections after cardiac surgery. J Am Coll Cardiol, 64:
372-81.
160. Halkos, M. E., L. Ford, D. Peterson, S. M. Bluestein, H. A. Liberman, P. Kilgo, J. D. Puskas, R. A.
Guyton, and R. Chowdhury. 2014. The impact of hybrid coronary revascularization on hospitalcosts and reimbursements. Ann Thorac Surg, 97: 1610-5; discussion 15-6.
161. Halkos, M. E., H. A. Liberman, C. Devireddy, P. Walker, A. V. Finn, W. Jaber, R. A. Guyton, andJ. D. Puskas. 2014. Early clinical and angiographic outcomes after robotic-assisted coronary artery
bypass surgery. J Thorac Cardiovasc Surg, 147: 179-85.
162. Harskamp, R. E., J. O. Bonatti, D. X. Zhao, J. D. Puskas, R. J. de Winter, J. H. Alexander, and M.
E. Halkos. 2014. Standardizing definitions for hybrid coronary revascularization. J Thorac
Cardiovasc Surg, 147: 556-60.
163. Harskamp, R. E., J. M. Brennan, Y. Xian, M. E. Halkos, J. D. Puskas, V. H. Thourani, J. S.
Gammie, B. S. Taylor, R. J. de Winter, S. Kim, S. O'Brien, E. D. Peterson, and J. G. Gaca. 2014.
Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States:
an analysis from the society of thoracic surgeons adult cardiac database. Circulation, 130: 872-9.
164. Harskamp, R. E., J. D. Puskas, J. G. Tijssen, P. F. Walker, H. A. Liberman, R. D. Lopes, T. A.
Vassiliades, E. D. Peterson, and M. E. Halkos. 2014. Comparison of hybrid coronary
revascularization versus coronary artery bypass grafting in patients>/=65 years with multivessel
coronary artery disease. Am J Cardiol, 114: 224-9.
165. Harskamp, R. E., P. F. Walker, J. H. Alexander, Y. Xian, H. A. Liberman, R. J. de Winter, T. A.
Vassiliades, E. D. Peterson, J. D. Puskas, and M. E. Halkos. 2014. Clinical outcomes of hybrid
coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus.
Am Heart J, 168: 471-8.
166. Iribarne, Alexander, Helena Chang, John H. Alexander, A. Marc Gillinov, Ellen Moquete, John D.
Puskas, Emilia Bagiella, Michael A. Acker, Mary Lou Mayer, T. Bruce Ferguson, Sandra Burks,Louis P. Perrault, Stacey Welsh, Karen C. Johnston, Mandy Murphy, Joseph J. DeRose, Alexis
Neill, Edlira Dobrev, Kim T. Baio, Wendy Taddei-Peters, Alan J. Moskowitz, and Patrick T.
O’Gara. 2014. Readmissions After Cardiac Surgery: Experience of&#xa0;the National Institutes of
Health/Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network. The Annalsof Thoracic Surgery, 98: 1274-80.
167. Polomsky, M., P. D. Kilgo, J. D. Puskas, M. E. Halkos, V. H. Thourani, H. M. Kelli, R. A. Guyton,
and O. M. Lattouf. 2014. Long-term survival for patients with metabolic syndrome after
bioprosthetic or mechanical valve replacement. J Card Surg, 29: 26-34.

John D. Puskas, MD, MSc, FACS, FACC

Page 46 of 60

168. Puskas, J. D., A. Pawale, and S. K. Sharma. 2014. Hybrid coronary revascularization: a newtreatment paradigm for selected patients with multivessel coronary artery disease. JACC Cardiovasc
Interv, 7: 1284-6.
169. Puskas, J., M. Gerdisch, D. Nichols, R. Quinn, C. Anderson, B. Rhenman, L. Fermin, M. McGrath,
B. Kong, C. Hughes, G. Sethi, M. Wait, T. Martin, and A. Graeve. 2014. Reduced anticoagulation
after mechanical aortic valve replacement: interim results from the prospective randomized on-X
valve anticoagulation clinical trial randomized Food and Drug Administration investigational
device exemption trial. J Thorac Cardiovasc Surg, 147: 1202-10; discussion 10-1.
170. Puskas, John D., Harold L. Lazar, Michael J. Mack, Joseph F. Sabik, III, and David Paul Taggart.
2014. State-of-the-Art Coronary Artery Bypass Graft. Seminars in Thoracic and Cardiovascular
Surgery, 26: 76-94.
171. Razavi, S. A., A. B. Carter, J. D. Puskas, S. R. Gregg, I. F. Aziz, and T. G. Buchman. 2014.
Reduced red blood cell transfusion in cardiothoracic surgery after implementation of a novel
clinical decision support tool. J Am Coll Surg, 219: 1028-36.
172. Salzberg, Sacha P., John D. Puskas, and Maximilian Y. Emmert. 2014. Letter Regarding Article,“Should Off-Pump Coronary Artery Bypass Grafting Be Abandoned”. Circulation, 129: e388-e88.
173. Shapira, O. M., V. Badhwar, D. Shahian, J. P. Jacobs, U. Izhar, Y. Bao, A. Korach, O. M. Lattouf,
F. L. Grover, and J. D. Puskas. 2014. International participation in the Society of Thoracic
Surgeons National Database. Ann Thorac Surg, 97: 1127-30.
174. Smith, P. K., J. D. Puskas, D. D. Ascheim, P. Voisine, A. C. Gelijns, A. J. Moskowitz, J. W. Hung,
M. K. Parides, G. Ailawadi, L. P. Perrault, M. A. Acker, M. Argenziano, V. Thourani, J. S.
Gammie, M. A. Miller, P. Page, J. R. Overbey, E. Bagiella, F. Dagenais, E. H. Blackstone, I. L.
Kron, D. J. Goldstein, E. A. Rose, E. G. Moquete, N. Jeffries, T. J. Gardner, P. T. O'Gara, J. H.
Alexander, and R. E. Michler. 2014. Surgical treatment of moderate ischemic mitral regurgitation,
N Engl J Med, 371: 2178-88.
175. Thourani, V. H., S. A. Razavi, T. C. Nguyen, P. D. Kilgo, J. D. Puskas, R. A. Guyton, O. M.
Lattouf, B. G. Leshnower, E. P. Chen, E. L. Sarin, and M. E. Halkos. 2014. Incidence of
postoperative stroke using the Heartstring device in 1,380 coronary artery bypass graft patients withmild to severe atherosclerosis of the ascending aorta. Ann Thorac Surg, 97: 2066-72; discussion 72.
176. El-Chami, M. F., J. N. Binongo, M. Levy, F. M. Merchant, M. Halkos, V. Thourani, O. Lattouf, R.
Guyton, J. Puskas, and A. R. Leon. 2015. Effect of Surgical Atrial Fibrillation Ablation at the Timeof Cardiac Surgery on Risk of Postoperative Pacemaker Implantation. Am J Cardiol, 116: 88-91.
177. Emery, R., E. Solien, and J. Puskas. 2015a. Saphenous Vein Graft Wrapping by Nitinol Mesh: A
Word of Caution. Thorac Cardiovasc Surg, 63: 298-9.
178. Emery, R. W., E. Solien, and J. D. Puskas. 2015b. Implantation of the eSVS Mesh: modification ofrecommended technique. Innovations (Phila), 10: 146-9.
179. Gaudino, M., D. Taggart, H. Suma, J. D. Puskas, F. Crea, and M. Massetti. 2015. The Choice ofConduits in Coronary Artery Bypass Surgery. J Am Coll Cardiol, 66: 1729-37.

John D. Puskas, MD, MSc, FACS, FACC

Page 47 of 60

180. Gillinov, A. M., A. C. Gelijns, M. K. Parides, J. J. DeRose, Jr., A. J. Moskowitz, P. Voisine, G.
Ailawadi, D. Bouchard, P. K. Smith, M. J. Mack, M. A. Acker, J. C. Mullen, E. A. Rose, H. L.
Chang, J. D. Puskas, J. P. Couderc, T. J. Gardner, R. Varghese, K. A. Horvath, S. F. Bolling, R. E.
Michler, N. L. Geller, D. D. Ascheim, M. A. Miller, E. Bagiella, E. G. Moquete, P. Williams, W. C.
Taddei-Peters, P. T. O'Gara, E. H. Blackstone, and M. Argenziano. 2015. Surgical ablation of atrial
fibrillation during mitral-valve surgery. N Engl J Med, 372: 1399-409.
181. Harskamp, R. E., T. A. Vassiliades, R. H. Mehta, R. J. de Winter, R. D. Lopes, Y. Xian, E. D.
Peterson, J. D. Puskas, and M. E. Halkos. 2015. Comparative Effectiveness of Hybrid Coronary
Revascularization vs Coronary Artery Bypass Grafting. J Am Coll Surg, 221: 326-34.e1.
182. Kron, I. L., J. Hung, J. R. Overbey, D. Bouchard, A. C. Gelijns, A. J. Moskowitz, P. Voisine, P. T.
O'Gara, M. Argenziano, R. E. Michler, M. Gillinov, J. D. Puskas, J. S. Gammie, M. J. Mack, P. K.
Smith, C. Sai-Sudhakar, T. J. Gardner, G. Ailawadi, X. Zeng, K. O'Sullivan, M. K. Parides, R.
Swayze, V. Thourani, E. A. Rose, L. P. Perrault, and M. A. Acker. 2015. Predicting recurrent mitral
regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc
Surg, 149: 752-61.e1.
183. Masson, S., J. H. Wu, C. Simon, S. Barlera, R. Marchioli, J. Mariani, A. Macchia, F. Lombardi, T.
Vago, A. Aleksova, L. Dreas, R. R. Favaloro, A. R. Hershson, J. D. Puskas, L. Dozza, M. G.
Silletta, G. Tognoni, D. Mozaffarian, and R. Latini. 2015. Circulating cardiac biomarkers andpostoperative atrial fibrillation in the OPERA trial. Eur J Clin Invest, 45: 170-8.
184. Moss, E., J. D. Puskas, V. H. Thourani, P. Kilgo, E. P. Chen, B. G. Leshnower, O. M. Lattouf, R.
A. Guyton, K. E. Glas, and M. E. Halkos. 2015. Avoiding aortic clamping during coronary artery
bypass grafting reduces postoperative stroke. J Thorac Cardiovasc Surg, 149: 175-80.
185. Puskas, J. D., J. Martin, D. C. Cheng, S. Benussi, J. O. Bonatti, A. Diegeler, F. D. Ferdinand, T. M.
Kieser, A. Lamy, M. J. Mack, N. C. Patel, M. Ruel, J. F. Sabik, 3rd, B. Yanagawa, and V. Zamvar.
2015. ISMICS Consensus Conference and Statements of Randomized Controlled Trials of OffPump Versus Conventional Coronary Artery Bypass Surgery. Innovations (Phila), 10: 219-29.
186. Tranbaugh, R. F., D. J. Lucido, K. R. Dimitrova, D. M. Hoffman, C. M. Geller, G. R. Dincheva,
and J. D. Puskas. 2015. Multiple arterial bypass grafting should be routine. J Thorac Cardiovasc
Surg, 150: 1537-44; discussion 44-5.
187. Umpierrez, G., S. Cardona, F. Pasquel, S. Jacobs, L. Peng, M. Unigwe, C. A. Newton, D. SmileyByrd, P. Vellanki, M. Halkos, J. D. Puskas, R. A. Guyton, and V. H. Thourani. 2015a. Randomized
Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing
Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial. Diabetes Care, 38: 1665-72.
188. Umpierrez, Guillermo, Saumeth Cardona, Francisco Pasquel, Sol Jacobs, Limin Peng, Michael
Unigwe, Christopher A. Newton, Dawn Smiley-Byrd, Priyathama Vellanki, Michael Halkos, John
D. Puskas, Robert A. Guyton, and Vinod H. Thourani. 2015b. Randomized Controlled Trial of
Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass
Graft Surgery: GLUCO-CABG Trial. Diabetes Care, 38: 1665-72.
189. Yanagawa, B., V. Orozco-Sevilla, A. Pawale, and J. D. Puskas. 2015. Piggyback techniquefacilitates off-pump coronary artery bypass graft by using a proximal anastamostic device witharterial conduits. J Thorac Cardiovasc Surg, 150: 725-7.
190. Yanagawa, B., and J. D. Puskas. 2015a. 'Invited Commentary', Ann Thorac Surg, 100: 2261.
2015b. State-of-the-art surgical coronary revascularization: Multiple arterial conduits, minimal
aortic manipulation. J Thorac Cardiovasc Surg, 150: 259-61.

John D. Puskas, MD, MSc, FACS, FACC

Page 48 of 60

200. Domanski, M., M. E. Farkouh, V. Zak, J. French, J. H. Alexander, A. Bochenek, M. Hamon, K.
Mahaffey, J. Puskas, P. Smith, P. Shrader, and V. Fuster. 2016. Relation of Post-Coronary Artery
Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular
Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease. Am J Cardiol,
118: 1655-60.
201. Kron, I. L., M. A. Acker, D. H. Adams, G. Ailawadi, S. F. Bolling, J. W. Hung, D. S. Lim, D. J.
LaPar, M. J. Mack, P. T. O'Gara, M. K. Parides, and J. D. Puskas. 2016. The American Association
for Thoracic Surgery Consensus Guidelines: Ischemic mitral valve regurgitation. J Thorac
Cardiovasc Surg, 151: 940-56.
202. Michler, R. E., P. K. Smith, M. K. Parides, G. Ailawadi, V. Thourani, A. J. Moskowitz, M. A.
Acker, J. W. Hung, H. L. Chang, L. P. Perrault, A. M. Gillinov, M. Argenziano, E. Bagiella, J. R.
Overbey, E. G. Moquete, L. N. Gupta, M. A. Miller, W. C. Taddei-Peters, N. Jeffries, R. D. Weisel,
E. A. Rose, J. S. Gammie, J. J. DeRose, Jr., J. D. Puskas, F. Dagenais, S. G. Burks, I. El-Hamamsy,
C. A. Milano, P. Atluri, P. Voisine, P. T. O'Gara, and A. C. Gelijns. 2016. Two-Year Outcomes ofSurgical Treatment of Moderate Ischemic Mitral Regurgitation. N Engl J Med, 374: 1932-41.
203. Puskas, J. D., M. E. Halkos, J. J. DeRose, E. Bagiella, M. A. Miller, J. Overbey, J. Bonatti, V. S.
Srinivas, M. Vesely, F. Sutter, J. Lynch, K. Kirkwood, T. A. Shapiro, K. D. Boudoulas, J.
Crestanello, T. Gehrig, P. Smith, M. Ragosta, S. J. Hoff, D. Zhao, A. C. Gelijns, W. Y. Szeto, G.
Weisz, M. Argenziano, T. Vassiliades, H. Liberman, W. Matthai, and D. D. Ascheim. 2016. HybridCoronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A
Multicenter Observational Study. J Am Coll Cardiol, 68: 356-65.
204. Puskas, J. D., B. Yanagawa, and D. P. Taggart. 2016a. Advancing the State of the Art in SurgicalCoronary Revascularization. Ann Thorac Surg, 101: 419-21.
205. Puskas, J. D., B. Yanagawa, and D. P. Taggart. 2016b. Off-pump, multiple arterial grafting withminimal aortic manipulation: Is it for everyone? J Thorac Cardiovasc Surg, 151: 4-6.
206. Rosenblum, J. M., R. E. Harskamp, N. Hoedemaker, P. Walker, H. A. Liberman, R. J. de Winter, T.
A. Vassiliades, J. D. Puskas, and M. E. Halkos. 2016. Hybrid coronary revascularization versus
coronary artery bypass surgery with bilateral or single internal mammary artery grafts. J Thorac
Cardiovasc Surg, 151: 1081-9.
207. Stone, G. W., J. F. Sabik, P. W. Serruys, C. A. Simonton, P. Genereux, J. Puskas, D. E. Kandzari,
M. C. Morice, N. Lembo, W. M. Brown, 3rd, D. P. Taggart, A. Banning, B. Merkely, F. Horkay, P.
W. Boonstra, A. J. van Boven, I. Ungi, G. Bogats, S. Mansour, N. Noiseux, M. Sabate, J. Pomar, M.
Hickey, A. Gershlick, P. Buszman, A. Bochenek, E. Schampaert, P. Page, O. Dressler, I. Kosmidou,
R. Mehran, S. J. Pocock, and A. P. Kappetein. 2016. Everolimus-Eluting Stents or Bypass Surgery
for Left Main Coronary Artery Disease. N Engl J Med, 375: 2223-35.
208. Yanagawa, B., R. Nedadur, and J. D. Puskas. 2016. The future of off-pump coronary artery bypass
grafting: a North American perspective. J Thorac Dis, 8: S832-s38.
209. Yanagawa, B., J. D. Puskas, S. Verma, and J. O. Friedrich. 2016. Coronary Artery Bypass Graft
Should Be Considered in Octogenarians With Multivessel Coronary Disease. Can J Cardiol, 32:
1045.e1-3.
210. Azzalini, L., G. Torregrossa, J. D. Puskas, E. S. Brilakis, W. L. Lombardi, D. Karmpaliotis, S.
Nakamura, A. Colombo, and M. Carlino. 2017. Percutaneous revascularization of chronic total
occlusions: Rationale, indications, techniques, and the cardiac surgeon's point of view. Int J
Cardiol, 231: 90-96.

John D. Puskas, MD, MSc, FACS, FACC

Page 49 of 60

211. Baron, S. J., K. Chinnakondepalli, E. A. Magnuson, D. E. Kandzari, J. D. Puskas, O. Ben-Yehuda,
G. A. van Es, D. P. Taggart, M. C. Morice, N. J. Lembo, W. M. Brown, 3rd, A. Banning, C. A.
Simonton, A. P. Kappetein, J. F. Sabik, P. W. Serruys, G. W. Stone, and D. J. Cohen. 2017.
Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results
From the EXCEL Trial. J Am Coll Cardiol, 70: 3113-22.
212. Gaudino, M., C. Antoniades, U. Benedetto, S. Deb, A. Di Franco, G. Di Giammarco, S. Fremes, D.
Glineur, J. Grau, G. W. He, D. Marinelli, L. B. Ohmes, C. Patrono, J. Puskas, R. Tranbaugh, L. N.
Girardi, and D. P. Taggart. 2017. Mechanisms, Consequences, and Prevention of Coronary Graft
Failure. Circulation, 136: 1749-64.
213. Gaudino, M., J. D. Puskas, A. Di Franco, L. B. Ohmes, M. Iannaccone, U. Barbero, D. Glineur, J.
B. Grau, U. Benedetto, F. D'Ascenzo, F. Gaita, L. N. Girardi, and D. P. Taggart. 2017. Three
Arterial Grafts Improve Late Survival: A Meta-Analysis of Propensity-Matched Studies.
Circulation, 135: 1036-44.
214. Halkos, M. E., A. Anderson, J. N. G. Binongo, A. Stringer, Y. Lasanajak, V. H. Thourani, O. M.
Lattouf, R. A. Guyton, K. T. Baio, E. Sarin, W. B. Keeling, N. R. Cook, K. Carssow, A. Neill, K. E.
Glas, and J. D. Puskas. 2017. Operative strategies to reduce cerebral embolic events during on- andoff-pump coronary artery bypass surgery: A stratified, prospective randomized trial. J Thorac
Cardiovasc Surg, 154: 1278-85.e1.
215. Head, S. J., M. Milojevic, D. P. Taggart, and J. D. Puskas. 2017. Current Practice of State-of-theArt Surgical Coronary Revascularization. Circulation, 136: 1331-45.
216. Kron, I. L., D. J. LaPar, M. A. Acker, D. H. Adams, G. Ailawadi, S. F. Bolling, J. W. Hung, D. S.
Lim, M. J. Mack, P. T. O'Gara, M. K. Parides, and J. D. Puskas. 2017a. 2016 update to The
American Association for Thoracic Surgery (AATS) consensus guidelines: Ischemic mitral valve
regurgitation. J Thorac Cardiovasc Surg, 153: e97-e114.
217. Kron, I. L., D. J. LaPar, M. A. Acker, D. H. Adams, G. Ailawadi, S. F. Bolling, J. W. Hung, D. S.
Lim, M. J. Mack, P. T. O'Gara, M. K. Parides, and J. D. Puskas. 2017b. 2016 update to The
American Association for Thoracic Surgery consensus guidelines: Ischemic mitral valve
regurgitation. J Thorac Cardiovasc Surg, 153: 1076-79.
218. Mejia, O. A. V., Mpbo Sa, M. O. Deininger, L. R. P. Dallan, R. C. Segalote, M. A. P. Oliveira, F.
A. Atik, M. A. D. Santos, Pgmbe Silva, R. M. Milani, A. C. Hueb, R. Monteiro, R. C. Lima, L. A.
F. Lisboa, L. A. O. Dallan, J. Puskas, and F. B. Jatene. 2017. Off-pump versus On-pump Coronary
Artery Bypass Grafting in Frail Patients: Study Protocol for the FRAGILE Multicenter Randomized
Controlled Trial. Braz J Cardiovasc Surg, 32: 428-34.
219. Puskas, J. D., J. E. Bavaria, L. G. Svensson, E. H. Blackstone, B. Griffith, J. S. Gammie, D. A.
Heimansohn, J. Sadowski, K. Bartus, D. R. Johnston, J. Rozanski, T. Rosengart, L. N. Girardi, C. T.
Klodell, M. A. Mumtaz, H. Takayama, M. Halkos, V. Starnes, P. Boateng, T. A. Timek, W. Ryan,
S. Omer, and C. R. Smith. 2017. The COMMENCE trial: 2-year outcomes with an aortic
bioprosthesis with RESILIA tissue. Eur J Cardiothorac Surg, 52: 432-39.
220. Som, S., T. Danilov, J. Puskas, and D. Finkielstein. 2017. Recurrent Early Prosthetic Valve
Endocarditis Caused by Streptococcus dysgalactiae Subspecies equisimilis. Am J Med Sci, 353:
190-92.
221. Taggart, D. P., and J. D. Puskas. 2017. Five-Year Outcomes after On-Pump and Off-Pump
Coronary-Artery Bypass. N Engl J Med, 377: 1897.

John D. Puskas, MD, MSc, FACS, FACC

Page 50 of 60

222. Yanagawa, B., S. Verma, P. Juni, D. Y. Tam, A. Mazine, J. D. Puskas, and J. O. Friedrich. 2017. A
systematic review and meta-analysis of in situ versus composite bilateral internal thoracic artery
grafting. J Thorac Cardiovasc Surg, 153: 1108-16.e16.
223. Yanagawa, B., S. Verma, A. Mazine, D. Y. Tam, P. Juni, J. D. Puskas, S. Murugavel, and J. O.
Friedrich. 2017. Impact of total arterial revascularization on long term survival: A systematic
review and meta-analysis of 130,305 patients. Int J Cardiol, 233: 29-36.
224. Zhao, D. F., J. J. Edelman, M. Seco, P. G. Bannon, M. K. Wilson, M. J. Byrom, V. Thourani, A.
Lamy, D. P. Taggart, J. D. Puskas, and M. P. Vallely. 2017. Coronary Artery Bypass Grafting
With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis. J Am Coll
Cardiol, 69: 924-36.
225. Ahmadi, A., D. Stanger, J. Puskas, D. Taggart, Y. Chandrashekhar, and J. Narula. 2018. Is there arole for fractional flow reserve in coronary artery bypass graft (CABG) planning? Ann
Cardiothorac Surg, 7: 546-51.
226. Gaudino, M., G. D. Angelini, C. Antoniades, F. Bakaeen, U. Benedetto, A. M. Calafiore, A. Di
Franco, M. Di Mauro, S. E. Fremes, L. N. Girardi, D. Glineur, J. Grau, G. W. He, C. Patrono, J. D.
Puskas, M. Ruel, T. A. Schwann, D. Y. Tam, J. Tatoulis, R. Tranbaugh, M. Vallely, M. A. Zenati,
M. Mack, and D. P. Taggart. 2018. Off-Pump Coronary Artery Bypass Grafting: 30 Years of
Debate. J Am Heart Assoc, 7: e009934.
227. Gaudino, M., F. Bakaeen, U. Benedetto, M. Rahouma, A. Di Franco, D. Y. Tam, M. Iannaccone, T.
A. Schwann, R. Habib, M. Ruel, J. D. Puskas, J. Sabik, L. N. Girardi, D. P. Taggart, and S. E.
Fremes. 2018. Use Rate and Outcome in Bilateral Internal Thoracic Artery Grafting: Insights Froma Systematic Review and Meta-Analysis. J Am Heart Assoc, 7(11):e009361.
Doi:10.1161/JAHA.118.009361
228. Gaudino, M., F. Bakaeen, P. Davierwala, A. Di Franco, S. E. Fremes, N. Patel, J. D. Puskas, M.
Ruel, G. Torregrossa, M. Vallely, and D. P. Taggart. 2018. New Strategies for Surgical Myocardial
Revascularization. Circulation, 138: 2160-68.
229. Gaudino, M., U. Benedetto, F. Bakaeen, M. Rahouma, D. Y. Tam, A. Abouarab, A. Di Franco, J.
Leonard, A. Elmously, J. D. Puskas, G. D. Angelini, L. N. Girardi, S. E. Fremes, and D. P.
Taggart. 2018. Off- Versus On-Pump Coronary Surgery and the Effect of Follow-Up Length andSurgeons' Experience: A Meta-Analysis. J Am Heart Assoc, 7(21): e010034.
Doi:101161/JAHA.118.010034.
230. Gaudino, M., U. Benedetto, S. Fremes, G. Biondi-Zoccai, A. Sedrakyan, J. D. Puskas, G. D.
Angelini, B. Buxton, G. Frati, D. L. Hare, P. Hayward, G. Nasso, N. Moat, M. Peric, K. J. Yoo, G.
Speziale, L. N. Girardi, and D. P. Taggart. 2018. Radial-Artery or Saphenous-Vein Grafts inCoronary-Artery Bypass Surgery. N Engl J Med, 378: 2069-77.
231. Giustino, G., R. Mehran, P. W. Serruys, J. F. Sabik, 3rd, M. Milojevic, C. A. Simonton, J. D.
Puskas, D. E. Kandzari, M. C. Morice, D. P. Taggart, A. H. Gershlick, P. Genereux, Z. Zhang, T.
McAndrew, B. Redfors, M. Ragosta, 3rd, I. L. Kron, O. Dressler, M. B. Leon, S. J. Pocock, O. BenYehuda, A. P. Kappetein, and G. W. Stone. 2018. Left Main Revascularization With PCI or CABG
in Patients With Chronic Kidney Disease: EXCEL Trial. J Am Coll Cardiol, 72: 754-65.
232. Green, G. E., and J. D. Puskas. 2018. After 50 years, a personal reflection on the development ofinternal thoracic artery (ITA) grafting. Ann Cardiothorac Surg, 7: 644-51.

John D. Puskas, MD, MSc, FACS, FACC

Page 51 of 60

233. Kayatta, M. O., M. E. Halkos, and J. D. Puskas. 2018. Hybrid coronary revascularization for thetreatment of multivessel coronary artery disease. Ann Cardiothorac Surg, 7: 500-05.
234. Kosmidou, I., S. Chen, A. P. Kappetein, P. W. Serruys, B. J. Gersh, J. D. Puskas, D. E. Kandzari,
D. P. Taggart, M. C. Morice, P. E. Buszman, A. Bochenek, E. Schampaert, P. Page, J. F. Sabik, 3rd,
T. McAndrew, B. Redfors, O. Ben-Yehuda, and G. W. Stone. 2018. New-Onset Atrial Fibrillation
After PCI or CABG for Left Main Disease: The EXCEL Trial. J Am Coll Cardiol, 71: 739-48.
235. Leonard, J. R., M. Rahouma, A. A. Abouarab, A. N. Schwann, G. Scuderi, C. Lau, T. S. Guy, M.
Demetres, J. D. Puskas, D. P. Taggart, L. N. Girardi, and M. Gaudino. 2018. Totally endoscopic
coronary artery bypass surgery: A meta-analysis of the current evidence. Int J Cardiol, 261: 42-46.
236. Leviner, D. B., G. Torregrossa, and J. D. Puskas. 2018. Incomplete revascularization: what thesurgeon needs to know. Ann Cardiothorac Surg, 7: 463-69.
237. Mazine, A., J. O. Friedrich, R. Nedadur, S. Verma, M. Ouzounian, P. Juni, J. D. Puskas, and B.
Yanagawa. 2018. Systematic review and meta-analysis of chordal replacement versus leaflet
resection for posterior mitral leaflet prolapse. J Thorac Cardiovasc Surg, 155: 120-28.e10.
238. Melly, L., G. Torregrossa, T. Lee, J. L. Jansens, and J. D. Puskas. 2018. Fifty years of coronary
artery bypass grafting. J Thorac Dis, 10: 1960-67.
239. Puskas, J. D. 2018. Reply: Low-Thrombogenicity Mechanical Heart Valves: Which
Antithrombotic Strategy? J Am Coll Cardiol, 72: 1879-80.
240. Puskas, J. D., M. Gerdisch, D. Nichols, L. Fermin, B. Rhenman, D. Kapoor, J. Copeland, R.
Quinn, G. C. Hughes, H. Azar, M. McGrath, M. Wait, B. Kong, T. Martin, E. C. Douville, S.
Meyer, J. Ye, W. R. E. Jamieson, L. Landvater, R. Hagberg, T. Trotter, J. Armitage, J. Askew, K.
Accola, P. Levy, D. Duncan, B. Yanagawa, J. Ely, and A. Graeve. 2018. Anticoagulation andAntiplatelet Strategies After On-X Mechanical Aortic Valve Replacement. J Am Coll Cardiol, 71:
2717-26.
241. Schwann, Thomas A., Robert H. Habib, Amelia Wallace, David M. Shahian, Sean O’Brien, Jeffery
P. Jacobs, John D. Puskas, Paul A. Kurlansky, Milo C. Engoren, Robert F. Tranbaugh, and Mark
R. Bonnell. 2018. Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary
Bypass Grafting. The Annals of Thoracic Surgery, 105: 1109-19.
242. Yanagawa, B., S. Verma, A. Bagai, and J. D. Puskas. 2018. Should functional assessment of lesion
severity be used to guide coronary bypass? Curr Opin Cardiol, 33: 565-70.
243. Ben-Yehuda, O., S. Chen, B. Redfors, T. McAndrew, A. Crowley, I. Kosmidou, D. E. Kandzari, J.
D. Puskas, M. C. Morice, D. P. Taggart, M. B. Leon, N. J. Lembo, W. M. Brown, C. A. Simonton,
O. Dressler, A. P. Kappetein, J. F. Sabik, P. W. Serruys, and G. W. Stone. 2019. Impact of large
periprocedural myocardial infarction on mortality after percutaneous coronary intervention andcoronary artery bypass grafting for left main disease: an analysis from the EXCEL trial. Eur HeartJ, 40: 1930-41.
244. Benedetto, U., J. Puskas, A. P. Kappetein, W. M. Brown, 3rd, F. Horkay, P. W. Boonstra, G.
Bogats, N. Noiseux, O. Dressler, G. D. Angelini, G. W. Stone, P. W. Serruys, J. F. Sabik, and D. P.
Taggart. 2019. Off-Pump Versus On-Pump Bypass Surgery for Left Main Coronary Artery Disease.
J Am Coll Cardiol, 74: 729-40.
245. Chen, S., D. Karmpaliotis, B. Redfors, E. Shlofmitz, O. Ben-Yehuda, A. Crowley, G. Mehdipoor, J.
D. Puskas, D. E. Kandzari, A. P. Banning, M. C. Morice, D. P. Taggart, J. F. Sabik, 3rd, P. W.

John D. Puskas, MD, MSc, FACS, FACC

Page 52 of 60

Serruys, A. P. Kappetein, and G. W. Stone. 2019. Does an occluded RCA affect prognosis inpatients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL
trial. EuroIntervention, 15: e531-e38.
246. DeRose, J. J., Jr., D. M. Mancini, H. L. Chang, M. Argenziano, F. Dagenais, G. Ailawadi, L. P.
Perrault, M. K. Parides, W. C. Taddei-Peters, M. J. Mack, D. D. Glower, B. A. Yerokun, P. Atluri,
J. C. Mullen, J. D. Puskas, K. O'Sullivan, N. M. Sledz, H. Tremblay, E. Moquete, B. S. Ferket, A.
J. Moskowitz, A. Iribarne, A. C. Gelijns, P. T. O'Gara, E. H. Blackstone, and A. M. Gillinov. 2019.
Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation. J Am Coll
Cardiol, 73: 2427-35.
247. Gaudino, M., F. G. Bakaeen, U. Benedetto, A. Di Franco, S. Fremes, D. Glineur, L. N. Girardi, J.
Grau, J. D. Puskas, M. Ruel, D. Y. Tam, and D. P. Taggart. 2019. Arterial Grafts for Coronary
Bypass: A Critical Review After the Publication of ART and RADIAL. Circulation, 140: 1273-84.
248. Gaudino, M., U. Benedetto, S. E. Fremes, D. L. Hare, P. Hayward, N. Moat, M. Moscarelli, A. Di
Franco, G. Nasso, M. Peric, I. Petrovic, J. D. Puskas, G. Speziale, K. J. Yoo, L. N. Girardi, and D.
P. Taggart. 2019. Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After
Coronary Bypass Surgery. J Am Coll Cardiol, 73: 2299-306.
249. Huang, X., B. Redfors, S. Chen, Y. Liu, O. Ben-Yehuda, J. D. Puskas, D. E. Kandzari, B. Merkely,
F. Horkay, A. J. van Boven, P. W. Boonstra, J. F. Sabik, P. W. Serruys, A. P. Kappetein, and G. W.
Stone. 2019. Impact of chronic obstructive pulmonary disease on prognosis after percutaneous
coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the
EXCEL trial. Eur J Cardiothorac Surg, 55: 1144-51.
250. Milojevic, M., P. W. Serruys, J. F. Sabik, 3rd, D. E. Kandzari, E. Schampaert, A. J. van Boven, F.
Horkay, I. Ungi, S. Mansour, A. P. Banning, D. P. Taggart, M. Sabate, A. H. Gershlick, A.
Bochenek, J. Pomar, N. J. Lembo, N. Noiseux, J. D. Puskas, A. Crowley, I. Kosmidou, R. Mehran,O. Ben-Yehuda, P. Genereux, S. J. Pocock, C. A. Simonton, G. W. Stone, and A. P. Kappetein.
2019. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.
J Am Coll Cardiol, 73: 1616-28.
251. Modolo, R., P. Chichareon, N. Kogame, O. Dressler, A. Crowley, O. Ben-Yehuda, J. Puskas, A.
Banning, D. P. Taggart, A. P. Kappetein, J. A. Sabik, Y. Onuma, G. W. Stone, and P. W. Serruys.
2019. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main
Disease. J Am Coll Cardiol, 73: 1877-86.
252. Puskas, J. D., M. Gaudino, and D. P. Taggart. 2019. Experience Is Crucial in Off-Pump Coronary
Artery Bypass Grafting. Circulation, 139: 1872-75.
253. Shlofmitz, E., P. Genereux, S. Chen, O. Dressler, O. Ben-Yehuda, M. C. Morice, J. D. Puskas, D.
P. Taggart, D. E. Kandzari, A. Crowley, B. Redfors, G. Mehdipoor, A. P. Kappetein, J. F. Sabik,
3rd, P. W. Serruys, and G. W. Stone. 2019. Left Main Coronary Artery Disease Revascularization
According to the SYNTAX Score. Circ Cardiovasc Interv, 12: e008007.
254. Stone, G. W., A. P. Kappetein, J. F. Sabik, S. J. Pocock, M. C. Morice, J. Puskas, D. E. Kandzari,
D. Karmpaliotis, W. M. Brown, 3rd, N. J. Lembo, A. Banning, B. Merkely, F. Horkay, P. W.
Boonstra, A. J. van Boven, I. Ungi, G. Bogats, S. Mansour, N. Noiseux, M. Sabate, J. Pomar, M.
Hickey, A. Gershlick, P. E. Buszman, A. Bochenek, E. Schampaert, P. Page, R. Modolo, J.
Gregson, C. A. Simonton, R. Mehran, I. Kosmidou, P. Genereux, A. Crowley, O. Dressler, and P.
W. Serruys. 2019. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N
Engl J Med, 381: 1820-30.

John D. Puskas, MD, MSc, FACS, FACC

Page 53 of 60

255. Taggart, D. P., U. Benedetto, S. Gerry, D. G. Altman, A. M. Gray, B. Lees, M. Gaudino, V.
Zamvar, A. Bochenek, B. Buxton, C. Choong, S. Clark, M. Deja, J. Desai, R. Hasan, M. Jasinski, P.
O'Keefe, F. Moraes, J. Pepper, S. Seevanayagam, C. Sudarshan, U. Trivedi, S. Wos, J. Puskas, and
M. Flather. 2019. Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years. N Engl J
Med, 380: 437-46.
256. Thuijs, Djfm, M. W. A. Bekker, D. P. Taggart, A. P. Kappetein, T. M. Kieser, D. Wendt, G. Di
Giammarco, G. D. Trachiotis, J. D. Puskas, and S. J. Head. 2019. Improving coronary artery
bypass grafting: a systematic review and meta-analysis on the impact of adopting transit-time flow
measurement. Eur J Cardiothorac Surg, 56: 654-63.
257. Thuijs, Djfm, S. J. Head, G. W. Stone, J. D. Puskas, D. P. Taggart, P. W. Serruys, O. Dressler, A.
Crowley, W. M. Brown, F. Horkay, P. W. Boonstra, G. Bogats, N. Noiseux, J. F. Sabik, and A. P.
Kappetein. 2019. Outcomes following surgical revascularization with single versus bilateral internal
thoracic arterial grafts in patients with left main coronary artery disease undergoing coronary artery
bypass grafting: insights from the EXCEL trialdagger. Eur J Cardiothorac Surg, 55: 501-10.
258. Torregrossa, G., A. Amabile, E. E. Williams, and J. D. Puskas. 2019. Advanced techniques in
mitral annular calcification management. J Card Surg, 34: 1632-34.
259. Torregrossa, G., and J. D. Puskas. 2019. Commentary: Totally endoscopic bypass grafting:
Hunting for a Norwegian mushroom. J Thorac Cardiovasc Surg, 157: 1837-38.
260. Torregrossa, Gianluca, Miguel Bravo, Donna Mancini, and John Puskas. 2019. Robotic Coronary
Artery Bypass Grafting for Transplant Vasculopathy. Annals of Thoracic Surgery, 108: e77-e79.
261. Gaudino, M., J. Chikwe, V. Falk, J. S. Lawton, J. D. Puskas, and D. P. Taggart. 2020. Transatlantic
editorial: The use of multiple arterial grafts for coronary revascularization in Europe and North
America. J Thorac Cardiovasc Surg.
262. Gaudino, M., T. Schwann, J. Puskas, and P. Kolh. 2020. Analyse the evidence, generate new
evidence and apply the evidence: cardiac surgery is not only about cutting and sewing. Eur J
Cardiothorac Surg, 57: 28-29.
263. Taggart, D. P., Djfm Thuijs, G. Di Giammarco, J. D. Puskas, D. Wendt, G. D. Trachiotis, T. M.
Kieser, A. P. Kappetein, and S. J. Head. 2020. Intraoperative transit-time flow measurement andhigh-frequency ultrasound assessment in coronary artery bypass grafting. J Thorac Cardiovasc
Surg, 159: 1283-92.e2.
264. Thuijs DJFM, Milojevic M, Stone GW, Puskas JD, Serruys PW, Sabik JF, Dressler O, Crowley A,
Head SJ, Kappetein AP. 2020. Impact of left ventricular ejection fraction on clinical outcomes after
left main coronary artery revascularization: results from the randomized EXCEL trial. Eur J Heart
Fail 22(5):871-879.
265. Williams, E. E., A. Amabile, G. Torregrossa, and Puskas JD. 2020. Grafting an anomalous
coronary artery: a left anterior descending from the right coronary artery grafted with the rightinternal thoracic artery. J Card Surg, 35: 729-31.
266. Zapata, D., M. Halkos, J. Binongo, J. Puskas, R. Guyton, and O. Lattouf. 2020. Effects andoutcomes of cardiac surgery in patients with cardiometabolic syndrome. J Card Surg 35(4):794800.

John D. Puskas, MD, MSc, FACS, FACC

Page 54 of 60

267. Amabile, Andrea, Elbert E. Williams, Ujjwal Rastogi, Gianluca Torregrossa, and John D. Puskas.
2020. Naso-Gastric Tube: A Novel Way to Prevent Iatrogenic Bleeding in Emergent CABG. Ann
Thorac Surg 2020 Oct;110(4):e269-e270. doi: 10.1016/j.athoracsur.2020.02.033.
268. Daniel W, Kieser T, Giammarco G, Trachiotis G, Puskas J, Kappetein P, Ruhparwar A, Jakob H,
Head S, Taggart D. Intraoperative transit-time flow measurement in CABG: Insights from theregistry for quality assessment (RE-QUEST) study. Thorac Cardiovasc Surg 2020; 68(S01): S1S72.
269. Shah A, Levy S, Bravo M, Friedman S, Lin, Hung-mo, Casey M, O’Malley P, Puskas J, Bhatt, H.
Postoperative prevention of gastrointestinal complications in cardiac surgery patients. 2020 Critical
Care Medicine 48(1) p 116. DOI 10.1097/01.ccm.0000619428.34362.83.
270. Amabile A, Torregrossa G, Williams E, Puskas JD. 2020. Mastering off-pump, total arterial
coronary artery bypass grafting: a step-by-step approach. Multimed Man Cardiothorac Surg 2020
Jan 17; doi: 10.1510/mmcts.2020.003.
271. Giustino G, Serruys PW, Sabik JF, Mehran R, Maehara A, Puskas JD, Simonton CA, Lembo NJ,
Kandzari DE, Morice M-C, Taggart DP, Gershlick AH, Ragosta M 3rd, Kron IL, Liu Y, Zhang Z,
McAndrew T, Dressler O, Genereux P, Ben-Yehuda O, Pocock SJ, Kappetein AP, Stone GW. 2020.
JACC Cardiovasc Interv 2020 Feb 10;13(3):375-387.
272. Gaudino M, Benedetto U, Fremes SE, Hare DL, Hayward P, Moat N, Moscarelli M, Di Franco A,
Nasso G, Peric M, Petrovic I, Collins P, Webb CM, Puskas JD, Speziale G, Kyung JY, Girardi LN,
Taggart DP, RADIAL Investigators. 2020. Angiographic outcome of coronary artery bypass grafts:
the radial artery database international alliance. Ann Thorac Surg 2020 109(3):688-694.
273. Williams EE, Amabile A, Torregrossa G, Puskas JD. 2020. Grafting an anomalous coronary artery:a left anterior descending from the right coronary artery grafted with the right internal thoracic
artery. J Cardiac Surg 35(3):729-731.
274. Taggart DP, Gaudino MF, Gerry S, Gray A, Lees B, Dimagli A, Puskas JD, Zamvar V, Pawlaczyk
R, Royse AG, Flather M, Benedetto U on behalf of the ART Investigators. 2020. Effect of totalarterial grafting in the Arterial Revascularization Trial. J Thorac Cardiovasc Surg 2020 163(3):102-1009. Doi.org/10.1016/j.jtcvs.2020.03.013.
275. Lala A, Kirkwood K, Iribarne A, Moskowitz A, Overbey J, Charles EJ, Goldstein DJ, O’Gara PT,
Puskas JD, Bagiella E, Taddei-Peters W, O’Sullivan K, Miller M, Laurin C, Giustino G, Yerokun
B, Gillinov M, Gelijns A, Acker M and Stevenson L. 2020. Improvement in patient centeredoutcomes following mitral valve surgery for severe ischemic mitral regurgitation. J Am Coll
Cardiol. 2020 75(11 S1) 2168.
276. Taggart DP, Thuijs DJFM, Di Giammarco G, Puskas JD, Wendt D, Trachiotis GD, Kieser TM,
Kappetein AP, Head SJ. 2020. J Thorac Cardiovasc Surg 2020 159(4):1283-1292.e2. doi:
10.1016/j.jtcvs.2019.05.087.
277. Puskas JD. 2020. Invited Commentary: “OPCAB: It matters how you do it”. 2020. Ann Thorac
Surg 109(4):1119
278. Zapata D, Halkos M, Binongo J, Puskas JD, Guyton R, Lattouf O. 2020. Effects and outcomes ofcardiac surgery in pateint with cardiometabolic syndrome. J Cardiac Surg 35(4): 794-800.
279. Thuijs DJFM, Habib RH, Head SJ, Puskas JD, Taggart DP, Stone GW, Zhang A, Serruys PW,
Sabik JF, Kappetein AP. 2020. Prognostic performance of the society of thoracic surgeons risk

John D. Puskas, MD, MSc, FACS, FACC

Page 55 of 60

score in patients with left main coronary artery disease undergoing revascularization: a post hoc
analysis fo the EXCEL trial. Eurointervention 16:36-43; doi 10.4244/EIJ-D-19-00417.
280. Gaudino M, Chikwe J, Falk V, Lawton JS, Puskas JD, Taggart DP. 2020. Transatlantic editorial:
the use of multiple arterial grafts for coronary revacularization in Europe and North America. Eur J
Cardiothorac Surg 57(6):1032-1037.
281. Gaudino M, Benedetto U, Fremes S, Ballman K, Biondi-Zoccai G, Sedrakyan A, Nasso G, Raman J,
Buxton B, Hayward PA, Moat N, Collins P, Webb C, Peric M, Petrovic I, You KJ, Hameed I, Di
Franco A, Moscarelli M, Speziale G, Puskas JD, Girardi LN, Hare DL, Taggart DP for the
RADIAL Investigators. 2020. JAMA Jul 14;324(2):179-187.
282. Shahim B, Redfors B, Chen S, Morice M-C, Gersh BJ, Puskas JD, Kandzari DE, Merkely B,
Horkay F, Crowley A, Serruys PW, Kappetein AP, Sabik JF, Ben-Yehuda O, Stone GW. 2020.
Outcomes after left main coronary artery revascularization by percutaneou coronary intervention or
coronary artery bypass grafting according to smoking status. Am J Cardiol Jul 15:127:16-24.
283. Moreno PR, Stone GW, Gonzalez-Lengua CA, Puskas JD. 2020. The hybrid coronary approach for
optimal revascularization; JACC Review Topic of the Week. J Am Coll Cardiol 76(3):321-333.
284. Shah AG, Taduran C, Friedman S, Sarosky K, Jones M, Victory-Stewart M, Dunau F, Liesenfeld M,
Pasqualini D, Mandel S, Fiol N, Ghia S, Puskas JD, Bhatt HV, Shapiro J, Tomey M, Yimen M.
2020. Relocating IV pumps for critically ill isolated coronarvirus disease 2019 patients frombedside to outside the patient room. Crit Care Explor Aug 2(8):e0168. Doi:
10.1097/CCE.0000000000000168.
285. Jawitz OK, Wang TY, Lopes RD, Chavez A, Boyer B, Kim H, Anstrom KJ, Becker RC, Blackstone
E, Ruel M, Thourani VH, Puskas JD, Gerdisch MW, Johnston D, Capps S, Alexander JH,
Svensson LG. 2020. Rationale and design of PROACT Xa: A randomized, multicenter, open-label,clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with amechanical On-X aortic heart valve. Am Heart J Sep;227:91-99.
286. Tharaken S, Bellaire C, Roy J, Bravo M, Puskas JD, Di Luozzo G. 2020. Natural history ofascending aortic aneurysms with bicuspid and tricuspid aortic valves. Circulation.
2020;142:A16649.
287. Shah A, Carale J, Friedman S, Casey M, Puskas JD, Bhatt H, Yimen M. 2021. Postoperative atrial
fibrillation amiodarone prophylaxis in coronary artery bypass graft patients. Critical Care
Medicine: Jan 2021 49(1):p 187.
288. Gaudino M, Ruel M, Obadia J-F, De Bonis M, Puskas JD, Biondi-Zoccai G, Angiolillo DJ,
Charlson M, Crea F, Taggart DP. 2021. Methodologic considerations on four cardiovascularinterventions trials with contradictory results. Ann Thorac Surg 2021 Feb;11(2):690-699.
289. Ramponi F, Seco M, Brereton RJL, Gaudino MFL, Puskas JD, Calafiore AM, Vallely MP. 2021.
Toward stroke-free coronary surgery: The role of anaortic off-pump bypass technique. J Card Surg
2021 Apr;36(4):1499-1510. Doi: 10.1111/jocs.15372.
290. Rosati CM, Torregrossa G, Balkhy HH, Puskas JD. 2021. Dedicated training in advanced coronary
surgery: need and opportunity. J Thorac Cardiovasc Surg 161(6):2130-2134.
291. Shah A, Xu J, Friedman S, Puskas JD, Bhatt HV, Yimen M. 2021. Comparative analysis of
intravenous pumps relocation for critically ill isolated COVID-19 patients from bedside to outside
the patient room. J Intensive Care Med 36(6):719-725.

John D. Puskas, MD, MSc, FACS, FACC

Page 56 of 60

292. Rosenfeld ES, Trachiotis GD, Sparks AD, Napolitano MA, Lee KB, Wendt D, Kieser TM, Puskas
JD, DiGiammarco G, Taggart DP. 2021. Intraoperative surgical strategy changes in patients withchronic and end-stage renal disease undergoing coronary artery bypass grafting. Eur J
Cardiothoracic Surg 59(6):1210-1217. Doi:10.1093/ejcts/ezab104.
293. Bakaeen FG, Gaudino M, Whitman G, Doenst T, uel M, Taggart DP, Stulak JM, Benedetto U,
Anyanwu A, Chikwe J, Bozkurt B, Puskas JD, Silvestry SC, Velazquez E, Slaughter MS,
McCarthy PM, Soltesz EG, Moon MR. 2021. The american association for thoracic surgery expert
consensus document: coronary artery bypass grafting in pateints with ischemic cardiomyopathy andheart failure. J Thorac Cardiovasc Surg 162(3):829-850.
294. Gaudino M, Sandner S, Di Giammarco G, Di Franco A, Arai H, Asai T, Bakaeen F, Doenst T,
Fremes SE, Glineur D, Kieser TM, Lawton JS, Lorusso R, Patel N, Puskas JD, Tatoulis J, Taggart
DP, Vallely M, Ruel M. 2021. The use of intraoperative transit time flow measurement for coronary
artery bypass surgery: systematic review of the evidence and expert opinion statements. Circulation
2021;144:1160-1171.
295. Johnston DR, Griffith BP, Puskas JD, Bavaria JE, Svensson LG for the COMMENCE Trial
Investigators. 2021. Intermediate-term outcomes of aortic valve replacement using a bioprosthesis
with a novel tissue. J Thorac Cardiovasc Surg. 2021 Nov;162(5):1478-1485.
296. Leviner DB, Similon MvM, Rosati CM, Amabile A, Thuijs DJFM, Di Giammarco G, Wendt D,
Trachiotis GD, Kieser TM, Kappetein AP, Head SJ, Taggart DP and Puskas JD.2021. Transit timeflow measurement of coronary bypass grafts before and after protamine administration. J
Cadiothoracic Surgery16:195-204. Doi.org/10.1186/s13019-021-01575-y.
297. Amabile A, Williams EE, Rosati CM, Torregrossa G, Puskas JD. 2021. Off-pump coronary artery
bypass grafting: How I teach it. Ann Thorac Surg 112(6):1741-1745.
298. Yammine M, Puskas J, El Moheb M, Lattouf O. 2021. The surgical technique of the convergent
procedure. J Cardiovasc Electrophysiology 32(12):3221-3227.
299. Rosati CM, Sharma SK, Robbins MJ, Patil A, Vu MQ, Yammine M, Puskas JD. 2021. Stentectomy
for LAD “full metal jacket” with in-stent restenosis: How to do it. J Card Surg 36(12):4533-4536.
Doi: 10.1111/jocs.16017.
300. Vallely MP, Seco M, Ramponi F, Puskas JD. 2021. Total-arterial, anaortic, off-pump coronary
artery surgery: why, when and how. JTCVS Techniques 10:140-148.
Doi:10.1016/j.xjtc.2021.09.050.
301. Gaudino M, Sanna T, Ballman KV, Robinson NB, Hameed I, Audisio K, Rahouma M, Di Franco A,
Soletti GJ, Lau C, Rong LQ, Massetti M, Gillinov M, Ad N, Voisine P, DiMaio MJ, Chikwe J,
Fremes SE, Crea F, Puskas JD, Girardi L for the PALACS Investigators. 2021. Posterior left
pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, singlecentre, single-blind, randomised, controlled trial. The Lancet 398:pp2075-2083.
Doi.org/10.1016/S0140-6736(21)02390-9.
302. Rosenfeld ES, Trachiotis GD, Mapolitano MA, Sparks AD, Wendt D, Kieser TM, Puskas JD, Di
Giammarco G, Taggart DP. 2021. Intraoperative transit-time flow measurement and high-frequency
untrasound in coronary artery bypass grafting: impact in off- versus on-pump, arterial versus venous
grafting and cardiac territory grafted. Eur J Cardiothorac Surg 61(1):204-213. Doi:
10.1093/ejcts/ezab239.

John D. Puskas, MD, MSc, FACS, FACC

Page 57 of 60

303. Shah A, Patel A, Bhatt H, Apigo A, Huang K, Friedman S, Yimen M, Puskas J. 2021. Perioperative
pregabalin implementation in an enhanced recovery after cardiac surgery protocol. Critical Care
Medicine 50(1): p193.
304. Bavaria JE, Griffith B, Heimansohn DA, Rozanski J, Johnston DR, Bartus K, Girardi LN, Beaver T,
Takayama H, Mumtaz, MA, Rosengart TK, Starnes V, Timek TA, Boateng P, Ryan W, Cornwell
LD, Blackstone EH, Borger MA, Pibarot P, Thourani VH, Svensson LG, Puskas JD for the
COMMENCE Trial Investigators. 2022. Five-year outcomes of the COMMENCE trial investigating
aortic valve replacement with RESILIA tissue. Ann Thorac Surg 2022 Jan 20;S00034975(22)00063-7. Doi: 10.1016/j.athoracsur.2021.12.058.
305. Ghandour H, Weiss AJ, Gaudino M, Halkos M, Chu D, Taylor BS, Puskas J, Bhatt DL, Zenati M,
Stulak J, Rosengart T, Balkhy HH, Blackstone EH, Svensson LG, Bakaeen FG and the CABG
Public Reporting Working Group. 2022. Public reporting for coronary artery bypass graft surgery:the quest for the optimal scorecard. J Thorac Cardiovasc Surg 2022 ar 16;S0022-5223(22)00322-1.
Doi: 10.1016/j.jtcvs.2022.01.051.
306. Sandner SE, Donovan TJ, Edelstein S, Puskas JD, Angleitner P, Krasopoulos G, Channon K,
Gehrig T, Rajakaruna C, Ladyshenskij L, De Silva R, Bonaros N, Bolotin G, Jacobs S, Thielmann
M, Choi Y-H, Ohri S, Lipey A, Friedrich I, Taggart DP. 2022. Effects of the harvesting techniqueand external stenting on progression of vein graft disease 2 years after coronary artery bypass. Eur J
Cardiothorac Surg 2022 Jun 15;62(1):ezac045. Doi: 10.1093/ejcts/ezac045.
307. Bagiella E, Puskas JD, Moskowitz AJ, Gelijns AC, Alexander JH, Narula J, Smith PK, Hutcheson
K, Chang HL, GammieJS, Iribarne A, Marks ME, Vengrenyuk Y, Yasumaura K, Rabymond S,
Taylor BS, Yarden O, Orion E, Dgenais F, Ailawadi G, Chu MWA, Gupta L, Levitan RG, Williams
JB Jr, Crestanello JA, Jessup M, Rose EA, Scavo V, Acker MA, Gillinov M, O’Gara PT, Voisine P,
Mack MJ, Goldstein DJ. 2022. Rationale and design of a randomized trial evaluating an external
support device for saphenous vein coronary grafts. Am Heart J 2022 Apr;246:12-20.doi:
10.1016/j.ahj.2021.12.009.
308. Bellaire CP, Tharakan SM, Roy J, Puskas JD, Di Luozzo G. 2022. Natural history of bicuspid
aortic valves and ascending aortic aneurysms: Aortic center experience. J Card Surg 2022
Aug;37(8):2326-2335.
309. Leviner DB, Rosati CM, Similon MvM, Amabile A, Thuijs DJFM, Di Giammarco G, Wendt D,
Trachiotis GD, Kieser TM, Kappetein AP, Head SJ, Taggart DP, Puskas JD. 2022. Graft flow
evaluation with intraoperative transit-time flow measurement in off-pump versus on-pump coronary
artery bypass grafting. JTCVS Techniques vol 15, pp95-106.doi.org/10.1016/j.xjtc.2022.05.002.
310. Van den Eyne J, Bomhals K, Noe D, Jacquemyn X, McCutcheon K, Bennett J, Puskas JD,
Oosterlinck W.2022.Revascularization strategies in patients with multivessel coronary arterydisease: a Bayesian network meta-analysis. Interact Cardiovasc Thorac Surg 2022 Jun1;34(6):947957.
311. Goldstein DJ, Puskas JD, Alexander JH, Chang HL, Gammie JS, Marks ME, Iriarne A, Vengrenuk
Y, Raymond S, Talyor BS, Yarden O, Orion E, Dagenais F, Ailawadi G, Chu MWA, DiMaio JM,
Narula J, Moquete EG, O’Sullivan K, Williams JB Jr, Crestanello JA, Jessup M, Rose EA, Scavo
V, Acker MA, Gillinov M, Mack MJ, Gelijns AC< O’Gara PT, Moskowitz AJ, Bagiella E, Voisine
P. 2022. External support for saphenous vein grafts in coronary artery bypass surgery: A
randomized clinical trial. JAMA Cardiology 2022 Aug 1;7(8):808-816.

John D. Puskas, MD, MSc, FACS, FACC

Page 58 of 60

312. Gomes WJ, Dayan V, Myers PO, Almeida R, Puskas JD, Taggart DP, Arai H, Ono M, Okita Y,
Yadava OP, Kim K-B, Zheng Z, Rodrigue-Roda J, Parolari A, Uva MS, Sadaba JR. 2022. The 2021
ACC/AHA/SCAI guideline for coronary artery revascularization. A worldwide call for consistency
and logic. J Thorac Cardiovasc SurgS0022-5223(22)01020-0. Doi.org/10.1016/j.jtcvs.2022.09.032.

TEXTBOOK CREATOR/EDITOR:
Co-Editor with Professor David Taggart, “State of the Art in Surgical Coronary Revascularization”, published by
Oxford University Press, 71 chapters totaling 521 pages. Published 2021. The first major textbook devoted entirely
to the art and science of coronary bypass surgery. Authored/co-authored numerous chapters.

BOOK CHAPTERS:
1. Winston AD and Puskas JD. "Techniques for Multivessel OPCAB". Minimally Invasive Cardiac Surgery.
2ndEdition, edited by Oz MC and Goldstein DJ, Humana Press, 2003.
2. Thourani VH and Puskas JD. "Perioperative Evaluation of Graft Patency in OPCAB". Minimally Invasive
Cardiac Surgery. 2nd Edition, edited by Oz MC and Goldstein DJ, Humana Press, 2003.
3. Thourani VH and Puskas JD. "Myocardial Protection in Beating Heart Coronary Artery Surgery", in Recent
Advances in Myocardial Protection, edited by Salerno TA; Futura Publishing Co., 2004.
4. Sharoni E and Puskas JD. "Techniques in Multivessel OPCAB". Operative Cardiac Surgery, edited by
Gardner T J and Spray TL, Arnold Publishers, 2004.
5. Thourani VH and Puskas JD. "Coronary Artery Bypass Procedures·. Medical Management of the SurgicalPatient. Fourth Edition, edited by Lubin MF, Walker HK, Smith RB III, 2006.
6. Song HK and Puskas JD. "Off-pump Coronary Artery Bypass Surgery". Mastery of Cardiothoracic Surgery,2nd Edition, Lippincott Williams and Wilkins, New York, 2007.
7. Jain Bhaskara Pillai, John D. Puskas. "Off Pump Coronary Artery Surgery: A Safe Approach".
Complications in Cardiothoracic Surgery. Avoidance and Treatment, 2nd Edition, Chapter 17; Nov. 2009.
8. Richard J. Myung and John D. Puskas. "Off-Pump Coronary Artery Bypass Grafting for Repeat Coronary
Revascularization", Redo Cardiac Surgery in Adults, 2nd Edition, Edited by Venkat R. Machiraju, Hartzell
V. Schaff and Lars G. Svensson. Springer. 2011.
9. Michael E. Halkos, John D. Puskas. "Myocardial Revascularization after Acute Myocardial Infarction".
Cardiac Surgery, 4th Edition, Edited by Lawrence H. Cohn. 2011.
10. Michael E. Halkos, John D. Puskas. "Minimally Invasive Coronary Artery Bypass Graft to Cardiac Surgery:
Recent Advances and Techniques, 2012.
11. Azeem R. Khan, Michael E. Halkos and John D. Puskas. "Off-pump Coronary Artery Bypass".
Cardiothoracic Surgery Review, Edited by Kenneth Franco and Vinod Thourani. Wolters
K1uwer/Lippincott Williams & Wilkins. 2012.

John D. Puskas, MD, MSc, FACS, FACC

Page 59 of 60

12. Yanagawa B and Puskas JD. “Off-Pump Coronary Artery Bypass Grafting”, in Mastery of Techniques in
Cardiac Surgery, 2016.
13. Yanagawa B, Halkos ME, Puskas JD. “Off-Pump Coronary Artery Bypass Grafting”, in Cardiac Surgery
in the Adult 5th Edition, Editor Lawrence Cohen, McGraw Hill, 2016.
14. Mittnacht AJC, London MJ, Puskas JD and Kaplan JA. “Anesthesia for Myocardial Revascularization”, in
Kaplan’s Cardiac Anesthesia 7th Edition, Editors Joel Kaplan, David Reich and Joseph Savino, Elsevier
Press, 2016.
15. Michael E. Halkos, Emmanuel Moss, and John D. Puskas. “Chapter 2 Off-pump versus on-pump coronary
artery bypass grafting”, in Core Concepts in Cardiac Surgery, Edited by David Taggart and Yasir AbuOmar, Oxford University Press, 2018.
16. Bobby Yanagawa, Michael E. Halkos, John D. Puskas. “Chapter 21: Myocardial Revascularization Without
Cardiopulmonary Bypass”, in Cardiac Surgery in the Adult, 5e, Edited by Lawrence H. Cohn, David H.
Adams, Cenveo® Publisher Services, 2018.
17. Williams EE, Torregrossa G, Puskas JD. “Hybrid Coronary Revascularization”, in Cardiac Surgery (pp193198) DOI: 10.1007/978-3-030-24174-2, 2020.
18. Puskas JD and Taggart DP. “Closing the gap between best evidence and common practice in surgicalcoronary revascularization: The rationale for superspecialization”, in Technical Aspects of Modern
Coronary Artery Bypass Surgery (Chapter 1, pp 1-7), Edited by Mario Gaudino. Doi.org/10.1016/B978-012-820348-4.00001-7 2021.
Manuals, videos, computer programs, and other teaching aids:• Teaching Video on multivessel off-pump CABG for the Society of Thoracic Surgeons, 2000.
• Live Tele-surgery Demonstration for OPCAB Training Courses at Emory University Hospital 1999, 2000.
• Course Director, OPCAB/PADCAB course, 2000. Emory University Hospital, Cardiothoracic ResearchLaboratory• Articles in Emory Momentum on OPCAB, 1999 & 2000 issues.
• Live Tele-surgery of multivessel OPCAB at Emory University Hospital transmitted to the Cardiothoracic
Techniques and Technologies meeting, New Orleans, LA, 2001.
• Creation of teaching video for prospective cardiac surgical patients at Emory University, 2001.
• Creation of OPCAB instructional videos for cardiac surgeons, distributed by Medtronic, 2001-2002.
• Creation of teaching video: "A Challenging Case of Off-Pump CABG in Dextrocardia" presented at Fifth
Annual New Era Cardiac Care, Dana Point, California. 2002.
• New York Times, Sunday Edition, featured with photo in article on OPCAB, 2003.
• International Herald Tribune, featured with photo in article on OPCAB, 2003.
• Southern Thoracic Surgical Association 50thAnnual Meeting, surgical video presentation: "Off-pump AllArterial Coronary Bypass: Surgical Revascularization for the New Millennium". Naples, FL, 2003.
• Print, radio and TV coverage of the JAMA 2004;291:1841-9 paper in over 250 major new outlets
nationwide and numerous international news agencies as well, 2004,• Newsweek Magazine Feature Article. 2005 pages 56-57 "And The Beat Goes On".
• Local/National Television Media "spots" for OPCAB:§ Local human interest TV news spots on Channel 2 and Channel 11 in 1998 and 1999.
§ Discovery Channel story on innovative techniques in cardiac surgery, taped Mar, 2000,

John D. Puskas, MD, MSc, FACS, FACC

Page 60 of 60

•

•

•

•

aired Dec. 2000.
§ CNN story on OPCAB taped, spring of 2000, aired fall of 2000.
American Association for Thoracic Surgery, Education Committee, 2006. Created a 40-minute, interactive
e-learning module for OPCAB, sponsored by AATS, in collaboration with the Cleveland Clinic andAccelera Inc. Multiple intraoperative video clips shot at Emory Crawford Long Hospital. Instructional
script. Quizzes and CME material developed at Emory, funded by AATS. This was the first comprehensive
e-learning module developed by AATS for education of practicing surgeons and CT residents. Accessible
online at aats.org.
Numerous media video pieces related to leading the conversion of the Department of Cardiovascular
Surgery at Mount Sinai Morningside Hospital into an advanced COVID-19 care facility:o https://www.wsj.com/articles/national-study-finds-convalescent-plasma-to-treat-covid-19-is-safe11589453869
o https://www.cnn.com/2020/09/24/health/heart-attack-covid-19-recoverywellness/index.html
Numerous media video pieces related to exceptional clinical outcomes in advanced coronary surgery at
Mount Sinai Morningside Hospital:o https://abc7ny.com/health/man-gets-2nd-chance-at-life-after-heart-attack-while-running/5347315/
o https://www.nydailynews.com/coronavirus/ny-coronavirus-heart-surgery-20200522a4uitprlvfeu7hgeovtwgzy6tu-story.html
o https://www.aspenideas.org/articles/challenging-convention-in-the-operating-roomo https://www.youtube.com/embed/jS-SWXclpHQ?autoplay=1
o https://www.mountsinai.org/about/patient-stories/patient-gets-second-chance-after-heart-attackwhile-running
Wikipedia.org page:o https://en.m.wikipedia.org/wiki/John_Puskas